[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR102629442B1 - Epoxy-based reactive diluent and epoxy resin composition containing the same - Google Patents

Epoxy-based reactive diluent and epoxy resin composition containing the same Download PDF

Info

Publication number
KR102629442B1
KR102629442B1 KR1020187011472A KR20187011472A KR102629442B1 KR 102629442 B1 KR102629442 B1 KR 102629442B1 KR 1020187011472 A KR1020187011472 A KR 1020187011472A KR 20187011472 A KR20187011472 A KR 20187011472A KR 102629442 B1 KR102629442 B1 KR 102629442B1
Authority
KR
South Korea
Prior art keywords
group
epoxy resin
epoxy
formula
resin composition
Prior art date
Application number
KR1020187011472A
Other languages
Korean (ko)
Other versions
KR20180080200A (en
Inventor
유키 우에다
유키 엔도
타케시 스와
Original Assignee
닛산 가가쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 닛산 가가쿠 가부시키가이샤 filed Critical 닛산 가가쿠 가부시키가이샤
Publication of KR20180080200A publication Critical patent/KR20180080200A/en
Application granted granted Critical
Publication of KR102629442B1 publication Critical patent/KR102629442B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/20Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the epoxy compounds used
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/68Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
    • C08G59/686Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/68Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used
    • C08G59/687Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the catalysts used containing sulfur
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/15Heterocyclic compounds having oxygen in the ring
    • C08K5/151Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1515Three-membered rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L63/00Compositions of epoxy resins; Compositions of derivatives of epoxy resins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Epoxy Resins (AREA)
  • Epoxy Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

[과제] 경화물의 내열성이나 경화성 등의 물성을 가능한 한 저감시키지 않고, 더 나아가, 유전율을 낮추는 효과를 부여할 수 있는, 저휘발성의 에폭시 수지용 반응성 희석제를 포함하는 에폭시 수지 조성물을 제공하는 것이다.
[해결수단] 식[1]로 표시되는 적어도 1종의 에폭시 화합물, 및 에폭시 수지를 포함하는 에폭시 수지 조성물, 그리고 이 수지 조성물과 경화제 또는 산발생제를 포함하는 경화성 조성물.

Figure 112018040298624-pct00021

(식 중, R1 및 R2는 탄소원자수 2 내지 27의 알킬기, R3은 수소원자 또는 탄소원자수 1 내지 25의 알킬기를 나타내고, 단 -CR1R2R3기의 탄소원자수의 합계는 10 내지 30이며, X는, *-C(=O)O-, *-CH2O- 또는 *-CH2OC(=O)-를 나타내고, L은 단결합, 또는 에테르결합을 포함할 수도 있는 탄소원자수 1 내지 8의 알킬렌기를 나타내고, E는 식[2] 또는 식[3]으로 표시되는 기를 나타낸다.)
Figure 112018040298624-pct00022

(식 중, R4 내지 R15는 수소원자 또는 탄소원자수 1 내지 10의 알킬기를 나타낸다.)[Problem] To provide an epoxy resin composition containing a low volatility reactive diluent for epoxy resin that does not reduce the physical properties such as heat resistance and curability of the cured product as much as possible and can further provide the effect of lowering the dielectric constant.
[Solution] An epoxy resin composition containing at least one epoxy compound represented by formula [1] and an epoxy resin, and a curable composition containing this resin composition and a curing agent or acid generator.
Figure 112018040298624-pct00021

(In the formula, R 1 and R 2 are an alkyl group having 2 to 27 carbon atoms, and R 3 is a hydrogen atom or an alkyl group having 1 to 25 carbon atoms, provided that the total number of carbon atoms of the -CR 1 R 2 R 3 group is 10. to 30, X represents *-C(=O)O-, *-CH 2 O- or *-CH 2 OC(=O)-, and L may include a single bond or an ether bond Represents an alkylene group having 1 to 8 carbon atoms, and E represents a group represented by formula [2] or formula [3].)
Figure 112018040298624-pct00022

(In the formula, R 4 to R 15 represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms.)

Description

에폭시계 반응성 희석제 및 이것을 포함하는 에폭시 수지 조성물Epoxy-based reactive diluent and epoxy resin composition containing the same

본 발명은 에폭시계 반응성 희석제 및 이것을 포함하는 에폭시 수지 조성물에 관한 것이다.The present invention relates to an epoxy-based reactive diluent and an epoxy resin composition containing the same.

종래, 에폭시 수지는, 경화제 또는 산발생제와 조합한 에폭시 수지 조성물로서, 도료, 접착제, 봉지제, 성형재료, 주형재료 등, 토목·건축용, 전기·전자부품용, 수송기용 재료로서 각종 분야에서 널리 이용되고 있다. 그리고 이들 적용분야나 적용개소에 따라 다양한 종류의 에폭시 수지가 채용되고 있다.Conventionally, epoxy resins are epoxy resin compositions combined with a curing agent or acid generator, and are used in various fields as paints, adhesives, encapsulants, molding materials, molding materials, etc., for civil engineering and construction, for electrical and electronic parts, and as materials for transportation. It is widely used. And various types of epoxy resins are used depending on the application field or application location.

캐스팅성형 등의 액상 성형에 있어서는, 비스페놀A형 에폭시 수지로 대표되는 액상의 에폭시 수지가 채용되고 있다. 그러나 이러한 액상 에폭시 수지의 대부분은 점도가 높은 것이며, 작업성이 양호하다고는 하기 어려운 점에서, 점도의 조제를 목적으로 하여 에폭시 수지용 반응성 희석제가 널리 채용되고 있다.In liquid molding such as casting molding, liquid epoxy resins such as bisphenol A type epoxy resin are used. However, most of these liquid epoxy resins have high viscosity, and it is difficult to say that they have good workability, so reactive diluents for epoxy resins are widely used for the purpose of adjusting viscosity.

이러한 반응성 희석제의 대표예로서, 부틸글리시딜에테르나 2-에틸헥실글리시딜에테르 등의 알킬글리시딜에테르류를 들 수 있고, 예를 들어 전자부품용 등, 그 용도로의 대응을 도모한 제법 등도 제안되어 있다(예를 들어 특허문헌 1).Representative examples of such reactive diluents include alkyl glycidyl ethers such as butyl glycidyl ether and 2-ethylhexyl glycidyl ether, and are intended for use in electronic components, etc. A manufacturing method has also been proposed (for example, patent document 1).

한편, 전기·전자부품재료의 기술분야에서는, 최근, 각종 전자기기에 있어서의 신호의 고속화, 고주파수화가 진행되고 있고, 이에 수반하여, 저유전율을 실현하는 재료가 요구되고 있다.Meanwhile, in the technical field of electrical and electronic component materials, the speed and frequency of signals in various electronic devices are increasing in recent years, and along with this, there is a demand for materials that realize low dielectric constants.

저유전율재료의 일례로서, 다분지의 고급알킬기를 갖는 알킬(메트)아크릴레이트를 함유하는 (메트)아크릴계 폴리머가 제안되어 있다(특허문헌 2). 그러나, 일반적으로 아크릴 수지는 에폭시 수지에 비해, 내열성이나 밀착성이 뒤떨어진다고 여겨진다.As an example of a low dielectric constant material, a (meth)acrylic polymer containing an alkyl (meth)acrylate having a multi-branched higher alkyl group has been proposed (Patent Document 2). However, acrylic resin is generally considered to be inferior to epoxy resin in heat resistance and adhesion.

일본특허공개 2002-293755호 공개Japanese Patent Publication No. 2002-293755 published 일본특허공개 2012-246477호 공개Japanese Patent Publication No. 2012-246477 published

상기 서술한 알킬글리시딜에테르류로 이루어진 반응성 희석제는 비점이 낮으므로 휘발성이 높고, 에폭시 수지의 경화시나 수지의 용융성형시의 가열조건에 따라서는, 희석제 자체가 휘발된다는 문제나, 이들 반응성 희석제를 에폭시 수지에 첨가한 경우, 경화물의 내열성이나 경화성이 크게 저하되는 등의 문제가 있었다.The reactive diluents made of the alkyl glycidyl ethers described above have a low boiling point and are therefore highly volatile. Depending on the heating conditions during curing of the epoxy resin or melt molding of the resin, there is a problem that the diluent itself volatilizes. When added to the epoxy resin, there were problems such as a significant decrease in heat resistance and curability of the cured product.

한편, 각종 전자기기의 고성능화에 수반하여, 그 구성재료에는 내열성 등의 종래로부터의 요구성에 더하여, 보다 낮은 유전율이 실현가능한 점도 요구되고 있다. 일반적으로 에폭시 수지는 한 분자당 에폭시기의 증가에 의해 내열성이나 강도는 향상되지만, 반면, 극성이 높은 에폭시기의 증가는 유전율의 증가를 초래하는 경향이 있다.Meanwhile, as the performance of various electronic devices increases, their constituent materials are required to have lower dielectric constants in addition to conventional requirements such as heat resistance. In general, the heat resistance and strength of epoxy resins improve as the number of epoxy groups per molecule increases, but on the other hand, an increase in the number of highly polar epoxy groups tends to result in an increase in dielectric constant.

본 발명은, 그 경화물의 내열성이나 경화성 등의 물성을 가능한 한 저감시키지 않고, 더 나아가, 유전율을 낮추는 효과를 부여할 수 있는, 저휘발성의 에폭시 수지용 반응성 희석제를 포함하는 에폭시 수지 조성물을 제공하는 것을 목적으로 한다.The present invention provides an epoxy resin composition containing a low-volatility reactive diluent for epoxy resin, which can provide the effect of lowering the dielectric constant without reducing the physical properties such as heat resistance and curability of the cured product as much as possible. The purpose is to

본 발명자들은, 상기 목적을 달성하기 위하여 예의검토한 결과, 분지한 알킬부위를 갖는 단관능 에폭시에스테르 또는 에테르 화합물이, 지금까지의 액상 에폭시 화합물 중에서는 매우 저점도인 액상 화합물이며, 또한 종래의 에폭시 수지와의 상용성도 우수한 것을 발견하고, 그 결과로부터, 에폭시 화합물의 반응성 희석제로서 유용한 것, 또한 종래 시판의 반응성 희석제(알킬글리시딜에테르류)에 비해 저휘발성인 것을 발견하였다. 그리고 상기 분지한 알킬부위를 갖는 단관능 에폭시 화합물과 에폭시 수지를 배합한 에폭시 수지 조성물은, 이것에 경화제나 경화촉매를 배합하여 경화성 조성물을 이루고, 이것을 경화시켜 얻어진 경화물에 있어서, 원래의 에폭시 수지의 경화물보다 유전율을 저감할 수 있음과 함께, 흡수율도 낮은 상태를 유지할 수 있는 것을 발견하고, 본 발명을 완성시켰다.In order to achieve the above object, the present inventors have carefully studied and found that the monofunctional epoxy ester or ether compound having a branched alkyl moiety is a liquid compound with a very low viscosity among the liquid epoxy compounds so far, and is also a liquid compound with a very low viscosity compared to conventional epoxy compounds. It was discovered that it had excellent compatibility with resin, and from the results, it was discovered that it was useful as a reactive diluent for epoxy compounds and that it had lower volatility than conventional commercially available reactive diluents (alkyl glycidyl ethers). In addition, the epoxy resin composition obtained by mixing the monofunctional epoxy compound having the branched alkyl moiety and the epoxy resin is mixed with a curing agent or a curing catalyst to form a curable composition, and in the cured product obtained by curing this, the original epoxy resin It was discovered that the dielectric constant could be reduced compared to the cured product and the water absorption could also be maintained at a low state, and the present invention was completed.

즉 본 발명은, 제1 관점으로서, 식[1]로 표시되는 적어도 1종의 에폭시 화합물, 및 에폭시 수지를 포함하는 에폭시 수지 조성물에 관한 것이다.That is, the present invention, as a first aspect, relates to an epoxy resin composition containing at least one type of epoxy compound represented by formula [1] and an epoxy resin.

[화학식 1][Formula 1]

Figure 112018040298624-pct00001
Figure 112018040298624-pct00001

(식 중, R1 및 R2는 각각 독립적으로, 탄소원자수 2 내지 27의 알킬기를 나타내고, R3은 수소원자 또는 탄소원자수 1 내지 25의 알킬기를 나타내고, 단 -CR1R2R3기의 탄소원자수의 합계는 10 내지 30이며, X는, *-C(=O)O-, *-CH2O- 또는 *-CH2OC(=O)-를 나타내고(여기서 *는 -CR1R2R3기에 결합하는 단을 나타낸다.), L은 단결합, 또는 에테르결합을 포함할 수도 있는 탄소원자수 1 내지 8의 알킬렌기를 나타내고, E는 식[2] 또는 식[3]으로 표시되는 기를 나타낸다.)(In the formula, R 1 and R 2 each independently represent an alkyl group having 2 to 27 carbon atoms, and R 3 represents a hydrogen atom or an alkyl group having 1 to 25 carbon atoms, provided that -CR 1 R 2 R 3 group The total number of carbon atoms is 10 to 30, and X represents *-C(=O)O-, *-CH 2 O-, or *-CH 2 OC(=O)- (where * is -CR 1 R 2 represents a stage bonded to the R 3 group.), L represents a single bond or an alkylene group with 1 to 8 carbon atoms that may include an ether bond, and E is represented by formula [2] or formula [3] It represents energy.)

[화학식 2][Formula 2]

Figure 112018040298624-pct00002
Figure 112018040298624-pct00002

(식 중, R4 내지 R15는 각각 독립적으로, 수소원자 또는 탄소원자수 1 내지 10의 알킬기를 나타낸다.)(In the formula, R 4 to R 15 each independently represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms.)

제2 관점으로서, 상기 -CR1R2R3기가 탄소원자수 14 내지 26의 기인, 제1 관점에 기재된 에폭시 수지 조성물에 관한 것이다.As a second aspect, it relates to the epoxy resin composition described in the first aspect, wherein the -CR 1 R 2 R 3 group is a group having 14 to 26 carbon atoms.

제3 관점으로서, 상기 -CR1R2R3기가 탄소원자수 14 내지 20의 기인, 제2 관점에 기재된 에폭시 수지 조성물에 관한 것이다.As a third aspect, it relates to the epoxy resin composition described in the second aspect, wherein the -CR 1 R 2 R 3 group is a group having 14 to 20 carbon atoms.

제4 관점으로서, 상기 X가 *-C(=O)O-인, 제1 관점 내지 제3 관점 중 어느 하나에 기재된 에폭시 수지 조성물에 관한 것이다.As a fourth aspect, it relates to the epoxy resin composition according to any one of the first to third aspects, wherein X is *-C(=O)O-.

제5 관점으로서, 상기 X가 *-CH2O-인, 제1 관점 내지 제3 관점 중 어느 하나에 기재된 에폭시 수지 조성물에 관한 것이다.As a fifth aspect, it relates to the epoxy resin composition according to any one of the first to third aspects, wherein X is *-CH 2 O-.

제6 관점으로서, 상기 E가 식[2]로 표시되는 기인, 제1 관점 내지 제5 관점 중 어느 하나에 기재된 에폭시 수지 조성물에 관한 것이다.As a sixth aspect, it relates to the epoxy resin composition according to any one of the first to fifth aspects, wherein E is a group represented by formula [2].

제7 관점으로서, 상기 L이, 단결합 또는 메틸렌기인, 제1 관점 내지 제6 관점 중 어느 하나에 기재된 에폭시 수지 조성물에 관한 것이다.As a seventh aspect, it relates to the epoxy resin composition according to any one of the first to sixth aspects, wherein L is a single bond or a methylene group.

제8 관점으로서, (a)제1 관점 내지 제7 관점 중 어느 하나에 기재된 에폭시 수지 조성물, 및 (b)경화제를 포함하는, 경화성 조성물에 관한 것이다.As an eighth viewpoint, it relates to a curable composition containing (a) the epoxy resin composition according to any one of the first to seventh viewpoints, and (b) a curing agent.

제9 관점으로서, 상기 (b)경화제가, 산무수물, 아민, 페놀 수지, 폴리아미드 수지, 이미다졸류, 및 폴리메르캅탄으로 이루어진 군으로부터 선택되는 적어도 1종인, 제8 관점에 기재된 경화성 조성물에 관한 것이다.As a ninth aspect, the curing agent (b) is at least one selected from the group consisting of acid anhydrides, amines, phenol resins, polyamide resins, imidazoles, and polymercaptans. It's about.

제10 관점으로서, 상기 (a)에폭시 수지 조성물의 에폭시기 1당량에 대하여, 0.5~1.5당량의 상기 (b)경화제를 포함하는, 제8 관점 또는 제9 관점에 기재된 경화성 조성물에 관한 것이다.As a tenth aspect, it relates to the curable composition according to the eighth or ninth aspect, which contains 0.5 to 1.5 equivalents of the curing agent (b) relative to 1 equivalent of the epoxy group of the epoxy resin composition (a).

제11 관점으로서, (a)제1 관점 내지 제7 관점 중 어느 하나에 기재된 에폭시 수지 조성물, 및 (c1)산발생제 및/또는 (c2)염기발생제로 이루어진 (c)경화촉매를 포함하는, 경화성 조성물에 관한 것이다.As an eleventh aspect, comprising (a) an epoxy resin composition according to any one of the first to seventh aspects, and (c) a curing catalyst consisting of (c1) an acid generator and/or (c2) a base generator, It relates to a curable composition.

제12 관점으로서, 상기 (c)경화촉매가 (c1)산발생제인, 제11 관점에 기재된 경화성 조성물에 관한 것이다.As a twelfth aspect, it relates to the curable composition according to the eleventh aspect, wherein the curing catalyst (c) is an acid generator (c1).

제13 관점으로서, 상기 (c1)산발생제가, 광산발생제, 및 열산발생제로 이루어진 군으로부터 선택되는 적어도 1종인, 제12 관점에 기재된 경화성 조성물에 관한 것이다.As a thirteenth aspect, it relates to the curable composition according to the twelfth aspect, wherein the (c1) acid generator is at least one selected from the group consisting of a photoacid generator and a thermal acid generator.

제14 관점으로서, 상기 (c1)산발생제가 오늄염인, 제13 관점에 기재된 경화성 조성물에 관한 것이다.As a fourteenth aspect, it relates to the curable composition according to the thirteenth aspect, wherein the acid generator (c1) is an onium salt.

제15 관점으로서, 상기 (c1)산발생제가, 설포늄염, 또는 요오드늄염인, 제14 관점에 기재된 경화성 조성물에 관한 것이다.As a 15th aspect, it relates to the curable composition according to the 14th aspect, wherein the acid generator (c1) is a sulfonium salt or an iodonium salt.

제16 관점으로서, 상기 (a)에폭시 수지 조성물 100질량부에 대하여, 상기 (c1)산발생제 0.1~20질량부를 포함하는, 제12 관점 내지 제15 관점 중 어느 하나에 기재된 경화성 조성물에 관한 것이다.As a 16th aspect, it relates to the curable composition according to any one of the 12th to 15th aspects, comprising 0.1 to 20 parts by mass of the acid generator (c1) relative to 100 parts by mass of the epoxy resin composition (a). .

제17 관점으로서, 식[1]로 표시되는 적어도 1종의 에폭시 화합물의, 에폭시 수지 조성물에 있어서의 반응성 희석제로서의 사용에 관한 것이다.As a seventeenth aspect, it relates to the use of at least one type of epoxy compound represented by formula [1] as a reactive diluent in an epoxy resin composition.

[화학식 3][Formula 3]

Figure 112018040298624-pct00003
Figure 112018040298624-pct00003

(식 중, R1 및 R2는 각각 독립적으로, 탄소원자수 2 내지 27의 알킬기를 나타내고, R3은 수소원자 또는 탄소원자수 1 내지 25의 알킬기를 나타내고, 단 -CR1R2R3기의 탄소원자수의 합계는 10 내지 30이며, X는, *-C(=O)O-, *-CH2O- 또는 *-CH2OC(=O)-를 나타내고(여기서 *는 -CR1R2R3기에 결합하는 단을 나타낸다.), L은 단결합, 또는 에테르결합을 포함할 수도 있는 탄소원자수 1 내지 8의 알킬렌기를 나타내고, E는 식[2] 또는 식[3]으로 표시되는 기를 나타낸다.)(In the formula, R 1 and R 2 each independently represent an alkyl group having 2 to 27 carbon atoms, and R 3 represents a hydrogen atom or an alkyl group having 1 to 25 carbon atoms, provided that -CR 1 R 2 R 3 group The total number of carbon atoms is 10 to 30, and X represents *-C(=O)O-, *-CH 2 O-, or *-CH 2 OC(=O)- (where * is -CR 1 R 2 represents a stage bonded to the R 3 group.), L represents a single bond or an alkylene group with 1 to 8 carbon atoms that may include an ether bond, and E is represented by formula [2] or formula [3] It represents energy.)

[화학식 4][Formula 4]

Figure 112018040298624-pct00004
Figure 112018040298624-pct00004

(식 중, R4 내지 R15는 각각 독립적으로, 수소원자 또는 탄소원자수 1 내지 10의 알킬기를 나타낸다.)(In the formula, R 4 to R 15 each independently represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms.)

제18 관점으로서, 식[1a]로 표시되는 에폭시 화합물에 관한 것이다.As an eighteenth aspect, it relates to an epoxy compound represented by formula [1a].

[화학식 5][Formula 5]

Figure 112018040298624-pct00005
Figure 112018040298624-pct00005

(식 중, R1 및 R2는 각각 독립적으로, 탄소원자수 2 내지 27의 알킬기를 나타내고, R3은 수소원자 또는 탄소원자수 1 내지 25의 알킬기를 나타내고, 단 -CR1R2R3기의 탄소원자수는 10 내지 30이며, R4 내지 R6은 각각 독립적으로, 수소원자 또는 탄소원자수 1 내지 10의 알킬기를 나타내고, L은 에테르결합을 포함할 수도 있는 탄소원자수 1 내지 8의 알킬렌기를 나타낸다.)(In the formula, R 1 and R 2 each independently represent an alkyl group having 2 to 27 carbon atoms, and R 3 represents a hydrogen atom or an alkyl group having 1 to 25 carbon atoms, provided that -CR 1 R 2 R 3 group The number of carbon atoms is 10 to 30, R 4 to R 6 each independently represent a hydrogen atom or an alkyl group with 1 to 10 carbon atoms, and L represents an alkylene group with 1 to 8 carbon atoms that may include an ether bond. .)

본 발명의 에폭시 수지 조성물은, 에폭시 수지와 반응성 희석제로서 분지한 알킬부위를 갖는 단관능 에폭시 화합물을 배합함으로써, 상용성 및 핸들링성이 우수한 조성물로 할 수 있을 뿐만 아니라, 종래의 에폭시계 반응성 희석제를 이용한 조성물에 비해, 높은 내열성을 갖는 경화물을 제작할 수 있다. 또한 본 발명의 에폭시 수지 조성물은, 그것에 경화제나 경화촉매를 배합하여 경화성 조성물을 이루고, 이것을 경화시켜 얻어진 경화물에 있어서, 상기 분지한 알킬부위를 갖는 단관능 에폭시 화합물(반응성 희석제)을 배합하지 않는 조성물로부터 제작한 경화물에 비해, 낮은 유전율을 가짐과 함께, 흡수율이 낮은 경화물을 제작할 수 있다.The epoxy resin composition of the present invention can be made into a composition with excellent compatibility and handleability by mixing an epoxy resin and a monofunctional epoxy compound having a branched alkyl moiety as a reactive diluent, and can also be used as a reactive diluent based on conventional epoxy resins. Compared to the composition used, a cured product with high heat resistance can be produced. In addition, the epoxy resin composition of the present invention forms a curable composition by mixing a curing agent or a curing catalyst, and the cured product obtained by curing this composition does not contain the monofunctional epoxy compound (reactive diluent) having the branched alkyl moiety. Compared to a cured product produced from the composition, a cured product having a low dielectric constant and low water absorption can be produced.

또한 상기 분지한 알킬부위를 갖는 단관능 에폭시 화합물은, 액상 에폭시 화합물 중에서도 매우 저점도인 에폭시 화합물(대략 100mPa·s 이하)이며, 또한 종래 시판의 에폭시계 반응성 희석제에 비해 저휘발성의 화합물이며, 다른 액상 에폭시 수지와의 상용성도 우수하다. 나아가 이 에폭시 화합물을 배합하여 제작한 에폭시경화성 조성물은, 저유전율의 경화물을 제작할 수 있다. 그러므로, 상기 분지한 알킬부위를 갖는 단관능 에폭시 화합물은, 에폭시 수지 조성물의 반응성 희석제로서 호적하게 사용할 수 있고, 그리고 이에 따라, 에폭시 수지 조성물에 있어서의 핸들링성 및 경화성의 향상뿐만 아니라, 이 조성물을 이용하여 제작한 경화물에 있어서, 내열성 더 나아가 저유전특성을 부여할 수 있다.In addition, the monofunctional epoxy compound having the branched alkyl moiety is an epoxy compound with a very low viscosity (approximately 100 mPa·s or less) among liquid epoxy compounds, and is also a low volatility compound compared to conventional commercially available epoxy-based reactive diluents. Compatibility with liquid epoxy resin is also excellent. Furthermore, an epoxy curable composition produced by mixing this epoxy compound can produce a cured product with a low dielectric constant. Therefore, the monofunctional epoxy compound having the branched alkyl moiety can be suitably used as a reactive diluent for an epoxy resin composition, and thereby not only improves the handling properties and curability of the epoxy resin composition, but also improves the composition. In the cured product produced using it, heat resistance and further low dielectric properties can be imparted.

본 발명의 에폭시계 반응성 희석제 및 이것을 포함하는 에폭시 수지 조성물은, 반도체봉지재료, 투명봉지제, 전자재료용 접착제, 광학용 접착제, 프린트배선기판재료, 층간절연막 재료, 섬유강화플라스틱, 광조형용 잉크, 도료용 잉크, 발수성 코팅재료, 활수성 코팅재료, 친유성 코팅재료, 자기수복성 재료, 생체친화성 재료, 복굴절제어재료, 안료분산제, 필러분산제, 고무개질제 등의 각종 재료의, 주제, 가교제, 희석제, 레벨링제, 상용화제로서 호적하게 사용할 수 있다.The epoxy-based reactive diluent of the present invention and the epoxy resin composition containing the same include semiconductor encapsulation materials, transparent encapsulants, adhesives for electronic materials, optical adhesives, printed wiring board materials, interlayer insulating film materials, fiber-reinforced plastics, inks for stereolithography, Various materials such as paint ink, water-repellent coating material, water-repellent coating material, lipophilic coating material, self-healing material, biocompatible material, birefringence control material, pigment dispersant, filler dispersant, rubber modifier, etc., base material, crosslinking agent, It can be suitably used as a diluent, leveling agent, and compatibilizer.

[(a) 에폭시 수지 조성물][(a) Epoxy resin composition]

본 발명은, 하기 식[1]로 표시되는 적어도 1종의 에폭시 화합물, 및 에폭시 수지를 포함하는 에폭시 수지 조성물에 관한 것이고, 또한 하기 식[1]로 표시되는 에폭시 화합물의 에폭시 수지 조성물에 있어서의 반응성 희석제로서의 사용도 본 발명의 대상이다.The present invention relates to an epoxy resin composition containing at least one type of epoxy compound represented by the following formula [1] and an epoxy resin, and further relates to an epoxy resin composition of the epoxy compound represented by the following formula [1]: Use as a reactive diluent is also a subject of the present invention.

<에폭시 화합물><Epoxy compound>

본 발명의 에폭시 수지 조성물에 포함되는 에폭시 화합물은, 하기 식[1]로 표시된다.The epoxy compound contained in the epoxy resin composition of the present invention is represented by the following formula [1].

[화학식 6][Formula 6]

Figure 112018040298624-pct00006
Figure 112018040298624-pct00006

상기 식 중, R1 및 R2는 각각 독립적으로, 탄소원자수 2 내지 27의 알킬기를 나타내고, R3은 수소원자 또는 탄소원자수 1 내지 25의 알킬기를 나타내고, 단 -CR1R2R3기의 탄소원자수의 합계는 10 내지 30이며, X는, *-C(=O)O-, *-CH2O- 또는 *-CH2OC(=O)-를 나타내고(여기서 *는 -CR1R2R3기에 결합하는 단을 나타낸다.), L은 단결합, 또는 에테르결합을 포함할 수도 있는 탄소원자수 1 내지 8의 알킬렌기를 나타내고, E는 식[2] 또는 식[3]으로 표시되는 기를 나타낸다.In the above formula, R 1 and R 2 each independently represent an alkyl group having 2 to 27 carbon atoms, and R 3 represents a hydrogen atom or an alkyl group having 1 to 25 carbon atoms, provided that -CR 1 R 2 R 3 group The total number of carbon atoms is 10 to 30, and X represents *-C(=O)O-, *-CH 2 O-, or *-CH 2 OC(=O)- (where * is -CR 1 R 2 represents a stage bonded to the R 3 group.), L represents a single bond or an alkylene group with 1 to 8 carbon atoms that may include an ether bond, and E is represented by formula [2] or formula [3] It represents energy.

[화학식 7][Formula 7]

Figure 112018040298624-pct00007
Figure 112018040298624-pct00007

상기 식 중, R4 내지 R15는 각각 독립적으로, 수소원자 또는 탄소원자수 1 내지 10의 알킬기를 나타낸다.In the above formula, R 4 to R 15 each independently represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms.

상기 R1 및 R2에 있어서의 탄소원자수 2 내지 27의 알킬기로는, 직쇄구조뿐만 아니라, 분지구조, 환상구조를 가질 수도 있다.The alkyl group having 2 to 27 carbon atoms for R 1 and R 2 may have not only a straight chain structure but also a branched structure or a cyclic structure.

구체적으로는, 에틸기, 프로필기, 부틸기, 펜틸기(아밀기), 헥실기, 헵틸기, 옥틸기, 노닐기, 데실기, 운데실기, 도데실기(라우릴기), 트리데실기, 테트라데실기(미리스틸기), 펜타데실기, 헥사데실기(팔미틸기), 헵타데실기(마가릴(マルガリル)기), 옥타데실기(스테아릴기), 노나데실기, 이코실기(아랄킬기), 헨이코실기, 도코실기(베헤닐기), 트리코실기, 테트라코실기(리그노세릴기), 펜타코실기, 헥사코실기, 헵타코실기 등의 직쇄상 알킬기; 이소프로필기, 이소부틸기, sec-부틸기, tert-부틸기, 이소펜틸기, 네오펜틸기, tert-펜틸기, sec-이소아밀기, 이소헥실기, 텍실(テキシル)기, 4-메틸헥실기, 5-메틸헥실기, 2-에틸펜틸기, 헵탄-3-일기, 헵탄-4-일기, 4-메틸헥산-2-일기, 3-메틸헥산-3-일기, 2,3-디메틸펜탄-2-일기, 2,4-디메틸펜탄-2-일기, 4,4-디메틸펜탄-2-일기, 6-메틸헵틸기, 2-에틸헥실기, 옥탄-2-일기, 6-메틸헵탄-2-일기, 6-메틸옥틸기, 3,5,5-트리메틸헥실기, 노난-4-일기, 2,6-디메틸헵탄-3-일기, 3,6-디메틸헵탄-3-일기, 3-에틸헵탄-3-일기, 3,7-디메틸옥틸기, 8-메틸노닐기, 3-메틸노난-3-일기, 4-에틸옥탄-4-일기, 9-메틸데실기, 운데칸-5-일기, 3-에틸노난-3-일기, 5-에틸노난-5-일기, 2,2,4,5,5-펜타메틸헥산-4-일기, 10-메틸운데실기, 11-메틸도데실기, 트리데칸-6-일기, 트리데칸-7-일기, 7-에틸운데칸-2-일기, 3-에틸운데칸-3-일기, 5-에틸운데칸-5-일기, 12-메틸트리데실기, 13-메틸테트라데실기, 펜타데칸-7-일기, 펜타데칸-8-일기, 14-메틸펜타데실기, 15-메틸헥사데실기, 헵타데칸-8-일기, 헵타데칸-9-일기, 3,13-디메틸펜타데칸-7-일기, 2,2,4,8,10,10-헥사메틸운데칸-5-일기, 16-메틸헵타데실기, 17-메틸옥타데실기, 노나데칸-9-일기, 노나데칸-10-일기, 2,6,10,14-테트라메틸펜타데칸-7-일기, 18-메틸노나데실기, 19-메틸이코실기, 헨이코산-10-일기, 20-메틸헨이코실기, 21-메틸도코실기, 트리코산-11-일기, 22-메틸트리코실기, 23-메틸테트라코실기, 펜타코산-12-일기, 펜타코산-13-일기, 2,22-디메틸트리코산-11-일기, 3,21-디메틸트리코산-11-일기, 9,15-디메틸트리코산-11-일기, 24-메틸펜타코실기, 25-메틸헥사코실기, 헵타코산-13-일기 등의 분지쇄상 알킬기; 시클로프로필기, 시클로부틸기, 시클로펜틸기, 시클로헥실기, 4-tert-부틸시클로헥실기, 1,6-디메틸시클로헥실기, 멘틸기, 시클로헵틸기, 시클로옥틸기, 비시클로[2.2.1]헵탄-2-일기, 보닐(ボルニル)기, 이소보닐기, 1-아다만틸기, 2-아다만틸기, 트리시클로[5.2.1.02,6]데칸-4-일기, 트리시클로[5.2.1.02,6]데칸-8-일기, 시클로도데실기 등의 지환식 알킬기를 들 수 있다.Specifically, ethyl group, propyl group, butyl group, pentyl group (amyl group), hexyl group, heptyl group, octyl group, nonyl group, decyl group, undecyl group, dodecyl group (lauryl group), tridecyl group, tetra. Decyl group (myristyl group), pentadecyl group, hexadecyl group (palmityl group), heptadecyl group (margaryl group), octadecyl group (stearyl group), nonadecyl group, icosyl group (aralkyl group) ), linear alkyl groups such as henicosyl group, docosyl group (behenyl group), tricosyl group, tetracosyl group (lignoseryl group), pentacosyl group, hexacosyl group, and heptacosyl group; Isopropyl group, isobutyl group, sec-butyl group, tert-butyl group, isopentyl group, neopentyl group, tert-pentyl group, sec-isoamyl group, isohexyl group, texyl group, 4-methyl Hexyl group, 5-methylhexyl group, 2-ethylpentyl group, heptan-3-yl group, heptan-4-yl group, 4-methylhexan-2-yl group, 3-methylhexan-3-yl group, 2,3-dimethyl Pentan-2-yl group, 2,4-dimethylpentan-2-yl group, 4,4-dimethylpentan-2-yl group, 6-methylheptyl group, 2-ethylhexyl group, octan-2-yl group, 6-methylheptane -2-yl group, 6-methyloctyl group, 3,5,5-trimethylhexyl group, nonan-4-yl group, 2,6-dimethylheptan-3-yl group, 3,6-dimethylheptan-3-yl group, 3 -Ethylheptan-3-yl group, 3,7-dimethyloctyl group, 8-methylnonyl group, 3-methylnonan-3-yl group, 4-ethyloctan-4-yl group, 9-methyldecyl group, undecane-5 -yl group, 3-ethylnonan-3-yl group, 5-ethylnonan-5-yl group, 2,2,4,5,5-pentamethylhexan-4-yl group, 10-methylundecyl group, 11-methyldodecyl group , tridecan-6-yl group, tridecan-7-yl group, 7-ethylundecan-2-yl group, 3-ethylundecan-3-yl group, 5-ethylundecan-5-yl group, 12-methyltride Syl group, 13-methyltetradecyl group, pentadecane-7-yl group, pentadecane-8-yl group, 14-methylpentadecyl group, 15-methylhexadecyl group, heptadecan-8-yl group, heptadecan-9-yl group , 3,13-dimethylpentadecan-7-yl group, 2,2,4,8,10,10-hexamethylundecan-5-yl group, 16-methylheptadecyl group, 17-methyloctadecyl group, nonadecane -9-yl group, nonadecan-10-yl group, 2,6,10,14-tetramethylpentadecan-7-yl group, 18-methylnonadecyl group, 19-methylicosyl group, henicosan-10-yl group, 20-methylhenicosyl group, 21-methyldocosyl group, tricosan-11-yl group, 22-methyltricosyl group, 23-methyltetracosyl group, pentacosan-12-yl group, pentacosan-13-yl group, 2,22 -Dimethyltricosan-11-yl group, 3,21-dimethyltricosan-11-yl group, 9,15-dimethyltricosan-11-yl group, 24-methylpentacosyl group, 25-methylhexacosyl group, heptacosane Branched chain alkyl groups such as -13-yl group; Cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, 4-tert-butylcyclohexyl group, 1,6-dimethylcyclohexyl group, menthyl group, cycloheptyl group, cyclooctyl group, bicyclo [2.2. 1]heptan-2-yl group, bornyl (ボルニル) group, isobornyl group, 1-adamantyl group, 2-adamantyl group, tricyclo [5.2.1.0 2,6 ] decan-4-yl group, tricyclo [5.2 .1.0 2,6 ] alicyclic alkyl groups such as decan-8-yl group and cyclododecyl group.

상기 R1 및 R2는 각각 독립적으로, 바람직하게는 탄소원자수 4 내지 16의 알킬기이며, 보다 바람직하게는 탄소원자수 6 내지 10의 알킬기이다.R 1 and R 2 are each independently, preferably an alkyl group having 4 to 16 carbon atoms, and more preferably an alkyl group having 6 to 10 carbon atoms.

그 중에서도, R1 및 R2는 각각 독립적으로, 분지쇄상의 알킬기인 것이 바람직하고, 보다 바람직하게는 탄소원자수 4 내지 16의 분지쇄상 알킬기, 더욱 바람직하게는 탄소원자수 6 내지 10의 분지쇄상 알킬기이다.Among them, R 1 and R 2 are each independently preferably a branched alkyl group, more preferably a branched alkyl group with 4 to 16 carbon atoms, and even more preferably a branched alkyl group with 6 to 10 carbon atoms. .

구체적으로는, R1 및 R2는 각각 독립적으로, 헥실기, 헵틸기, 옥틸기, 노닐기, 4,4-디메틸펜탄-2-일기, 6-메틸헵탄-2-일기, 6-메틸옥틸기, 3,5,5-트리메틸헥실기, 3,7-디메틸옥틸기인 것이 특히 바람직하다.Specifically, R 1 and R 2 are each independently hexyl group, heptyl group, octyl group, nonyl group, 4,4-dimethylpentan-2-yl group, 6-methylheptan-2-yl group, 6-methylocyl group. Tyl group, 3,5,5-trimethylhexyl group, and 3,7-dimethyloctyl group are particularly preferable.

상기 R3에 있어서의 탄소원자수 1 내지 25의 알킬기로는, 직쇄구조 뿐만 아니라, 분지구조, 환상구조를 가질 수도 있다.The alkyl group having 1 to 25 carbon atoms for R 3 may have not only a straight chain structure, but also a branched structure or a cyclic structure.

이러한 탄소원자수 1 내지 25의 알킬기로는, 메틸기, 에틸기, 프로필기, 부틸기, 펜틸기(아밀기), 헥실기, 헵틸기, 옥틸기, 노닐기, 데실기, 운데실기, 도데실기(라우릴기), 트리데실기, 테트라데실기(미리스틸기), 펜타데실기, 헥사데실기(팔미틸기), 헵타데실기(마가릴기), 옥타데실기(스테아릴기), 노나데실기, 이코실기(아랄킬기), 헨이코실기, 도코실기(베헤닐기), 트리코실기, 테트라코실기(리그노세릴기), 펜타코실기 등의 직쇄상 알킬기; 이소프로필기, 이소부틸기, sec-부틸기, tert-부틸기, 이소펜틸기, 네오펜틸기, tert-펜틸기, sec-이소아밀기, 이소헥실기, 텍실기, 4-메틸헥실기, 5-메틸헥실기, 2-에틸펜틸기, 헵탄-3-일기, 헵탄-4-일기, 4-메틸헥산-2-일기, 3-메틸헥산-3-일기, 2,3-디메틸펜탄-2-일기, 2,4-디메틸펜탄-2-일기, 4,4-디메틸펜탄-2-일기, 6-메틸헵틸기, 2-에틸헥실기, 옥탄-2-일기, 6-메틸헵탄-2-일기, 6-메틸옥틸기, 3,5,5-트리메틸헥실기, 노난-4-일기, 2,6-디메틸헵탄-3-일기, 3,6-디메틸헵탄-3-일기, 3-에틸헵탄-3-일기, 3,7-디메틸옥틸기, 8-메틸노닐기, 3-메틸노난-3-일기, 4-에틸옥탄-4-일기, 9-메틸데실기, 운데칸-5-일기, 3-에틸노난-3-일기, 5-에틸노난-5-일기, 2,2,4,5,5-펜타메틸헥산-4-일기, 10-메틸운데실기, 11-메틸도데실기, 트리데칸-6-일기, 트리데칸-7-일기, 7-에틸운데칸-2-일기, 3-에틸운데칸-3-일기, 5-에틸운데칸-5-일기, 12-메틸트리데실기, 13-메틸테트라데실기, 펜타데칸-7-일기, 펜타데칸-8-일기, 14-메틸펜타데실기, 15-메틸헥사데실기, 헵타데칸-8-일기, 헵타데칸-9-일기, 3,13-디메틸펜타데칸-7-일기, 2,2,4,8,10,10-헥사메틸운데칸-5-일기, 16-메틸헵타데실기, 17-메틸옥타데실기, 노나데칸-9-일기, 노나데칸-10-일기, 2,6,10,14-테트라메틸펜타데칸-7-일기, 18-메틸노나데실기, 19-메틸이코실기, 헨이코산-10-일기, 20-메틸헨이코실(メチルヘンイコシル)기, 21-메틸도코실기, 트리코산-11-일기, 22-메틸트리코실(メチルトリコシル)기, 23-메틸테트라코실기, 펜타코산-12-일기, 펜타코산-13-일기, 2,22-디메틸트리코산-11-일기, 3,21-디메틸트리코산-11-일기, 9,15-디메틸트리코산-11-일기 등의 분지쇄상 알킬기; 시클로프로필기, 시클로부틸기, 시클로펜틸기, 시클로헥실기, 4-tert-부틸시클로헥실기, 1,6-디메틸시클로헥실기, 멘틸기, 시클로헵틸기, 시클로옥틸기, 비시클로[2.2.1]헵탄-2-일기, 보닐기, 이소보닐기, 1-아다만틸기, 2-아다만틸기, 트리시클로[5.2.1.02,6]데칸-4-일기, 트리시클로[5.2.1.02,6]데칸-8-일기, 시클로도데실기 등의 지환식 알킬기를 들 수 있다.Such alkyl groups having 1 to 25 carbon atoms include methyl group, ethyl group, propyl group, butyl group, pentyl group (amyl group), hexyl group, heptyl group, octyl group, nonyl group, decyl group, undecyl group, dodecyl group (ra) Uryl group), tridecyl group, tetradecyl group (myristyl group), pentadecyl group, hexadecyl group (palmityl group), heptadecyl group (margaryl group), octadecyl group (stearyl group), nonadecyl group , straight-chain alkyl groups such as icosyl group (aralkyl group), henicosyl group, docosyl group (behenyl group), tricosyl group, tetracosyl group (lignoseryl group), and pentacosyl group; Isopropyl group, isobutyl group, sec-butyl group, tert-butyl group, isopentyl group, neopentyl group, tert-pentyl group, sec-isoamyl group, isohexyl group, texyl group, 4-methylhexyl group, 5-methylhexyl group, 2-ethylpentyl group, heptan-3-yl group, heptan-4-yl group, 4-methylhexan-2-yl group, 3-methylhexan-3-yl group, 2,3-dimethylpentan-2 -yl group, 2,4-dimethylpentan-2-yl group, 4,4-dimethylpentan-2-yl group, 6-methylheptyl group, 2-ethylhexyl group, octan-2-yl group, 6-methylheptan-2- Diyl group, 6-methyloctyl group, 3,5,5-trimethylhexyl group, nonan-4-yl group, 2,6-dimethylheptan-3-yl group, 3,6-dimethylheptan-3-yl group, 3-ethylheptane -3-yl group, 3,7-dimethyloctyl group, 8-methylnonyl group, 3-methylnonan-3-yl group, 4-ethyloctan-4-yl group, 9-methyldecyl group, undecane-5-yl group, 3-ethylnonan-3-yl group, 5-ethylnonan-5-yl group, 2,2,4,5,5-pentamethylhexan-4-yl group, 10-methylundecyl group, 11-methyldodecyl group, tridecane -6-yl group, tridecan-7-yl group, 7-ethylundecan-2-yl group, 3-ethylundecan-3-yl group, 5-ethylundecan-5-yl group, 12-methyltridecyl group, 13 -methyltetradecyl group, pentadecane-7-yl group, pentadecane-8-yl group, 14-methylpentadecyl group, 15-methylhexadecyl group, heptadecan-8-yl group, heptadecan-9-yl group, 3, 13-dimethylpentadecan-7-yl group, 2,2,4,8,10,10-hexamethylundecan-5-yl group, 16-methylheptadecyl group, 17-methyloctadecyl group, nonadecan-9- diyl group, nonadecan-10-yl group, 2,6,10,14-tetramethylpentadecan-7-yl group, 18-methylnonadecyl group, 19-methylicosyl group, henicosan-10-yl group, 20-methyl Henicosyl group, 21-methyldocosyl group, tricosan-11-yl group, 22-methyltricosyl group, 23-methyltetracosyl group, pentacosan-12-yl group, branched alkyl groups such as pentacosan-13-yl group, 2,22-dimethyltricosan-11-yl group, 3,21-dimethyltricosan-11-yl group, and 9,15-dimethyltricosan-11-yl group; Cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, 4-tert-butylcyclohexyl group, 1,6-dimethylcyclohexyl group, menthyl group, cycloheptyl group, cyclooctyl group, bicyclo [2.2. 1]heptan-2-yl group, bornyl group, isobornyl group, 1-adamantyl group, 2-adamantyl group, tricyclo[5.2.1.0 2,6 ]decan-4-yl group, tricyclo[5.2.1.0 2 ,6 ]alicyclic alkyl groups such as decan-8-yl group and cyclododecyl group.

그 중에서도 R3은, 수소원자인 것이 바람직하다.Among these, R 3 is preferably a hydrogen atom.

상기 R1, R2 및 R3을 갖는 기: -CR1R2R3기는, 그 탄소원자수의 합계가 10 내지 30이며, 바람직하게는 탄소원자수 14 내지 26의 기이며, 특히 바람직하게는 탄소원자수 14 내지 20의 기이다.The group having R 1 , R 2 and R 3 : -CR 1 R 2 R 3 group has a total number of carbon atoms of 10 to 30, preferably a group of 14 to 26 carbon atoms, and particularly preferably a carbon source. It is a flag of 14 to 20 embroidery.

상기 -CR1R2R3기의 구체예로는, 3-메틸노난-3-일기, 4-에틸옥탄-4-일기, 운데칸-5-일기, 3-에틸노난-3-일기, 5-에틸노난-5-일기, 2,2,4,5,5-펜타메틸헥산-4-일기, 트리데칸-6-일기, 트리데칸-7-일기, 7-에틸운데칸-2-일기, 3-에틸운데칸-3-일기, 5-에틸운데칸-5-일기, 펜타데칸-7-일기, 펜타데칸-8-일기, 헵타데칸-8-일기, 헵타데칸-9-일기, 3,13-디메틸펜타데칸-7-일기, 2,2,4,8,10,10-헥사메틸운데칸-5-일기, 노나데칸-9-일기, 노나데칸-10-일기, 2,6,10,14-테트라메틸펜타데칸-7-일기, 헨이코산-10-일기, 트리코산-11-일기, 펜타코산-12-일기, 펜타코산-13-일기, 2,22-디메틸트리코산-11-일기, 3,21-디메틸트리코산-11-일기, 9,15-디메틸트리코산-11-일기, 헵타코산-13-일기, 노나코산-14-일기 등을 들 수 있다.Specific examples of the -CR 1 R 2 R 3 group include 3-methylnonan-3-yl group, 4-ethyloctan-4-yl group, undecane-5-yl group, 3-ethylnonan-3-yl group, 5 -Ethylnonan-5-yl group, 2,2,4,5,5-pentamethylhexan-4-yl group, tridecan-6-yl group, tridecan-7-yl group, 7-ethylundecan-2-yl group, 3-ethylundecan-3-yl group, 5-ethylundecan-5-yl group, pentadecane-7-yl group, pentadecane-8-yl group, heptadecan-8-yl group, heptadecan-9-yl group, 3, 13-dimethylpentadecan-7-yl group, 2,2,4,8,10,10-hexamethylundecan-5-yl group, nonadecan-9-yl group, nonadecan-10-yl group, 2,6,10 , 14-tetramethylpentadecan-7-yl group, henicosan-10-yl group, tricosan-11-yl group, pentacosan-12-yl group, pentacosan-13-yl group, 2,22-dimethyltricosan-11 -yl group, 3,21-dimethyltricosan-11-yl group, 9,15-dimethyltricosan-11-yl group, heptacosane-13-yl group, nonacosan-14-yl group, etc.

상기 X는, 그 중에서도 *-C(=O)O- 또는 *-CH2O-기인 것이 바람직하고, 특히 *-C(=O)O-기인 것이 바람직하다. Said

상기 L에 있어서의 에테르결합을 포함할 수도 있는 탄소원자수 1 내지 8의 알킬렌기로는, 메틸렌기, 에틸렌기, 트리메틸렌기, 메틸에틸렌기, 테트라메틸렌기, 1-메틸트리메틸렌기, 펜타메틸렌기, 2,2-디메틸트리메틸렌기, 헥사메틸렌기, 헵타메틸렌기, 옥타메틸렌기, 2-옥사테트라메틸렌기, 2,5-디옥사헵타메틸렌기, 2,5,8-트리옥사데카메틸렌기, 2-옥사-3-메틸테트라메틸렌기, 2,5-디옥사-3,6-디메틸헵타메틸렌기 등을 들 수 있다.Examples of the alkylene group having 1 to 8 carbon atoms that may contain an ether bond in L include methylene group, ethylene group, trimethylene group, methylethylene group, tetramethylene group, 1-methyltrimethylene group, and pentamethylene group. group, 2,2-dimethyltrimethylene group, hexamethylene group, heptamethylene group, octamethylene group, 2-oxatetramethylene group, 2,5-dioxaheptamethylene group, 2,5,8-trioxadecamethylene group, 2-oxa-3-methyltetramethylene group, 2,5-dioxa-3,6-dimethylheptamethylene group, etc.

상기 L로는, 바람직하게는 메틸렌기, 트리메틸렌기, 헥사메틸렌기, 2-옥사테트라메틸렌기, 보다 바람직하게는 메틸렌기를 들 수 있다.The L is preferably a methylene group, trimethylene group, hexamethylene group, or 2-oxatetramethylene group, and more preferably a methylene group.

상기 식[1] 중의 E인 식[2] 또는 식[3]으로 표시되는 기는 에폭시함유기이다.The group represented by formula [2] or formula [3], which is E in the above formula [1], is an epoxy-containing group.

식[2] 또는 식[3] 중의 R4 내지 R15에 있어서의 탄소원자수 1 내지 10의 알킬기로는, 메틸기, 에틸기, 프로필기, 이소프로필기, 시클로프로필기, 부틸기, 이소부틸기, sec-부틸기, tert-부틸기, 시클로부틸기, 펜틸기(아밀기), 이소펜틸기, 네오펜틸기, tert-펜틸기, sec-이소아밀기, 시클로펜틸기, 헥실기, 이소헥실기, 시클로헥실기, 헵틸기, 옥틸기, 2-에틸헥실기, 노닐기, 데실기 등을 들 수 있다.The alkyl group having 1 to 10 carbon atoms for R 4 to R 15 in formula [2] or formula [3] includes methyl group, ethyl group, propyl group, isopropyl group, cyclopropyl group, butyl group, isobutyl group, sec-butyl group, tert-butyl group, cyclobutyl group, pentyl group (amyl group), isopentyl group, neopentyl group, tert-pentyl group, sec-isoamyl group, cyclopentyl group, hexyl group, isohexyl group , cyclohexyl group, heptyl group, octyl group, 2-ethylhexyl group, nonyl group, decyl group, etc.

그 중에서도 R4 내지 R15는, 수소원자인 것이 바람직하다.Among them, it is preferable that R 4 to R 15 are hydrogen atoms.

한편 상기 식[1]로 표시되는 에폭시 화합물 중, 하기 식[1a]로 표시되는 화합물도 발명의 대상으로 한다.Meanwhile, among the epoxy compounds represented by the above formula [1], the compound represented by the following formula [1a] is also subject to the invention.

[화학식 8][Formula 8]

Figure 112018040298624-pct00008
Figure 112018040298624-pct00008

식 중, R1 및 R2는 각각 독립적으로, 탄소원자수 2 내지 27의 알킬기를 나타내고, R3은 수소원자 또는 탄소원자수 1 내지 25의 알킬기를 나타내고, 단 -CR1R2R3기의 탄소원자수는 10 내지 30이며, R4 내지 R6은 각각 독립적으로, 수소원자 또는 탄소원자수 1 내지 10의 알킬기를 나타내고, L은 에테르결합을 포함할 수도 있는 탄소원자수 1 내지 8의 알킬렌기를 나타낸다.In the formula, R 1 and R 2 each independently represent an alkyl group having 2 to 27 carbon atoms, and R 3 represents a hydrogen atom or an alkyl group having 1 to 25 carbon atoms, provided that the carbon source of the group -CR 1 R 2 R 3 The number is 10 to 30, R 4 to R 6 each independently represent a hydrogen atom or an alkyl group with 1 to 10 carbon atoms, and L represents an alkylene group with 1 to 8 carbon atoms that may include an ether bond.

상기 R1 내지 R6, 및 L의 구체적인 기는, 상기 서술한 바와 같다.The specific groups of R 1 to R 6 and L are as described above.

상기 식[1]로 표시되는 화합물은, 카르본산류나 알코올류를 출발원료로 하여, 종래 공지(예를 들어, 국제공개 2012/128325호 팜플렛, 일본특허공개 2012-25688호 공개 등에 기재)된 에폭시드의 합성방법에 의해 제조가능하다.The compound represented by the formula [1] is a conventionally known epoxy (for example, described in the pamphlet of International Publication No. 2012/128325, Japanese Patent Publication No. 2012-25688, etc.) using carboxylic acids or alcohols as starting materials. It can be manufactured by the synthetic method of De.

예를 들어 X가 *-C(=O)-O-기를 나타내는 에스테르 화합물인 경우에는, 일례로서, R1R2R3C-COOH로 표시되는 카르본산 또는 그 활성화체(산할로겐화물, 산무수물, 산아지드, 활성에스테르 등)와, 할로겐화알릴이나 알릴기를 갖는 알코올을 반응시켜 불포화결합을 갖는 에스테르 화합물(중간체)을 형성한 후, 이 중간체와 과산화물을 반응시켜 불포화결합을 에폭시화하는 방법에 의해 제조할 수 있다. 또한, R1R2R3C-COOH로 표시되는 카르본산과 에피클로로하이드린을 반응시키고, 폐환하는 방법에 의해서도 제조가능하다. 일례로서, E가 식[2]로 표시되는 기인 경우의 합성스킴을 이하에 나타낸다.For example, in the case where An ester compound (intermediate) with an unsaturated bond is formed by reacting (anhydride, acid azide, active ester, etc.) with an allyl halide or an alcohol having an allyl group, and then reacting this intermediate with peroxide to epoxidize the unsaturated bond. It can be manufactured by In addition, it can also be produced by reacting carboxylic acid represented by R 1 R 2 R 3 C-COOH with epichlorohydrin and ring closing. As an example, a synthesis scheme in the case where E is a group represented by formula [2] is shown below.

[화학식 9][Formula 9]

Figure 112018040298624-pct00009
Figure 112018040298624-pct00009

또한, 상기 식[1]에 있어서 X가 *-CH2-O-기를 나타내는 에테르 화합물의 경우에는, 예를 들어, R1R2R3C-CH2OH로 표시되는 알코올과, 할로겐화알릴과 반응시켜 불포화결합을 갖는 에테르 화합물(중간체)을 형성한 후, 이 중간체와 과산화물을 반응시켜 불포화결합을 에폭시화하는 방법에 의해 제조할 수 있다.In addition , in the case of an ether compound in which It can be produced by reacting to form an ether compound (intermediate) having an unsaturated bond, and then reacting this intermediate with peroxide to epoxidize the unsaturated bond.

상기 R1R2R3C-COOH로 표시되는 카르본산 및 R1R2R3C-CH2OH로 표시되는 알코올은 시판품을 사용할 수 있고, 예를 들어, 상기 R1R2R3C-COOH로 표시되는 화합물로는, 닛산화학공업(주)제 파인옥소콜(등록상표) 이소팔미트산, 동 이소스테아르산, 동 이소스테아르산N, 동 이소스테아르산T, 및 동 이소아라킨산을 들 수 있다. 또한 상기 R1R2R3C-CH2OH로 표시되는 화합물로는, 닛산화학공업(주)제 파인옥소콜(등록상표) 1600, 동 180, 동 180N, 동 180T, 및 동 2000 등을 들 수 있다.The carboxylic acid represented by R 1 R 2 R 3 C-COOH and the alcohol represented by R 1 R 2 R 3 C-CH 2 OH can be commercially available, for example, the R 1 R 2 R 3 C Compounds represented by -COOH include Fineoxochol (registered trademark) isopalmitic acid, isostearic acid, isostearic acid N, isostearic acid T, and isoaracnic acid manufactured by Nissan Chemical Industries, Ltd. can be mentioned. In addition, the compounds represented by R 1 R 2 R 3 C-CH 2 OH include Fineoxocol (registered trademark) 1600, No. 180, No. 180N, No. 180T, and No. 2000 manufactured by Nissan Chemical Industries, Ltd. I can hear it.

<에폭시 수지><Epoxy Resin>

본 발명의 에폭시 수지 조성물레 포함되는 에폭시 수지는, 일반적으로 분자내에 적어도 2개의 에폭시기를 갖는 에폭시 화합물을 가리키고, 본 발명에 있어서는 특별히 한정되는 일 없이 시판품을 포함하고 다양한 에폭시 수지를 사용가능하다.The epoxy resin contained in the epoxy resin composition of the present invention generally refers to an epoxy compound having at least two epoxy groups in the molecule, and in the present invention, there is no particular limitation, and various epoxy resins, including commercial products, can be used.

본 발명의 에폭시 수지 조성물에는, 취급작업상의 관점에서, 바람직하게는 액상의 에폭시 수지를 사용하는 것이 바람직하다. 한편 이 에폭시 수지가 고체이거나, 점도가 매우 높은 경우, 취급작업상의 편의를 도모하기 위해 용제에 용해되거나, 혹은 후술하는 바와 같이, 에폭시 수지 조성물의 조제시에 경화반응이 진행되지 않을 정도로 가열할 수 있다. 단 용제의 첨가는, 용제의 증발에 의해 경화물의 밀도저하나 세공의 생성에 의해 강도저하, 내수성의 저하를 발생시킬 우려가 있다. 이 때문에, 이 에폭시 수지 자체가 상온, 상압하에서 액상인 것을 채용하는 것이 바람직하다.From the viewpoint of handling, it is preferable to use a liquid epoxy resin for the epoxy resin composition of the present invention. On the other hand, if the epoxy resin is solid or has a very high viscosity, it can be dissolved in a solvent for convenience in handling, or, as described later, it can be heated to a level where the curing reaction does not proceed when preparing the epoxy resin composition. there is. However, the addition of a solvent may cause a decrease in the density of the cured product due to evaporation of the solvent, or a decrease in strength and water resistance due to the creation of pores. For this reason, it is preferable to employ the epoxy resin itself in a liquid state at room temperature and under normal pressure.

본 발명에서 사용가능한 에폭시 수지로는, 1,4-부탄디올디글리시딜에테르, 1,6-헥산디올디글리시딜에테르, (폴리)에틸렌글리콜디글리시딜에테르, (폴리)프로필렌글리콜디글리시딜에테르, 트리메틸올에탄트리글리시딜에테르, 트리메틸올프로판트리글리시딜에테르, 1,4-시클로헥산디메탄올디글리시딜에테르, 1,2-에폭시-4-(에폭시에틸)시클로헥산, 글리세롤트리글리시딜에테르, 디글리세롤폴리디글리시딜에테르, 2,6-디글리시딜페닐글리시딜에테르, 1,1,3-트리스(4-글리시딜옥시페닐)프로판, 1,2-시클로헥산디카르본산디글리시딜에스테르, 4,4'-메틸렌비스(N,N-디글리시딜아닐린), 3,4-에폭시시클로헥산카르본산3',4'-에폭시시클로헥실메틸, 트리글리시딜-p-아미노페놀, 테트라글리시딜메타자일렌디아민, 테트라글리시딜디아미노디페닐메탄, 테트라글리시딜-1,3-비스아미노메틸시클로헥산, 비스페놀A디글리시딜에테르, 비스페놀S디글리시딜에테르, 테트라브로모비스페놀A디글리시딜에테르, 수소화비스페놀A디글리시딜에테르, 펜타에리스리톨디글리시딜에테르, 펜타에리스리톨테트라글리시딜에테르, 펜타에리스리톨폴리글리시딜에테르, 레조르시놀디글리시딜에테르, 프탈산디글리시딜, 테트라하이드로프탈산디글리시딜, 네오펜틸글리콜디글리시딜에테르, 비스페놀헥사플루오로아세톤디글리시딜에테르, 트리글리시딜이소시아누레이트, 트리스-(3,4-에폭시부틸)이소시아누레이트, 트리스-(4,5-에폭시펜틸)이소시아누레이트, 트리스-(5,6-에폭시헥실)이소시아누레이트, 트리스-(7,8-에폭시옥틸)이소시아누레이트, 트리스(2-글리시딜옥시에틸)이소시아누레이트, 모노알릴디글리시딜이소시아누레이트, N,N'-디글리시딜N''-(2,3-디프로피오닐옥시프로필)이소시아누레이트, N,N'-비스(2,3-디프로피오닐옥시프로필)N''-글리시딜이소시아누레이트, 트리스(2,2-비스(글리시딜옥시메틸)부틸)3,3',3''-(2,4,6-트리옥소-1,3,5-트리아진-1,3,5-트리일)트리프로파노에이트, 솔비톨폴리글리시딜에테르, 아디프산디글리시딜, o-프탈산디글리시딜, 디브로모페닐글리시딜에테르, 1,2,7,8-디에폭시옥탄, 1,6-디메틸올퍼플루오로헥산디글리시딜에테르, 4-(스피로[3,4-에폭시시클로헥산-1,5'-[1,3]디옥산]-2'-일)-1,2-에폭시시클로헥산, 1,2-비스(3,4-에폭시시클로헥실메톡시)에탄, 4,5-에폭시-2-메틸시클로헥산카르본산4',5'-에폭시-2'-메틸시클로헥실메틸, 에틸렌글리콜비스(3,4-에폭시시클로헥산카르복시레이트), 비스(3,4-에폭시시클로헥실메틸)아디페이트, 비스(2,3-에폭시시클로펜틸)에테르 등을 들 수 있으나, 이들로 한정되는 것은 아니다.Epoxy resins usable in the present invention include 1,4-butanediol diglycidyl ether, 1,6-hexanediol diglycidyl ether, (poly)ethylene glycol diglycidyl ether, and (poly)propylene glycol dily. Glycidyl ether, trimethylolethane triglycidyl ether, trimethylolpropane triglycidyl ether, 1,4-cyclohexanedimethanol diglycidyl ether, 1,2-epoxy-4-(epoxyethyl)cyclohexane, Glycerol triglycidyl ether, diglycerol polydiglycidyl ether, 2,6-diglycidylphenyl glycidyl ether, 1,1,3-tris(4-glycidyloxyphenyl)propane, 1,2 -Cyclohexanedicarboxylic acid diglycidyl ester, 4,4'-methylenebis(N,N-diglycidylaniline), 3,4-epoxycyclohexanecarboxylic acid 3',4'-epoxycyclohexylmethyl, Triglycidyl-p-aminophenol, tetraglycidyl metaxylenediamine, tetraglycidyldiaminodiphenylmethane, tetraglycidyl-1,3-bisaminomethylcyclohexane, bisphenol A diglycidyl ether , Bisphenol S diglycidyl ether, tetrabromobisphenol A diglycidyl ether, hydrogenated bisphenol A diglycidyl ether, pentaerythritol diglycidyl ether, pentaerythritol tetraglycidyl ether, pentaerythritol polyglycidyl ether. Dyl ether, resorcinol diglycidyl ether, diglycidyl phthalate, diglycidyl tetrahydrophthalate, neopentyl glycol diglycidyl ether, bisphenol hexafluoroacetone diglycidyl ether, triglycidyl isocidyl ether. Anurate, Tris-(3,4-epoxybutyl)isocyanurate, Tris-(4,5-epoxypentyl)isocyanurate, Tris-(5,6-epoxyhexyl)isocyanurate, Tris- (7,8-epoxyoctyl)isocyanurate, tris(2-glycidyloxyethyl)isocyanurate, monoallyldiglycidylisocyanurate, N,N'-diglycidylN' '-(2,3-dipropionyloxypropyl)isocyanurate, N,N'-bis(2,3-dipropionyloxypropyl)N''-glycidylisocyanurate, tris(2 ,2-bis(glycidyloxymethyl)butyl)3,3',3''-(2,4,6-trioxo-1,3,5-triazine-1,3,5-triyl) Tripropanoate, sorbitol polyglycidyl ether, diglycidyl adipic acid, diglycidyl o-phthalate, dibromophenyl glycidyl ether, 1,2,7,8-diepoxyoctane, 1, 6-dimethylolperfluorohexanediglycidyl ether, 4-(spiro[3,4-epoxycyclohexane-1,5'-[1,3]dioxane]-2'-yl)-1,2 -Epoxycyclohexane, 1,2-bis(3,4-epoxycyclohexylmethoxy)ethane, 4,5-epoxy-2-methylcyclohexanecarboxylic acid 4',5'-epoxy-2'-methylcyclohexyl Examples include methyl, ethylene glycol bis(3,4-epoxycyclohexanecarboxylate), bis(3,4-epoxycyclohexylmethyl)adipate, and bis(2,3-epoxycyclopentyl)ether. It is not limited.

이들 에폭시 수지는 단독으로 또는 2종 이상의 혼합물로서 사용할 수 있다.These epoxy resins can be used individually or as a mixture of two or more types.

한편 상기 에폭시 수지의 일례로서, 이하의 시판품을 들 수 있다.Meanwhile, examples of the epoxy resin include the following commercial products.

고체에폭시 수지로는, TEPIC(등록상표)-G, 동 S, 동 L, 동 HP[모두 닛산화학공업(주)제] 등을 들 수 있다.Examples of solid epoxy resins include TEPIC (registered trademark)-G, S, L, and HP (all manufactured by Nissan Chemical Industries, Ltd.).

또한, 액상 에폭시 수지로는, TEPIC(등록상표)-PAS B22, 동 PAS B26, 동 PAS B26L, 동 VL, 동 UC, 동 FL[모두 닛산화학공업(주)제], jER(등록상표) 828, 동 YX8000[모두 미쯔비시화학(주)제], 리카레진(등록상표) DME100[신일본이화(주)제], 셀록사이드2021P[(주)다이셀제] 등을 들 수 있다.In addition, liquid epoxy resins include TEPIC (registered trademark) - PAS B22, PAS B26, PAS B26L, VL, UC, FL (all manufactured by Nissan Chemical Industries, Ltd.), and jER (registered trademark) 828. , YX8000 [all manufactured by Mitsubishi Chemical Corporation], Rikka Resin (registered trademark) DME100 [manufactured by Nippon Ewha Corporation], and Celoxide 2021P [manufactured by Daicel Corporation].

본 발명의 에폭시 수지 조성물에 있어서, 식[1]로 표시되는 에폭시 화합물과, 에폭시 수지의 배합비율은, 질량비로, 식[1]로 표시되는 에폭시 화합물:에폭시 수지=3:97~60:40의 범위로 하는 것이 바람직하고, 5:95~40:60의 범위로 하는 것이 보다 바람직하다. 식[1]로 표시되는 에폭시 화합물의 배합량을 상기 비율이상으로 함으로써, 충분한 점도저하효과가 얻어지고, 또한 얻어지는 수지 조성물에 있어서 충분한 유전율의 저감으로 이어진다. 또한 식[1]로 표시되는 에폭시 화합물의 배합량을 상기 비율 이하로 함으로써, 가교밀도의 저하를 억제하고, 후에 얻어지는 경화물의 내열성이나 기계적 물성을 유지할 수 있다.In the epoxy resin composition of the present invention, the mixing ratio of the epoxy compound represented by formula [1] and the epoxy resin is mass ratio, epoxy compound represented by formula [1]: epoxy resin = 3:97 to 60:40. It is preferable to set it in the range, and it is more preferable to set it in the range of 5:95 to 40:60. By setting the blending amount of the epoxy compound represented by formula [1] to the above ratio or more, a sufficient viscosity lowering effect is obtained, which also leads to a sufficient reduction in dielectric constant in the resulting resin composition. Additionally, by keeping the blending amount of the epoxy compound represented by formula [1] below the above ratio, a decrease in crosslink density can be suppressed and the heat resistance and mechanical properties of the cured product obtained later can be maintained.

본 발명의 에폭시 수지 조성물은 상기 식[1]로 표시되는 에폭시 화합물 및 상기 에폭시 수지를 혼합함으로써 제조할 수 있고, 이 혼합은 균일하게 혼합할 수 있으면, 특별히 한정되는 것은 아니나, 예를 들어 믹서나 혼련기를 사용하고, 또한 점도를 고려하여, 필요에 따라 가열하에서 실시될 수 있으며, 예를 들어 10~150℃의 온도에서 0.5~10시간 정도 혼합함으로써 조제할 수 있다.The epoxy resin composition of the present invention can be produced by mixing the epoxy compound represented by the formula [1] and the epoxy resin, and this mixing is not particularly limited as long as it can be mixed uniformly, for example, using a mixer or It can be carried out using a kneader and, taking viscosity into consideration, under heating as needed. For example, it can be prepared by mixing at a temperature of 10 to 150°C for about 0.5 to 10 hours.

[(b) 경화제 및 이것을 포함하는 경화성 조성물][(b) Curing agent and curable composition containing the same]

본 발명은, 상기 서술한 에폭시 수지 조성물, 및 (b)경화제를 포함하는 경화성 조성물을 대상으로 한다. 본 경화성 조성물에는, (b)경화제에 첨가하여, 경화촉진제를 병용할 수 있다.The present invention is directed to a curable composition containing the above-described epoxy resin composition and (b) a curing agent. In this curable composition, a curing accelerator can be used in combination with the curing agent (b).

경화제로는, 산무수물, 아민, 페놀 수지, 폴리아미드 수지, 이미다졸류, 또는 폴리메르캅탄을 이용할 수 있다. 이들 중에서도, 특히 산무수물 및 아민이 바람직하다. 이들 경화제는, 고체로도 용제에 용해함으로써 사용할 수 있다. 그러나, 용제의 증발에 의해 경화물의 밀도저하나 세공의 생성에 의해 강도저하, 내수성의 저하를 발생하므로, 경화제 자체가 상온, 상압하에서 액상인 것이 바람직하다.As the curing agent, acid anhydrides, amines, phenol resins, polyamide resins, imidazoles, or polymercaptans can be used. Among these, acid anhydrides and amines are particularly preferable. These curing agents can be used as solids by dissolving them in a solvent. However, evaporation of the solvent causes a decrease in the density of the cured product and a decrease in strength and water resistance due to the creation of pores, so it is preferable that the curing agent itself is liquid at room temperature and pressure.

경화제는, (a)에폭시 수지 조성물, 즉, 상기 서술한 식[1]로 표시되는 에폭시 화합물 및 에폭시 수지의 전체에 있어서의, 에폭시기 1당량에 대하여 0.5~1.5당량, 바람직하게는 0.8~1.2당량의 비율로 함유할 수 있다. 에폭시 화합물에 대한 경화제의 당량은, 에폭시기에 대한 경화제의 경화성기의 당량비로 나타낸다.The curing agent is present in an amount of 0.5 to 1.5 equivalents, preferably 0.8 to 1.2 equivalents, based on 1 equivalent of the epoxy group in the epoxy resin composition (a), that is, the entire epoxy compound and epoxy resin represented by the formula [1] described above. It can be contained in a ratio of . The equivalent weight of the curing agent to the epoxy compound is expressed as the equivalent ratio of the curable group of the curing agent to the epoxy group.

산무수물로는 한 분자 중에 복수의 카르복실기를 갖는 화합물의 무수물이 바람직하다. 이들 산무수물로는, 예를 들어, 무수프탈산, 무수트리멜리트산, 무수피로멜리트산, 무수벤조페논테트라카르본산, 에틸렌글리콜비스트리멜리테이트, 글리세롤트리스트리멜리테이트, 무수말레산, 테트라하이드로무수프탈산, 메틸테트라하이드로무수프탈산, 엔도메틸렌테트라하이드로무수프탈산, 메틸엔도메틸렌테트라하이드로무수프탈산, 메틸부테닐테트라하이드로무수프탈산, 도데세닐무수석신산, 헥사하이드로무수프탈산, 메틸헥사하이드로무수프탈산, 무수석신산, 메틸시클로헥센디카르본산무수물, 클로렌드산무수물 등을 들 수 있다.The acid anhydride is preferably an anhydride of a compound having multiple carboxyl groups in one molecule. These acid anhydrides include, for example, phthalic anhydride, trimellitic anhydride, pyromellitic anhydride, benzophenone tetracarboxylic acid anhydride, ethylene glycol bistrimellitate, glycerol tristrimellitate, maleic anhydride, and tetrahydromellitic anhydride. Phthalic acid, methyltetrahydrophthalic anhydride, endomethylenetetrahydrophthalic anhydride, methylendomethylenetetrahydrophthalic anhydride, methylbutenyltetrahydrophthalic anhydride, dodecenyl succinic anhydride, hexahydrophthalic anhydride, methylhexahydrophthalic anhydride, anhydrite Acidic acid, methylcyclohexenedicarboxylic acid anhydride, chlorendic acid anhydride, etc. can be mentioned.

이들 중에서도 상온, 상압에서 액상인 메틸테트라하이드로무수프탈산, 메틸-5-노보넨-2,3-디카르본산무수물(메틸나딕산무수물, 무수메틸하이믹산), 수소화메틸나딕산무수물, 메틸부테닐테트라하이드로무수프탈산, 도데세닐무수석신산, 메틸헥사하이드로무수프탈산, 메틸헥사하이드로무수프탈산과 헥사하이드로무수프탈산의 혼합물이 바람직하다. 이들 액상의 산무수물은 점도가 25℃에서의 측정으로 10~1,000mPa·s 정도이다. 산무수물기에 있어서, 1개의 산무수물기는 1당량으로서 계산된다.Among these, methyltetrahydrophthalic anhydride, methyl-5-norbornene-2,3-dicarboxylic anhydride (methylnadic anhydride, methylhymic anhydride), hydrogenated methylnadic anhydride, and methylbutenyl are liquid at room temperature and pressure. Tetrahydrophthalic anhydride, dodecenylsuccinic anhydride, methylhexahydrophthalic anhydride, and mixtures of methylhexahydrophthalic anhydride and hexahydrophthalic anhydride are preferred. These liquid acid anhydrides have a viscosity of about 10 to 1,000 mPa·s when measured at 25°C. For acid anhydride groups, one acid anhydride group is calculated as one equivalent.

아민으로는, 예를 들어, 피페리딘, N,N-디메틸피페라진, 트리에틸렌디아민, 2,4,6-트리스(디메틸아미노메틸)페놀, 벤질디메틸아민, 2-(디메틸아미노메틸)페놀, 디에틸렌트리아민, 트리에틸렌테트라민, 테트라에틸렌펜타민, 디에틸아미노프로필아민, N-아미노에틸피페라진, 디(1-메틸-2-아미노시클로헥실)메탄, 멘탄디아민, 이소포론디아민, 디아미노디시클로헥실메탄, 1,3-비스(아미노메틸)시클로헥산, 자일렌디아민, 메타페닐렌디아민, 디아미노디페닐메탄, 디아미노디페닐설폰 등을 들 수 있다. 이들 중에서도, 액상인 디에틸렌트리아민, 트리에틸렌테트라민, 테트라에틸렌펜타민, 디에틸아미노프로필아민, N-아미노에틸피페라진, 비스(1-메틸-2-아미노시클로헥실)메탄, 멘탄디아민, 이소포론디아민, 디아미노디시클로헥실메탄 등을 바람직하게 이용할 수 있다.Amines include, for example, piperidine, N,N-dimethylpiperazine, triethylenediamine, 2,4,6-tris(dimethylaminomethyl)phenol, benzyldimethylamine, and 2-(dimethylaminomethyl)phenol. , diethylenetriamine, triethylenetetramine, tetraethylenepentamine, diethylaminopropylamine, N-aminoethylpiperazine, di(1-methyl-2-aminocyclohexyl)methane, menthanediamine, isophoronediamine, Diaminodicyclohexylmethane, 1,3-bis(aminomethyl)cyclohexane, xylenediamine, metaphenylenediamine, diaminodiphenylmethane, diaminodiphenylsulfone, etc. are mentioned. Among these, liquid diethylenetriamine, triethylenetetramine, tetraethylenepentamine, diethylaminopropylamine, N-aminoethylpiperazine, bis(1-methyl-2-aminocyclohexyl)methane, menthanediamine, Isophorone diamine, diaminodicyclohexylmethane, etc. can be preferably used.

페놀 수지로는, 예를 들어, 페놀노볼락 수지, 크레졸노볼락 수지 등을 들 수 있다.Examples of the phenol resin include phenol novolak resin and cresol novolak resin.

폴리아미드 수지는, 다이머산과 폴리아민의 축합에 의해 생성되는 것으로, 분자 중에 1급 아민과 2급 아민을 갖는 폴리아미드아민이다.Polyamide resin is produced by condensation of dimer acid and polyamine, and is a polyamide amine having primary amine and secondary amine in the molecule.

이미다졸류로는, 예를 들어, 2-메틸이미다졸, 2-에틸-4-메틸이미다졸, 1-시아노에틸-2-운데실이미다졸륨트리멜리테이트, 에폭시이미다졸어덕트 등을 들 수 있다.Imidazoles include, for example, 2-methylimidazole, 2-ethyl-4-methylimidazole, 1-cyanoethyl-2-undecylimidazolium trimellitate, and epoxyimidazole adduct. etc. can be mentioned.

폴리메르캅탄은, 예를 들어, 폴리프로필렌글리콜쇄의 말단에 메르캅탄기가 존재하는 것이나, 폴리에틸렌글리콜쇄의 말단에 메르캅탄기가 존재하는 것이며, 액상인 것이 바람직하다.Polymercaptans, for example, have a mercaptan group at the end of a polypropylene glycol chain or a mercaptan group at the end of a polyethylene glycol chain, and are preferably in a liquid form.

또한, 본 발명의 경화성 조성물로부터 경화물을 얻을 때, 적당히, 경화촉진제(경화조제라고도 함)가 병용될 수도 있다.Additionally, when obtaining a cured product from the curable composition of the present invention, a curing accelerator (also referred to as a curing aid) may be used together as appropriate.

경화촉진제로는, 트리페닐포스핀, 트리부틸포스핀 등의 유기인 화합물; 에틸트리페닐포스포늄브로마이드, 테트라부틸포스포늄O,O-디에틸포스포로디티오에이트 등의 제4급 포스포늄염; 1,8-디아자비시클로[5.4.0]운데카-7-엔, 1,8-디아자비시클로[5.4.0]운데카-7-엔과 옥틸산의 염, 옥틸산아연, 테트라부틸암모늄브로마이드 등의 제4급 암모늄염 등을 들 수 있다. 또한 상기 서술한 경화제로서 든 2-메틸이미다졸, 2-에틸-4-메틸이미다졸 등의 이미다졸류나, 2,4,6-트리스(디메틸아미노메틸)페놀, 벤질디메틸아민 등의 아민류도 다른 종류의 경화제에 대한 경화촉진제로서 이용할 수 있다.Examples of the curing accelerator include organophosphorus compounds such as triphenylphosphine and tributylphosphine; Quaternary phosphonium salts such as ethyltriphenylphosphonium bromide and tetrabutylphosphonium O,O-diethylphosphorodithioate; 1,8-Diazabicyclo[5.4.0]undeca-7-ene, salt of 1,8-diazabicyclo[5.4.0]undeca-7-ene and octylic acid, zinc octylate, tetrabutylammonium and quaternary ammonium salts such as bromide. In addition, imidazoles such as 2-methylimidazole and 2-ethyl-4-methylimidazole, and amines such as 2,4,6-tris(dimethylaminomethyl)phenol and benzyldimethylamine as the curing agents mentioned above. It can also be used as a curing accelerator for other types of curing agents.

이들 경화촉진제는, 경화제 1질량부에 대하여, 0.001~0.1질량부의 비율로 이용할 수 있다.These curing accelerators can be used in a ratio of 0.001 to 0.1 parts by mass per 1 part by mass of the curing agent.

본 발명에서는, 상기 식[1]로 표시되는 에폭시 화합물 및 에폭시 수지를 포함하는 에폭시 수지 조성물에, 상기 (b)경화제와 필요에 따라 경화촉진제를 혼합함으로써, 경화성 조성물이 얻어진다.In the present invention, a curable composition is obtained by mixing the curing agent (b) and, if necessary, a curing accelerator into an epoxy resin composition containing an epoxy compound and an epoxy resin represented by the formula [1].

이들 성분의 혼합은, 균일하게 혼합할 수 있으면 특별히 한정되는 것은 아니나, 예를 들어 반응플라스크와 교반날개 혹은 믹서 등을 이용하거나, 혹은 혼련기를 사용하는 것이 바람직하고, 예를 들어 자전공전식 교반기에 의한 충분한 교반하에서 행하는 것이 바람직하다.Mixing of these components is not particularly limited as long as they can be mixed uniformly, but it is preferable to use, for example, a reaction flask and a stirring blade or a mixer, or to use a kneader, for example, using a rotating stirrer. It is preferable to carry out under sufficient stirring.

혼합은 점도를 고려하여 필요에 따라 가열하에서 행해지고, 10~100℃의 온도에서 0.5~1시간 행해진다. 에폭시 수지 조성물의 점도가 높고, 균일한 혼합이 신속하게 진행되지 않는 경우는, 경화반응이 진행되지 않을 정도로 가열을 행함으로써 점도가 저감화되고, 조작성이 향상된다.Mixing is performed under heating as necessary considering viscosity, and is performed at a temperature of 10 to 100°C for 0.5 to 1 hour. When the viscosity of the epoxy resin composition is high and uniform mixing does not proceed quickly, the viscosity is reduced and operability is improved by heating to a level where the curing reaction does not proceed.

또한, 상기 서술한 바와 같이, 에폭시 화합물로서 용제에 용해한 에폭시 화합물을 이용하거나, 경화제에 용제가 포함되는 경우, 얻어지는 경화성 조성물에 있어서도 상기 용제가 포함될 수 있으나, 이 용제는 그 증발에 의해 경화물의 다양한 성능저하를 발생시키는 요인이 될 수 있으므로, 경화성 조성물의 조제 중에 혹은 조제 후에, 감압 또는 가열처리함으로써, 경화물을 형성하기 전에 경화성 조성물로부터 용제를 제거하는 것이 바람직하다.In addition, as described above, when an epoxy compound dissolved in a solvent is used as an epoxy compound or a solvent is included in the curing agent, the solvent may also be included in the resulting curable composition. Since it may be a factor in causing performance degradation, it is preferable to remove the solvent from the curable composition before forming the cured product by performing pressure reduction or heat treatment during or after preparation of the curable composition.

얻어진 경화성 조성물은, 예를 들어 액상 봉지재로서 이용하기 위한 적절한 점도를 갖는다. 본 발명의 경화성 조성물은, 임의의 점도로 조정이 가능하며, 캐스팅법, 포팅법, 디스펜서법, 인쇄법 등에 의해 LED 등의 투명봉지재로서 이용하기 위해, 그 임의개소에 부분적 봉지를 할 수 있다. 경화성 조성물을 상기 서술한 방법으로 액상 그대로 직접, LED 등에 실장한 후, 건조하고, 경화함으로써 에폭시 수지경화물이 얻어진다.The obtained curable composition has an appropriate viscosity for use as, for example, a liquid encapsulant. The curable composition of the present invention can be adjusted to an arbitrary viscosity, and can be partially encapsulated in an arbitrary location for use as a transparent encapsulating material for LEDs, etc. by casting, potting, dispenser, printing, etc. . A cured epoxy resin product is obtained by directly mounting the curable composition in its liquid form on an LED or the like using the method described above, followed by drying and curing.

상기 경화성 조성물로부터 얻어지는 경화물은, 이 경화성 조성물을 기재에 도포, 혹은 이형제를 도포한 주형판에 주입하여, 100~120℃의 온도에서 예비경화하고, 그리고 120~200℃의 온도에서 본 경화(후경화)함으로써 얻어진다.The cured product obtained from the curable composition is pre-cured at a temperature of 100 to 120 ° C. by applying the curable composition to a substrate or injecting it into a mold plate coated with a mold release agent, and then cured at a temperature of 120 to 200 ° C. It is obtained by post-curing).

가열시간은, 1~12시간, 예를 들어 예비경화 및 본 경화 모두 각각 2~5시간 정도이다.The heating time is 1 to 12 hours, for example, about 2 to 5 hours for both pre-curing and main curing.

본 발명의 경화성 조성물로부터 얻어지는 도막의 두께는, 경화물의 용도에 따라, 0.01μm~10mm 정도의 범위에서 선택할 수 있다.The thickness of the coating film obtained from the curable composition of the present invention can be selected in the range of about 0.01 μm to 10 mm depending on the intended use of the cured product.

[(c) 경화촉매 및 이것을 포함하는 경화성 조성물][(c) Curing catalyst and curable composition containing the same]

본 발명은, 상기 서술한 에폭시 수지 조성물, 및 (c)경화촉매를 포함하는 경화성 조성물도 대상으로 한다. (c)경화촉매는, (c1)산발생제 및/또는 (c2)염기발생제로 이루어진다.The present invention also applies to the curable composition containing the above-described epoxy resin composition and (c) a curing catalyst. (c) The curing catalyst consists of (c1) an acid generator and/or (c2) a base generator.

<(c1)산발생제><(c1) acid generator>

(c1)산발생제로는, 광산발생제 또는 열산발생제를 이용할 수 있고, 이들은, 광조사 또는 가열에 의해 직접 또는 간접적으로 산(루이스산 혹은 브렌스테드산)을 생성하는 것이면 특별히 한정되지 않는다.(c1) As the acid generator, a photoacid generator or a thermal acid generator can be used, and these are not particularly limited as long as they produce an acid (Lewis acid or Bransted acid) directly or indirectly by light irradiation or heating. .

광산발생제의 구체예로는, 요오드늄염, 설포늄염, 포스포늄염, 셀레늄염 등의 오늄염, 메탈로센착체 화합물, 철아렌착체 화합물, 디설폰계 화합물, 설폰산유도체 화합물, 트리아진계 화합물, 아세토페논유도체 화합물, 디아조메탄계 화합물, 등을 들 수 있다.Specific examples of photoacid generators include onium salts such as iodonium salts, sulfonium salts, phosphonium salts, and selenium salts, metallocene complex compounds, iron arene complex compounds, disulfone-based compounds, sulfonic acid derivative compounds, triazine-based compounds, Acetophenone derivative compounds, diazomethane-based compounds, etc. can be mentioned.

상기 오늄염 중, 요오드늄염으로는, 예를 들어, 디페닐요오드늄, 4,4'-디클로로디페닐요오드늄, 4,4'-디메톡시디페닐요오드늄, 4,4'-디-tert-부틸디페닐요오드늄, 4-메틸페닐(4-(2-메틸프로필)페닐)요오드늄, 3,3'-디니트로페닐요오드늄, 4-(1-에톡시카르보닐에톡시)페닐(2,4,6-트리메틸페닐)요오드늄, 4-메톡시페닐(페닐)요오드늄 등의 요오드늄의, 클로라이드, 브로마이드, 메실레이트, 토실레이트, 트리플루오로메탄설포네이트, 테트라플루오로보레이트, 테트라키스(펜타플루오로페닐)보레이트, 헥사플루오로포스페이트, 헥사플루오로아세네이트, 헥사플루오로안티모네이트 등의 디아릴요오드늄염을 들 수 있다.Among the above onium salts, iodonium salts include, for example, diphenyl iodonium, 4,4'-dichlorodiphenyl iodonium, 4,4'-dimethoxydiphenyl iodonium, and 4,4'-di-tert. -Butyldiphenyliodonium, 4-methylphenyl(4-(2-methylpropyl)phenyl)iodonium, 3,3'-dinitrophenyliodonium, 4-(1-ethoxycarbonylethoxy)phenyl (2 , 4,6-trimethylphenyl) iodonium, 4-methoxyphenyl (phenyl) iodonium, chloride, bromide, mesylate, tosylate, trifluoromethanesulfonate, tetrafluoroborate, tetra Diaryliodonium salts such as kiss (pentafluorophenyl) borate, hexafluorophosphate, hexafluoroacetate, and hexafluoroantimonate can be mentioned.

상기 설포늄염으로는, 예를 들어, 트리페닐설포늄, 디페닐(4-tert-부틸페닐)설포늄, 트리스(4-tert-부틸페닐)설포늄, 디페닐(4-메톡시페닐)설포늄, 트리스(4-메틸페닐)설포늄, 트리스(4-메톡시페닐)설포늄, 트리스(4-에톡시페닐)설포늄, 디페닐(4-(페닐티오)페닐)설포늄, 트리스(4-(페닐티오)페닐)설포늄 등의 설포늄의, 클로라이드, 브로마이드, 트리플루오로메탄설포네이트, 테트라플루오로보레이트, 헥사플루오로포스페이트, 헥사플루오로아세네이트, 헥사플루오로안티모네이트 등의 트리아릴설포늄염을 들 수 있다.Examples of the sulfonium salt include triphenylsulfonium, diphenyl(4-tert-butylphenyl)sulfonium, tris(4-tert-butylphenyl)sulfonium, and diphenyl(4-methoxyphenyl)sulfonium. Phonium, tris(4-methylphenyl)sulfonium, tris(4-methoxyphenyl)sulfonium, tris(4-ethoxyphenyl)sulfonium, diphenyl(4-(phenylthio)phenyl)sulfonium, tris(4) -Sulfonium such as (phenylthio)phenyl)sulfonium, chloride, bromide, trifluoromethane sulfonate, tetrafluoroborate, hexafluorophosphate, hexafluoroacetate, hexafluoroantimonate, etc. Triaryl sulfonium salts may be mentioned.

상기 포스포늄염으로는, 예를 들어, 테트라페닐포스포늄, 에틸트리페닐포스포늄, 테트라(p-메톡시페닐)포스포늄, 에틸트리(p-메톡시페닐)포스포늄, 벤질트리페닐포스포늄 등의 포스포늄의, 클로라이드, 브로마이드, 테트라플루오로보레이트, 헥사플루오로포스페이트, 헥사플루오로안티모네이트 등의 아릴포스포늄염을 들 수 있다.Examples of the phosphonium salt include tetraphenylphosphonium, ethyltriphenylphosphonium, tetra(p-methoxyphenyl)phosphonium, ethyltri(p-methoxyphenyl)phosphonium, and benzyltriphenylphosphonium. and arylphosphonium salts of phosphonium such as chloride, bromide, tetrafluoroborate, hexafluorophosphate, and hexafluoroantimonate.

상기 셀레늄염으로는, 트리페닐셀레늄헥사플루오로포스페이트 등의 트리아릴셀레늄염을 들 수 있다.Examples of the selenium salt include triaryl selenium salts such as triphenyl selenium hexafluorophosphate.

상기 철아렌착체 화합물로는, 예를 들어, 비스(η5-시클로펜타디에닐)(η6-이소프로필벤젠)철(II)헥사플루오로포스페이트 등을 들 수 있다.Examples of the iron arene complex compound include bis(η 5 -cyclopentadienyl)(η 6 -isopropylbenzene)iron(II)hexafluorophosphate.

이들 광산발생제는 단독으로, 또는 2종 이상을 조합하여 이용할 수 있다.These photoacid generators can be used individually or in combination of two or more types.

열산발생제로는, 설포늄염 및 포스포늄염을 들 수 있고, 이들 예시 화합물로는, 상기 서술한 광산발생제에 있어서 각종 오늄염의 예시로서 든 화합물을 들 수 있다. 또한, 벤질(4-하이드록시페닐)(메틸)설포늄헥사플루오로안티모네이트 등을 호적하게 이용할 수 있다.Examples of the thermal acid generator include sulfonium salts and phosphonium salts, and examples of these compounds include compounds cited as examples of various onium salts in the above-mentioned photoacid generators. Additionally, benzyl(4-hydroxyphenyl)(methyl)sulfonium hexafluoroantimonate and the like can be suitably used.

이들 열산발생제는 단독으로, 또는 2종 이상을 조합하여 이용할 수 있다.These thermal acid generators can be used individually or in combination of two or more types.

이들 중에서도, (c1)산발생제로서, 설포늄염 화합물 또는 요오드늄염 화합물이 바람직하고, 예를 들어 강산성을 나타낸 헥사플루오로포스페이트나 헥사플루오로안티모네이트 등의 음이온종을 갖는 화합물이 바람직하다.Among these, as the (c1) acid generator, a sulfonium salt compound or an iodonium salt compound is preferable, and for example, a compound having an anionic species such as hexafluorophosphate or hexafluoroantimonate, which exhibits strong acidity, is preferable.

(c1)산발생제는, (a)에폭시 수지 조성물 100질량부에 대하여, 0.1~20질량부, 바람직하게는 0.1~10질량부, 더욱 바람직하게는 0.5~10질량부의 비율로 함유할 수 있다.(c1) The acid generator can be contained in a ratio of 0.1 to 20 parts by mass, preferably 0.1 to 10 parts by mass, more preferably 0.5 to 10 parts by mass, based on 100 parts by mass of the (a) epoxy resin composition. .

<(c2)염기발생제><(c2) base generator>

(c2)염기발생제로는, 광염기발생제 또는 열염기발생제를 이용할 수 있고, 이들은, 광조사 또는 가열에 의해 직접 또는 간접적으로 염기(루이스염기 혹은 브렌스테드염기)를 생성하는 것이면 특별히 한정되지 않는다.(c2) As the base generator, a photobase generator or a thermobase generator can be used, and these are specifically limited as long as they generate a base (Lewis base or Bransted base) directly or indirectly by light irradiation or heating. It doesn't work.

광염기발생제로는, 예를 들어, 9-안트릴메틸=N,N-디에틸카바메이트 등의 알킬아민계 광염기발생제; 9-안트릴=N,N-디시클로헥실카바메이트, 1-(9,10-안트라퀴논-2-일)에틸=N,N-디시클로헥실카바메이트, 디시클로헥실암모늄=2-(3-벤조일페닐)프로피오네이트, 9-안트릴=N-시클로헥실카바메이트, 1-(9,10-안트라퀴논-2-일)에틸=N-시클로헥실카바메이트, 시클로헥실암모늄=2-(3-벤조일페닐)프로피오네이트, (E)-N-시클로헥실-3-(2-하이드록시페닐)아크릴아미드 등의 시클로알킬아민계 광염기발생제; 9-안트릴메틸=피페리딘-1-카르복시레이트, (E)-1-피페리디노-3-(2-하이드록시페닐)-2-프로펜-1-온, (2-니트로페닐)메틸=4-하이드록시피페리딘-1-카르복시레이트, (2-니트로페닐)메틸=4-(메타크릴로일옥시)피페리딘-1-카르복시레이트 등의 피페리딘계 광염기발생제; 구아니디늄=2-(3-벤조일페닐)프로피오네이트, 1,2-디이소프로필-3-(비스(디메틸아미노)메틸렌)구아니디늄=2-(3-벤조일페닐)프로피오네이트, 1,2-디시클로헥실-4,4,5,5-테트라메틸비구아니듐=n-부틸트리페닐보레이트, 1,5,7-트리아자비시클로[4.4.0]데카-5-에늄=2-(9-옥소크산텐-2-일)프로피오네이트 등의 구아니딘계 광염기발생제; 1-(9,10-안트라퀴논-2-일)에틸=이미다졸-1-카르복시레이트 등의 이미다졸계 광염기발생제 등을 들 수 있다.Examples of the photobase generator include alkylamine-based photobase generators such as 9-anthrylmethyl=N,N-diethylcarbamate; 9-Anthryl=N,N-dicyclohexylcarbamate, 1-(9,10-anthraquinon-2-yl)ethyl=N,N-dicyclohexylcarbamate, dicyclohexylammonium=2-(3 -benzoylphenyl)propionate, 9-anthryl=N-cyclohexylcarbamate, 1-(9,10-anthraquinon-2-yl)ethyl=N-cyclohexylcarbamate, cyclohexylammonium=2-( Cycloalkylamine-based photobase generators such as 3-benzoylphenyl)propionate and (E)-N-cyclohexyl-3-(2-hydroxyphenyl)acrylamide; 9-anthrylmethyl=piperidine-1-carboxylate, (E)-1-piperidino-3-(2-hydroxyphenyl)-2-propen-1-one, (2-nitrophenyl) Piperidine-based photobase generators such as methyl=4-hydroxypiperidine-1-carboxylate and (2-nitrophenyl)methyl=4-(methacryloyloxy)piperidine-1-carboxylate; Guanidinium=2-(3-benzoylphenyl)propionate, 1,2-diisopropyl-3-(bis(dimethylamino)methylene)guanidinium=2-(3-benzoylphenyl)propionate, 1,2-dicyclohexyl-4,4,5,5-tetramethylbiguanidium=n-butyltriphenylborate, 1,5,7-triazabicyclo[4.4.0]deca-5-enium=2 -Guanidine-based photobase generators such as (9-oxoxanthen-2-yl)propionate; and imidazole-based photobase generators such as 1-(9,10-anthraquinon-2-yl)ethyl=imidazole-1-carboxylate.

이들 광염기발생제는, 1종을 단독으로, 또는 2종 이상을 조합하여 이용할 수 있다.These photobase generators can be used individually or in combination of two or more types.

또한, 광염기발생제는 시판품으로서 입수가능하며, 예를 들어, 와코순약공업(주)제의 광염기발생제 WPBG시리즈(WPBG-018, 동 027, 동 082, 동 140, 동 266, 동 300 등) 등을 호적하게 이용할 수 있다.In addition, photobase generators are available as commercial products, for example, photobase generator WPBG series (WPBG-018, No. 027, No. 082, No. 140, No. 266, No. 300) manufactured by Wako Pure Chemical Industries, Ltd. etc.) can be used conveniently.

열염기발생제로는, 예를 들어, 1-메틸-1-(4-비페닐일)에틸카바메이트, 2-시아노-1,1-디메틸에틸카바메이트 등의 카바메이트류; 요소, N,N-디메틸-N'-메틸요소 등의 요소류; 트리클로로아세트산구아니딘, 페닐설포닐아세트산구아니딘, 페닐프로피올산구아니딘 등의 구아니딘류; 1,4-디하이드로니코틴아미드 등의 디하이드로피리딘류; N-(이소프로폭시카르보닐)-2,6-디메틸피페리딘, N-(tert-부톡시카르보닐)-2,6-디메틸피페리딘, N-(벤질옥시카르보닐)-2,6-디메틸피페리딘 등의 디메틸피페리딘류; 페닐설포닐아세트산테트라메틸암모늄, 페닐프로피올산테트라메틸암모늄 등의 4급화 암모늄염; 디시안디아미드 등을 들 수 있다. 또한, 1,8-디아자비시클로[5.4.0]운데카-7-엔(DBU)의 염인, U-CAT(등록상표) SA810, 동 SA831, 동 SA841, 동 SA851[이상, 산아프로(주)제] 등을 들 수 있다.Examples of the thermobase generator include carbamates such as 1-methyl-1-(4-biphenylyl)ethyl carbamate and 2-cyano-1,1-dimethylethyl carbamate; Urea, such as urea and N,N-dimethyl-N'-methylurea; Guanidines such as guanidine trichloroacetate, guanidine phenylsulfonylacetate, and guanidine phenylpropiolate; Dihydropyridines such as 1,4-dihydronicotinamide; N-(isopropoxycarbonyl)-2,6-dimethylpiperidine, N-(tert-butoxycarbonyl)-2,6-dimethylpiperidine, N-(benzyloxycarbonyl)-2, Dimethylpiperidines such as 6-dimethylpiperidine; Quaternary ammonium salts such as tetramethylammonium phenylsulfonylacetate and tetramethylammonium phenylpropiolate; Dicyandiamide, etc. can be mentioned. In addition, the salt of 1,8-diazabicyclo[5.4.0]undeca-7-ene (DBU), U-CAT (registered trademark) SA810, SA831, SA841, SA851 [above, San-Apro Co., Ltd. ) 1st], etc. may be mentioned.

이들 열염기발생제는, 1종을 단독으로, 또는 2종 이상을 조합하여 이용할 수 있다.These thermobase generators can be used individually or in combination of two or more types.

(c2)염기발생제는, (a)에폭시 수지 조성물 100질량부에 대하여, 0.1~20질량부, 바람직하게는 0.1~10질량부, 더욱 바람직하게는 0.5~10질량부의 비율로 함유할 수 있다.(c2) The base generator can be contained in a ratio of 0.1 to 20 parts by mass, preferably 0.1 to 10 parts by mass, more preferably 0.5 to 10 parts by mass, based on 100 parts by mass of the epoxy resin composition (a). .

본 발명에서는, 상기 식[1]로 표시되는 에폭시 화합물 및 에폭시 수지를 포함하는 에폭시 수지 조성물에, 상기 (c)경화촉매를 혼합함으로써, 경화성 조성물이 얻어진다. 이 경화성 조성물을 얻기 위한 혼합의 조작조건은 상기 서술한 바와 같다.In the present invention, a curable composition is obtained by mixing the curing catalyst (c) with an epoxy resin composition containing an epoxy compound and an epoxy resin represented by the formula [1]. The operating conditions for mixing to obtain this curable composition are as described above.

본 발명에서는, 상기 에폭시 수지 조성물과 (c)경화촉매를 포함하는 경화성 조성물을 기판 상에 도포하고, 광조사 혹은 가열함으로써 경화할 수 있다. 또한 광조사의 전후에 추가로 가열할 수도 있다.In the present invention, the curable composition containing the above-described epoxy resin composition and (c) a curing catalyst can be applied onto a substrate and cured by light irradiation or heating. Additionally, additional heating may be performed before or after light irradiation.

본 발명의 경화성 조성물을 기판 상에 도포하는 방법으로는, 예를 들어, 플로우코팅법, 스핀코팅법, 스프레이코팅법, 스크린인쇄법, 플렉소인쇄법, 잉크젯인쇄법, 캐스트법, 바코팅법, 커튼코팅법, 롤코팅법, 그래비어코팅법, 디핑법, 슬릿법 등을 들 수 있다.Methods for applying the curable composition of the present invention on a substrate include, for example, flow coating, spin coating, spray coating, screen printing, flexographic printing, inkjet printing, casting, and bar coating. , curtain coating method, roll coating method, gravure coating method, dipping method, slit method, etc.

본 발명의 경화성 조성물로부터 형성되는 도막의 두께는, 경화물의 용도에 따라, 0.01μm~10mm 정도의 범위에서 선택할 수 있고, 예를 들어, 포토레지스트에 이용하는 경우는 0.05~10μm(특히 0.1~5μm) 정도로 할 수 있고, 프린트배선기판에 이용하는 경우는 10μm~5mm(특히 100μm~1mm) 정도로 할 수 있고, 광학박막에 이용하는 경우는 0.1~100μm(특히 0.3~50μm) 정도로 할 수 있다.The thickness of the coating film formed from the curable composition of the present invention can be selected in the range of about 0.01 μm to 10 mm depending on the use of the cured product, for example, when used for photoresist, 0.05 to 10 μm (especially 0.1 to 5 μm). When used for printed wiring boards, it can be set to around 10 μm to 5 mm (especially 100 μm to 1 mm), and when used for optical thin films, it can be set to around 0.1 to 100 μm (especially 0.3 to 50 μm).

(c)경화촉매를 함유하는 경화성 조성물에 있어서, 광산발생제 또는 광염기발생제를 이용하는 경우의 조사 또는 노광하는 광으로는, 예를 들어, 감마선, X선, 자외선, 가시광선 등을 들 수 있고, 통상, 가시광선 또는 자외선, 특히 자외선이 이용되는 경우가 많다.(c) In the curable composition containing a curing catalyst, the light for irradiation or exposure when using a photoacid generator or photobase generator includes, for example, gamma rays, X-rays, ultraviolet rays, visible light, etc. Usually, visible light or ultraviolet rays, especially ultraviolet rays, are often used.

광의 파장은, 예를 들어, 150~800nm, 바람직하게는 150~600nm, 더욱 바람직하게는 200~400nm, 특히 300~400nm 정도이다.The wavelength of light is, for example, 150 to 800 nm, preferably 150 to 600 nm, more preferably 200 to 400 nm, and especially 300 to 400 nm.

노광량은, 도막의 두께에 따라 상이하나, 예를 들어, 2~20,000mJ/cm2, 바람직하게는 5~5,000mJ/cm2 정도로 할 수 있다.The exposure amount varies depending on the thickness of the coating film, but can be, for example, 2 to 20,000 mJ/cm 2 , preferably about 5 to 5,000 mJ/cm 2 .

광원으로는, 노광하는 광선의 종류에 따라 선택할 수 있고, 예를 들어, 자외선의 경우는 저압수은램프, 고압수은램프, 초고압수은램프, 중수소램프, 할로겐램프, 레이저광(헬륨-카드뮴레이저, 엑시머레이저 등), UV-LED 등을 이용할 수 있다. 이러한 광조사에 의해, 상기 조성물의 경화반응이 진행된다.The light source can be selected depending on the type of light to be exposed. For example, in the case of ultraviolet rays, low-pressure mercury lamp, high-pressure mercury lamp, ultra-high pressure mercury lamp, deuterium lamp, halogen lamp, laser light (helium-cadmium laser, excimer laser, etc.), UV-LED, etc. can be used. By such light irradiation, the curing reaction of the composition proceeds.

(c)경화촉매를 함유하는 경화성 조성물에 있어서, 열산발생제 또는 열염기발생제를 이용하는 경우나, 광산발생제 또는 광염기발생제를 이용하고 광조사 후에 필요에 따라 행해지는 도막의 가열은, 예를 들어, 실온(대략 23℃)~250℃ 정도로 행해진다. 가열시간은, 3초 이상(예를 들어, 3초~5시간 정도)의 범위에서 선택할 수 있고, 예를 들어, 5초~2시간 정도이다.(c) In the curable composition containing a curing catalyst, when using a thermal acid generator or a thermobase generator, or using a photoacid generator or a photobase generator, heating of the coating film performed as necessary after light irradiation is, For example, it is carried out at room temperature (approximately 23°C) to approximately 250°C. The heating time can be selected from a range of 3 seconds or more (for example, from 3 seconds to about 5 hours), for example, from 5 seconds to about 2 hours.

나아가, 패턴이나 화상을 형성하는 경우(예를 들어, 프린트배선기판 등을 제조하는 경우), 기재 상에 형성한 도막을 패턴노광할 수도 있다. 이 패턴노광은, 레이저광의 주사에 의해 행할 수도 있고, 포토마스크를 개재하여 광조사함으로써 행할 수도 있다. 이러한 패턴노광에 의해 생성한 비조사영역(미노광부)을 현상액으로 현상(또는 용해)함으로써 패턴 또는 화상을 형성할 수 있다.Furthermore, when forming a pattern or image (for example, when manufacturing a printed wiring board, etc.), the coating film formed on the substrate may be pattern exposed. This pattern exposure can be performed by scanning laser light, or by irradiating light through a photomask. A pattern or image can be formed by developing (or dissolving) the non-irradiated area (unexposed area) created by such pattern exposure with a developer.

현상액으로는, 알칼리수용액이나 유기용제를 이용할 수 있다.As a developer, an aqueous alkaline solution or an organic solvent can be used.

알칼리수용액으로는, 예를 들어, 수산화칼륨, 수산화나트륨, 탄산칼륨, 탄산나트륨 등의 알칼리금속수산화물의 수용액; 수산화테트라메틸암모늄, 수산화테트라에틸암모늄, 콜린 등의 수산화4급암모늄의 수용액; 에탄올아민, 프로필아민, 에틸렌디아민 등의 아민수용액 등을 들 수 있다.Examples of the aqueous alkaline solution include aqueous solutions of alkali metal hydroxides such as potassium hydroxide, sodium hydroxide, potassium carbonate, and sodium carbonate; Aqueous solutions of quaternary ammonium hydroxide such as tetramethylammonium hydroxide, tetraethylammonium hydroxide, and choline; and amine aqueous solutions such as ethanolamine, propylamine, and ethylenediamine.

상기 알칼리현상액은, 10질량% 이하의 수용액인 것이 일반적이고, 바람직하게는 0.1~3질량%의 수용액 등이 이용된다. 또한 상기 현상액에 알코올류나 계면활성제를 첨가하여 사용할 수 있고, 이들 첨가량은 각각, 현상액 100질량부에 대하여, 바람직하게는 0.05~10질량부이다. 구체적으로는, 0.1~2.38질량%의 수산화테트라메틸암모늄수용액 등을 이용할 수 있다.The alkaline developer is generally an aqueous solution of 10% by mass or less, and an aqueous solution of 0.1 to 3% by mass is preferably used. Additionally, alcohols or surfactants can be added to the developer, and the amount of these additions is preferably 0.05 to 10 parts by mass per 100 parts by mass of the developer. Specifically, a 0.1 to 2.38% by mass aqueous solution of tetramethylammonium hydroxide, etc. can be used.

또한, 현상액으로서의 유기용제는, 일반적인 유기용제를 이용하는 것이 가능하며, 예를 들어, 톨루엔 등의 방향족 탄화수소류; 유산에틸, 프로필렌글리콜모노메틸에테르아세테이트(PGMEA), 프로필렌글리콜모노에틸에테르아세테이트, 프로필렌글리콜모노프로필에테르아세테이트, 프로필렌글리콜모노부틸에테르아세테이트 등의 에스테르류; N,N-디메틸포름아미드(DMF) 등의 아미드류; 아세토니트릴 등의 니트릴류; 아세톤, 시클로헥산온 등의 케톤류; 메탄올, 에탄올, 2-프로판올, 프로필렌글리콜모노메틸에테르(PGME), 프로필렌글리콜모노에틸에테르, 프로필렌글리콜모노프로필에테르, 프로필렌글리콜모노부틸에테르 등의 알코올류 등을 들 수 있다. 이들은, 단독으로 또는 2종 이상의 혼합물로서 이용할 수 있다.In addition, the organic solvent used as a developer can be a general organic solvent, for example, aromatic hydrocarbons such as toluene; Ester such as ethyl lactate, propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, and propylene glycol monobutyl ether acetate; Amides such as N,N-dimethylformamide (DMF); Nitriles such as acetonitrile; Ketones such as acetone and cyclohexanone; Alcohols such as methanol, ethanol, 2-propanol, propylene glycol monomethyl ether (PGME), propylene glycol monoethyl ether, propylene glycol monopropyl ether, and propylene glycol monobutyl ether can be mentioned. These can be used individually or as a mixture of two or more types.

그 중에서도, 유산에틸, 프로필렌글리콜모노메틸에테르아세테이트(PGMEA), 프로필렌글리콜모노메틸에테르(PGME) 등을 바람직하게 사용할 수 있다.Among them, ethyl lactate, propylene glycol monomethyl ether acetate (PGMEA), propylene glycol monomethyl ether (PGME), etc. can be preferably used.

[용제][solvent]

상기의 에폭시 수지 조성물 및 (b)경화제를 포함하는 경화성 조성물, 그리고, 에폭시 수지 조성물 및 (c)경화촉매를 포함하는 경화성 조성물은, 필요에 따라 용제를 포함할 수 있다.The curable composition containing the above-mentioned epoxy resin composition and (b) a curing agent, and the curable composition containing the epoxy resin composition and (c) a curing catalyst may contain a solvent as needed.

본 발명의 (a)에폭시 수지 조성물에 있어서, 식[1]로 표시되는 에폭시 화합물은 반응성 희석제로서의 역할을 하고, 여기에 상기 서술한 (b)경화제 혹은 (c)경화촉매를 혼합하여 본 발명의 경화성 조성물은 얻어지는 점에서, 용제를 이용할 필요성은 기본적으로 적지만, 필요에 따라 용제를 첨가하는 것은 가능하다.In the (a) epoxy resin composition of the present invention, the epoxy compound represented by formula [1] serves as a reactive diluent, and is mixed with the above-described (b) curing agent or (c) curing catalyst to prepare the present invention. Since a curable composition is obtained, there is basically little need to use a solvent, but it is possible to add a solvent as needed.

예를 들어, 상기 서술한 (b)경화제가 고체인 경우와 마찬가지로, (c)경화촉매가 고체이며, 경화촉매를 탄산프로필렌 등의 용제에 용해하고 액상 에폭시 수지와 혼합하여 경화성 조성물을 제조할 수 있다. 또한, (a)에폭시 수지 조성물에 산발생제 등을 용해시킨 경우에도, 얻어지는 경화성 조성물의 점도조정을 위하여 일반적인 용제를 첨가할 수도 있다.For example, as in the case where (b) the curing agent described above is solid, (c) the curing catalyst is solid, a curable composition can be prepared by dissolving the curing catalyst in a solvent such as propylene carbonate and mixing it with a liquid epoxy resin. there is. Additionally, even when an acid generator or the like is dissolved in the (a) epoxy resin composition, a general solvent may be added to adjust the viscosity of the resulting curable composition.

용제로는, 예를 들어, 톨루엔, 자일렌 등의 방향족 탄화수소류; 아세트산메틸, 아세트산에틸, 아세트산프로필, 아세트산부틸 등의 에스테르류; 하이드록시아세트산메틸, 하이드록시아세트산에틸, 하이드록시아세트산부틸, 유산메틸, 유산에틸, 유산프로필, 유산부틸, 3-하이드록시프로피온산메틸, 3-하이드록시프로피온산에틸, 3-하이드록시프로피온산프로필, 3-하이드록시프로피온산부틸, 2-하이드록시-2-메틸프로피온산메틸, 2-하이드록시-2-메틸프로피온산에틸, 2-하이드록시-3-메틸부탄산메틸 등의 하이드록시에스테르류; 메톡시아세트산메틸, 메톡시아세트산에틸, 메톡시아세트산프로필, 메톡시아세트산부틸, 에톡시아세트산메틸, 에톡시아세트산에틸, 에톡시아세트산프로필, 에톡시아세트산부틸, 프로폭시아세트산메틸, 프로폭시아세트산에틸, 프로폭시아세트산프로필, 프로폭시아세트산부틸, 부톡시아세트산메틸, 부톡시아세트산에틸, 부톡시아세트산프로필, 부톡시아세트산부틸, 2-메톡시프로피온산메틸, 2-메톡시프로피온산에틸, 2-메톡시프로피온산프로필, 2-메톡시프로피온산부틸, 2-에톡시프로피온산메틸, 2-에톡시프로피온산에틸, 2-에톡시프로피온산프로필, 2-에톡시프로피온산부틸, 2-부톡시프로피온산메틸, 2-부톡시프로피온산에틸, 2-부톡시프로피온산프로필, 2-부톡시프로피온산부틸, 3-메톡시프로피온산메틸, 3-메톡시프로피온산에틸, 3-메톡시프로피온산프로필, 3-메톡시프로피온산부틸, 3-에톡시프로피온산메틸, 3-에톡시프로피온산에틸, 3-에톡시프로피온산프로필, 3-에톡시프로피온산부틸, 3-프로폭시프로피온산메틸, 3-프로폭시프로피온산에틸, 3-프로폭시프로피온산프로필, 3-프로폭시프로피온산부틸, 3-부톡시프로피온산메틸, 3-부톡시프로피온산에틸, 3-부톡시프로피온산프로필, 3-부톡시프로피온산부틸, 메틸셀로솔브아세테이트, 에틸셀로솔브아세테이트, 프로필렌글리콜모노메틸에테르아세테이트(PGMEA), 프로필렌글리콜모노에틸에테르아세테이트, 프로필렌글리콜모노프로필에테르아세테이트, 프로필렌글리콜모노부틸에테르아세테이트, 프로필렌글리콜모노메틸에테르프로피오네이트, 프로필렌글리콜모노에틸에테르프로피오네이트, 프로필렌글리콜모노프로필에테르프로피오네이트, 프로필렌글리콜모노부틸에테르프로피오네이트 등의 에테르에스테르류; 메틸에틸케톤(MEK), 4-하이드록시-4-메틸-2-펜타논, 시클로헥산온 등의 케톤류; 에틸렌글리콜모노메틸에테르, 에틸렌글리콜모노에틸에테르, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르, 프로필렌글리콜모노메틸에테르(PGME), 프로필렌글리콜모노에틸에테르, 프로필렌글리콜모노프로필에테르, 프로필렌글리콜모노부틸에테르 등의 알코올류; 테트라하이드로푸란(THF), 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜에틸메틸에테르 등의 에테르류 등을 들 수 있다.Examples of solvents include aromatic hydrocarbons such as toluene and xylene; esters such as methyl acetate, ethyl acetate, propyl acetate, and butyl acetate; Methyl hydroxyacetate, ethyl hydroxyacetate, butyl hydroxyacetate, methyl lactate, ethyl lactate, propyl lactate, butyl lactate, methyl 3-hydroxypropionate, ethyl 3-hydroxypropionate, 3-hydroxypropionate, 3- Hydroxy esters such as butyl hydroxypropionate, methyl 2-hydroxy-2-methylpropionate, ethyl 2-hydroxy-2-methylpropionate, and methyl 2-hydroxy-3-methylbutanoate; Methyl methoxyacetate, ethyl methoxyacetate, propyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, propyl ethoxyacetate, butyl ethoxyacetate, methyl propoxyacetate, ethyl propoxyacetate, Propoxyacetate, butyl propoxyacetate, methyl butoxyacetate, ethyl butoxyacetate, propyl butoxyacetate, butyl butoxyacetate, methyl 2-methoxypropionate, ethyl 2-methoxypropionate, 2-methoxypropionate. , 2-methoxybutyl propionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate, 2-ethoxypropyl propionate, butyl 2-ethoxypropionate, methyl 2-butoxypropionate, ethyl 2-butoxypropionate, 2-Butoxypropionate, butyl 2-butoxypropionate, 3-methoxymethyl propionate, ethyl 3-methoxypropionate, 3-methoxypropionate, butyl 3-methoxypropionate, 3-ethoxymethyl propionate, 3 -Ethyl ethoxypropionate, 3-ethoxypropyl propionate, 3-ethoxybutyl propionate, 3-methyl propionate, ethyl 3-propoxypropionate, 3-propoxypropionate, 3-butyl propoxypropionate, 3- Methyl butoxypropionate, ethyl 3-butoxypropionate, 3-butoxypropyl propionate, butyl 3-butoxypropionate, methyl cellosolve acetate, ethyl cellosolve acetate, propylene glycol monomethyl ether acetate (PGMEA), propylene glycol Monoethyl ether acetate, propylene glycol monopropyl ether acetate, propylene glycol monobutyl ether acetate, propylene glycol monomethyl ether propionate, propylene glycol monoethyl ether propionate, propylene glycol monopropyl ether propionate, propylene glycol monobutyl Ether esters such as ether propionate; Ketones such as methyl ethyl ketone (MEK), 4-hydroxy-4-methyl-2-pentanone, and cyclohexanone; Ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, propylene glycol monomethyl ether (PGME), propylene glycol monoethyl ether, propylene glycol monopropyl ether, propylene glycol mono Alcohols such as butyl ether; and ethers such as tetrahydrofuran (THF), diethylene glycol dimethyl ether, diethylene glycol diethyl ether, and diethylene glycol ethyl methyl ether.

본 발명의 경화성 조성물에 있어서 용제를 배합한 경우의 고형분의 비율은, 1~100질량%, 또는 5~100질량%, 또는 50~100질량%, 또는 80~100질량%로 할 수 있다. 고형분이란, 경화성 조성물로부터 용제를 제거한 나머지 성분의 비율이다.In the curable composition of the present invention, the solid content ratio when the solvent is mixed can be 1 to 100% by mass, or 5 to 100% by mass, or 50 to 100% by mass, or 80 to 100% by mass. Solid content is the ratio of the remaining components after removing the solvent from the curable composition.

[기타 경화성 모노머][Other curable monomers]

상기 본 발명의 경화성 조성물에는, 점도조정이나 경화성의 향상을 목적으로 하여, 에폭시 수지 이외의 양이온경화성 모노머로서, 비닐기함유 화합물, 옥세타닐기함유 화합물 등을 배합할 수도 있다.In the curable composition of the present invention, vinyl group-containing compounds, oxetanyl group-containing compounds, etc. may be added as cationic curable monomers other than epoxy resins for the purpose of adjusting viscosity or improving curability.

비닐기함유 화합물로는, 비닐기를 갖는 화합물이면 특별히 한정되지 않고, 예를 들어, 2-하이드록시에틸비닐에테르(HEVE), 디에틸렌글리콜모노비닐에테르(DEGV), 2-하이드록시부틸비닐에테르(HBVE), 트리에틸렌글리콜디비닐에테르 등의 비닐에테르 화합물 등을 들 수 있다. 또한, α위치 및/또는 β위치에 알킬기, 알릴기 등의 치환기를 갖는 비닐 화합물도 사용할 수 있다. 또한, 에폭시기 및/또는 옥세타닐기 등의 환상에테르기를 포함하는 비닐에테르 화합물을 사용할 수 있고, 예를 들어, 옥시노보넨디비닐에테르, 3,3-디메탄올옥세탄디비닐에테르 등을 들 수 있다.The vinyl group-containing compound is not particularly limited as long as it is a compound having a vinyl group, and examples include 2-hydroxyethyl vinyl ether (HEVE), diethylene glycol monovinyl ether (DEGV), and 2-hydroxybutyl vinyl ether ( HBVE), vinyl ether compounds such as triethylene glycol divinyl ether, etc. are mentioned. Additionally, vinyl compounds having a substituent such as an alkyl group or an allyl group at the α-position and/or β-position can also be used. In addition, vinyl ether compounds containing cyclic ether groups such as epoxy groups and/or oxetanyl groups can be used, for example, oxynorbornene divinyl ether, 3,3-dimethanoloxetane divinyl ether, etc. .

또한, 비닐기와 (메트)아크릴기를 갖는 화합물을 사용할 수 있고, 예를 들어, (메트)아크릴산2-(2-비닐옥시에톡시)에틸 등을 들 수 있다.Additionally, compounds having a vinyl group and a (meth)acrylic group can be used, for example, 2-(2-vinyloxyethoxy)ethyl (meth)acrylate, etc.

이들 비닐기함유 화합물은, 단독으로 또는 2종 이상을 조합하여 사용할 수 있다.These vinyl group-containing compounds can be used individually or in combination of two or more types.

옥세타닐기함유 화합물로는, 옥세타닐기를 갖는 화합물이면 특별히 한정되지 않고, 3-에틸-3-(하이드록시메틸)옥세탄(OXA), 3-에틸-3-(페녹시메틸)옥세탄(POX), 비스((3-에틸-3-옥세타닐)메틸)에테르(DOX), 1,4-비스(((3-에틸-3-옥세타닐)메톡시)메틸)벤젠(XDO), 3-에틸-3-(2-에틸헥실옥시메틸)옥세탄(EHOX), 3-에틸-3-((3-트리에톡시실릴프로폭시)메틸)옥세탄(TESOX), 옥세타닐실세스퀴옥산(OX-SQ), 페놀노볼락옥세탄(PNOX-1009) 등의 옥세탄 화합물 등을 들 수 있다.The oxetanyl group-containing compound is not particularly limited as long as it is a compound having an oxetanyl group, and includes 3-ethyl-3-(hydroxymethyl)oxetane (OXA) and 3-ethyl-3-(phenoxymethyl)oxetane. (POX), bis((3-ethyl-3-oxetanyl)methyl)ether (DOX), 1,4-bis(((3-ethyl-3-oxetanyl)methoxy)methyl)benzene (XDO ), 3-ethyl-3-(2-ethylhexyloxymethyl)oxetane (EHOX), 3-ethyl-3-((3-triethoxysilylpropoxy)methyl)oxetane (TESOX), oxetanylsil Oxetane compounds, such as sesquioxane (OX-SQ) and phenol novolax oxetane (PNOX-1009), etc. are mentioned.

또한, 옥세타닐기와 (메트)아크릴기를 갖는 화합물을 사용할 수 있고, 예를 들어, (3-에틸-3-옥세타닐)메틸(메트)아크릴레이트 등을 들 수 있다.Additionally, compounds having an oxetanyl group and a (meth)acryl group can be used, for example, (3-ethyl-3-oxetanyl)methyl (meth)acrylate.

이들 옥세타닐기함유 화합물은, 단독으로 또는 2종 이상을 조합하여 사용할 수 있다.These oxetanyl group-containing compounds can be used individually or in combination of two or more types.

[기타 성분][Other ingredients]

상기의 에폭시 수지 조성물 및 (b)경화제를 포함하는 경화성 조성물, 그리고, 에폭시 수지 조성물 및 (c)경화촉매를 포함하는 경화성 조성물은, 필요에 따라 관용의 첨가제를 포함할 수도 있다. 이러한 첨가제로는, 예를 들어, 안료, 착색제, 증점제, 산발생제, 소포제, 레벨링제, 도포성 개량제, 윤활제, 안정제(산화방지제, 열안정제, 내광안정제 등), 가소제, 계면활성제, 밀착촉진제, 용해촉진제, 충전제, 대전방지제, 경화제 등을 들 수 있다. 이들 첨가제는 단독으로 또는 2종 이상 조합할 수도 있다.The curable composition containing the above-described epoxy resin composition and (b) a curing agent, and the curable composition containing the epoxy resin composition and (c) a curing catalyst may contain customary additives as needed. These additives include, for example, pigments, colorants, thickeners, acid generators, antifoaming agents, leveling agents, applicability improvers, lubricants, stabilizers (antioxidants, heat stabilizers, light stabilizers, etc.), plasticizers, surfactants, and adhesion promoters. , dissolution accelerators, fillers, antistatic agents, hardeners, etc. These additives may be used individually or in combination of two or more.

예를 들어 본 발명의 경화성 조성물에는, 도포성을 향상시키는 목적으로 계면활성제를 첨가할 수도 있다. 이러한 계면활성제는, 불소계 계면활성제, 실리콘계 계면활성제, 비이온계 계면활성제 등을 들 수 있으나, 특히 이들로 한정되는 것은 아니다. 상기 계면활성제는, 단독으로 또는 2종류 이상을 조합하여 이용할 수 있다.For example, a surfactant may be added to the curable composition of the present invention for the purpose of improving applicability. Such surfactants include, but are not limited to, fluorine-based surfactants, silicone-based surfactants, and nonionic surfactants. The above surfactants can be used individually or in combination of two or more types.

이들 계면활성제 중에서, 도포성 개선효과의 높이로부터 불소계 계면활성제가 바람직하다. 불소계 계면활성제의 구체예로는, 예를 들어, 에프톱(등록상표) EF-301, 동 EF-303, 동 EF-352[모두 미쯔비시마테리얼전자화성(주)제], 메가팍(등록상표) F-171, 동 F-173, 동 F-482, 동 R-08, 동 R-30, 동 R-90, 동 BL-20[모두 DIC(주)제], 플로라드 FC-430, 동 FC-431[모두 쓰리엠재팬(주)제], 아사히가드(등록상표) AG-710[아사히가라스(주)제], 서프론 S-382, 동 SC-101, 동 SC-102, 동 SC-103, 동 SC-104, 동 SC-105, 동 SC-106[모두 AGC세이미케미칼(주)제] 등을 들 수 있으나, 이들로 한정되는 것은 아니다.Among these surfactants, fluorine-based surfactants are preferable due to their high applicability improvement effect. Specific examples of fluorine-based surfactants include, for example, Ftop (registered trademark) EF-301, EF-303, EF-352 (all manufactured by Mitsubishi Materials Electronics Co., Ltd.), Megapak (registered trademark) ) F-171, F-173, F-482, R-08, R-30, R-90, BL-20 [all made by DIC Co., Ltd.], Florad FC-430, etc. FC-431 [all manufactured by 3M Japan Co., Ltd.], Asahi Guard (registered trademark) AG-710 [all manufactured by Asahi Glass Co., Ltd.], Surfron S-382, SC-101, SC-102, SC -103, SC-104, SC-105, SC-106 (all manufactured by AGC Semichemical Co., Ltd.), etc., but are not limited to these.

본 발명의 경화성 조성물에 있어서의 계면활성제의 첨가량은, 이 경화성 조성물의 고형분(용제를 제거한 전체성분)의 질량에 기초하여, 0.01~5질량%, 바람직하게는 0.01~3질량%, 보다 바람직하게는 0.01~2질량%이다.The amount of surfactant added in the curable composition of the present invention is 0.01 to 5% by mass, preferably 0.01 to 3% by mass, more preferably, based on the mass of the solid content (total components excluding solvent) of the curable composition. is 0.01 to 2% by mass.

또한 본 발명의 경화성 조성물에는, 현상 후의 기판과의 밀착성을 향상시키는 목적으로, 밀착촉진제를 첨가할 수 있다. 이들 밀착촉진제로는, 예를 들어, 클로로트리메틸실란, 트리클로로(비닐)실란, 클로로(디메틸)(비닐)실란, 클로로(메틸)(디페닐)실란, 클로로(클로로메틸)(디메틸)실란 등의 클로로실란류; 메톡시트리메틸실란, 디메톡시디메틸실란, 디에톡시디메틸실란, 에톡시(디메틸)(비닐)실란, 디메톡시디페닐실란, 트리에톡시(페닐)실란, 3-클로로프로필트리메톡시실란, 3-아미노프로필트리에톡시실란, 3-(메트)아크릴로일옥시프로필트리메톡시실란, 3-글리시딜옥시프로필트리메톡시실란, 트리메톡시(3-(N-피페리디닐)프로필)실란 등의 알콕시실란류; 헥사메틸디실라잔, N,N'-비스(트리메틸실릴)우레아, 디메틸(트리메틸실릴)아민, 트리메틸실릴이미다졸 등의 실라잔류; 이미다졸, 인다졸, 벤조이미다졸, 벤조트리아졸, 메르캅토이미다졸, 메르캅토피리미딘2-메르캅토벤조이미다졸, 2-메르캅토벤조옥사졸, 2-메르캅토벤조티아졸, 우라졸, 티오우라실 등의 함질소헤테로환 화합물; 1,1-디메틸우레아, 1,3-디메틸우레아 등의 요소류 또는 티오요소류 등을 들 수 있다. 이들 밀착촉진제는, 단독으로 또는 2종류 이상을 조합하여 이용할 수 있다.Additionally, an adhesion promoter may be added to the curable composition of the present invention for the purpose of improving adhesion to the substrate after development. These adhesion accelerators include, for example, chlorotrimethylsilane, trichloro(vinyl)silane, chloro(dimethyl)(vinyl)silane, chloro(methyl)(diphenyl)silane, chloro(chloromethyl)(dimethyl)silane, etc. chlorosilanes; Methoxytrimethylsilane, dimethoxydimethylsilane, diethoxydimethylsilane, ethoxy(dimethyl)(vinyl)silane, dimethoxydiphenylsilane, triethoxy(phenyl)silane, 3-chloropropyltrimethoxysilane, 3- Aminopropyltriethoxysilane, 3-(meth)acryloyloxypropyltrimethoxysilane, 3-glycidyloxypropyltrimethoxysilane, trimethoxy(3-(N-piperidinyl)propyl)silane alkoxysilanes such as; Silazanes such as hexamethyldisilazane, N,N'-bis(trimethylsilyl)urea, dimethyl(trimethylsilyl)amine, and trimethylsilylimidazole; Imidazole, indazole, benzoimidazole, benzotriazole, mercaptoimidazole, mercaptopyrimidine 2-mercaptobenzoimidazole, 2-mercaptobenzoxazole, 2-mercaptobenzothiazole, ura nitrogen-containing heterocyclic compounds such as sol and thiouracil; Urea or thiourea such as 1,1-dimethylurea and 1,3-dimethylurea can be mentioned. These adhesion promoters can be used individually or in combination of two or more types.

본 발명의 경화성 조성물에 있어서의 밀착촉진제의 첨가량은, 이 경화성 조성물의 고형분(용제를 제거한 전체성분)의 질량에 기초하여, 통상 20질량% 이하, 바람직하게는 0.01~10질량%, 보다 바람직하게는 0.05~5질량%이다.The amount of the adhesion promoter added in the curable composition of the present invention is usually 20% by mass or less, preferably 0.01 to 10% by mass, more preferably 0.01 to 10% by mass, based on the mass of the solid content (total components without solvent) of the curable composition. is 0.05 to 5 mass%.

나아가 본 발명의 경화성 조성물은, 증감제를 포함할 수도 있다. 사용할 수 있는 증감제로는, 안트라센, 페노티아젠, 페릴렌, 티옥산톤, 벤조페논티옥산톤 등을 들 수 있다. 또한, 증감색소로는, 티오피릴륨염계 색소, 메로시아닌계 색소, 퀴놀린계 색소, 스티릴퀴놀린계 색소, 케토쿠마린계 색소, 티옥산텐계 색소, 크산텐계 색소, 옥소놀계 색소, 시아닌계 색소, 로다민계 색소, 피릴륨염계 색소 등이 예시된다. 특히 바람직한 것은, 안트라센계의 증감제이며, 양이온경화촉매(감방사성 양이온중합개시제)와 병용함으로써, 감도가 비약적으로 향상됨과 함께, 라디칼중합개시기능도 갖고 있으며, 예를 들어, 양이온경화시스템과 라디칼경화시스템을 병용하는 하이브리드타입을 채용하는 경우에는, 촉매종을 심플하게 할 수 있다. 구체적인 안트라센의 화합물로는, 디부톡시안트라센, 디프로폭시안트라퀴논 등이 유효하다.Furthermore, the curable composition of the present invention may contain a sensitizer. Sensitizers that can be used include anthracene, phenothiazene, perylene, thioxanthone, and benzophenonethioxanthone. In addition, the sensitizing dyes include thiopyrylium salt dyes, merocyanine dyes, quinoline dyes, styrylquinoline dyes, ketocoumarin dyes, thioxanthene dyes, xanthene dyes, oxonol dyes, and cyanine dyes. Pigments, rhodamine-based pigments, and pyrylium salt-based pigments are examples. Particularly preferred are anthracene-based sensitizers, which, when used in combination with a cationic curing catalyst (radiative cationic polymerization initiator), not only dramatically improve sensitivity, but also have a radical polymerization initiator function. For example, cationic curing systems and radicals When adopting a hybrid type that uses a curing system in combination, the catalyst species can be simple. As specific anthracene compounds, dibutoxyanthracene, dipropoxyanthraquinone, etc. are effective.

또한, 경화촉매로서 염기발생제를 이용하는 경우의 증감제로는, 예를 들어, 아세토페논류, 벤조인류, 벤조페논류, 안트라퀴논류, 크산톤류, 티옥산톤류, 케탈류, 3급 아민류 등을 들 수 있다.In addition, when using a base generator as a curing catalyst, sensitizers include, for example, acetophenones, benzoins, benzophenones, anthraquinones, xanthone, thioxanthone, ketal, tertiary amine, etc. I can hear it.

본 발명의 경화성 조성물에 있어서의 증감제의 첨가량은, 이 경화성 조성물의 고형분(용제를 제거한 전체성분)의 질량에 기초하여, 0.01~20질량%, 바람직하게는 0.01~10질량%이다.The amount of the sensitizer added in the curable composition of the present invention is 0.01 to 20% by mass, preferably 0.01 to 10% by mass, based on the mass of the solid content (total components with solvent removed) of the curable composition.

실시예Example

이하, 실시예를 들어 본 발명을 보다 구체적으로 설명하는데, 본 발명은 하기의 실시예로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to the following examples.

한편, 실시예에 있어서, 시료의 조제 및 물성의 분석에 이용한 장치 및 조건은, 이하와 같다.Meanwhile, in the examples, the equipment and conditions used for sample preparation and physical property analysis are as follows.

(1) 1H NMR스펙트럼(300MHz)(1) 1H NMR spectrum (300MHz)

장치: (주)JEOL RESONANCE제 JNM-ECX300Device: JNM-ECX300 manufactured by JEOL RESONANCE Co., Ltd.

기준: 테트라메틸실란(0.00ppm)Standard: tetramethylsilane (0.00ppm)

(2) 1H NMR스펙트럼(400MHz)(2) 1H NMR spectrum (400MHz)

장치: Varian사제 INOVA-400Device: INOVA-400 manufactured by Varian

기준: 테트라메틸실란(0.00ppm)Standard: tetramethylsilane (0.00ppm)

(3) GC(가스크로마토그래프)(3) GC (gas chromatograph)

장치: (주)시마즈제작소제 GC-2010 PlusDevice: GC-2010 Plus manufactured by Shimadzu Corporation

검출기: FIDDetector: FID

칼럼: 아질렌트·테크놀로지(주)제 Agilent J&W GC칼럼 HP-5(길이 30m, 내경 0.32mm, 막두께 0.25μm)Column: Agilent J&W GC column HP-5 manufactured by Agilent Technology Co., Ltd. (length 30 m, inner diameter 0.32 mm, film thickness 0.25 μm)

주입량: 1.0μLInjection volume: 1.0μL

주입구온도: 250℃Inlet temperature: 250℃

칼럼온도: 40℃(5분간), 20℃/분으로 300℃까지 승온, 300℃(12분간)Column temperature: 40°C (5 minutes), temperature increased to 300°C at 20°C/min, 300°C (12 minutes)

(4) GC-MS(가스크로마토그래프질량분석)(4) GC-MS (gas chromatography mass spectrometry)

장치: (주)시마즈제작소제 GCMS-QP2010 UltraDevice: GCMS-QP2010 Ultra manufactured by Shimadzu Corporation

칼럼: 아질렌트·테크놀로지(주)제 Agilent J&W GC칼럼 HP-5(길이 30m, 내경 0.32mm, 막두께 0.25μm)Column: Agilent J&W GC column HP-5 manufactured by Agilent Technology Co., Ltd. (length 30 m, inner diameter 0.32 mm, film thickness 0.25 μm)

주입량: 2.0μLInjection volume: 2.0μL

주입구온도: 250℃Inlet temperature: 250℃

칼럼온도: 40℃(5분간), 20℃/분으로 300℃까지 승온, 300℃(12분간)Column temperature: 40°C (5 minutes), temperature increased to 300°C at 20°C/min, 300°C (12 minutes)

(5) 점도(5) Viscosity

장치: 토키산업(주)제 TVE-22L, TVE-25HDevice: TVE-22L, TVE-25H manufactured by Toki Sangyo Co., Ltd.

(6) 융점(6) melting point

장치: NETZSCH사제 DSC 204 F1 PhoenixDevice: DSC 204 F1 Phoenix manufactured by NETZSCH

(7) 에폭시당량(7) Epoxy equivalent

장치: 교토전자공업(주)제 전위차자동적정장치 AT-510Device: Potentiometric automatic titration device AT-510 manufactured by Kyoto Electronics Co., Ltd.

(8) 5% 중량감소온도(Td5%)(8) 5% weight loss temperature (Td5 % )

장치: (주)리가쿠제 Thermo plus EVO/TG-DTA TG8120Device: Thermo plus EVO/TG-DTA TG8120 manufactured by Rigaku Co., Ltd.

(9) 비유전율(9) Relative permittivity

장치: 키사이트·테크놀로지즈사제 E4980A 프레시젼LCR미터Device: E4980A Precision LCR meter manufactured by Keysight Technologies.

샘플홀더: (주)토요테크니카제 12962형 실온샘플홀더Sample holder: Type 12962 room temperature sample holder made by Toyo Technica Co., Ltd.

(10) 유리전이점(Tg)(10) Glass transition point (Tg)

장치: 티·에이·인스트루먼츠·재팬(주)제 열기계측정장치 Q400Device: Thermomechanical measuring device Q400 manufactured by TA Instruments Japan Co., Ltd.

변형모드: 팽창Deformation mode: expansion

하중: 0.05NLoad: 0.05N

승온속도: 5℃/분Temperature increase rate: 5℃/min

(11) 교반탈포(11) Agitation degassing

장치: (주)싱키제 자전·공전믹서 아와토리렌타로(등록상표) ARE-310Device: Rotating/rotating mixer Awatori Rentaro (registered trademark) ARE-310 made by Shinki Co., Ltd.

(12) 오븐(12) Oven

장치: 야마토과학(주)제 송풍저온항온기 DNF400Device: Yamato Science Co., Ltd., blowing low-temperature thermostat DNF400

(13) 핫플레이트(13) Hot plate

장치: 야마토과학(주)제 송풍저온항온기 DNF400Device: Yamato Science Co., Ltd., blowing low-temperature thermostat DNF400

(14) UV노광(14) UV exposure

장치: 아이그래픽스(주)제 US5-0201Device: US5-0201 manufactured by iGraphics Co., Ltd.

램프: 아이그래픽스(주)제 H02-L41Lamp: H02-L41 manufactured by iGraphics Co., Ltd.

또한, 약기호는 이하의 의미를 나타낸다.In addition, the abbreviated symbols indicate the following meanings.

IAA: 5,9-디메틸-2-(1,5-디메틸헥실)데칸산[닛산화학공업(주)제 파인옥소콜(등록상표) 이소아라킨산]IAA: 5,9-dimethyl-2-(1,5-dimethylhexyl)decanoic acid [Fineoxocol (registered trademark) isoaracnic acid manufactured by Nissan Chemical Industries, Ltd.]

IPA: 2-헥실데칸산[닛산화학공업(주)제 파인옥소콜(등록상표) 이소팔미트산]IPA: 2-hexyldecanoic acid [Fineoxocol (registered trademark) isopalmitic acid manufactured by Nissan Chemical Industries, Ltd.]

ISA: 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산[닛산화학공업(주)제 파인옥소콜(등록상표) 이소스테아르산]ISA: 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid [Fineoxocol (registered trademark) isostearic acid manufactured by Nissan Chemical Industries, Ltd.]

ISAN: 8-메틸-2-(4-메틸헥실)데칸산[닛산화학공업(주)제 파인옥소콜(등록상표) 이소스테아르산N]ISAN: 8-methyl-2-(4-methylhexyl)decanoic acid [Fineoxocol (registered trademark) isostearic acid N manufactured by Nissan Chemical Industries, Ltd.]

ISAT: 2-옥틸데칸산[닛산화학공업(주)제 파인옥소콜(등록상표) 이소스테아르산T]ISAT: 2-octyldecanoic acid [Fineoxocol (registered trademark) isostearic acid T manufactured by Nissan Chemical Industries, Ltd.]

ISOL: 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄-1-올[닛산화학공업(주)제 파인옥소콜(등록상표) 180]ISOL: 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctan-1-ol [Fineoxocol (registered trademark) 180 manufactured by Nissan Chemical Industries, Ltd.]

PA: 팔미트산[도쿄화성공업(주)제]PA: Palmitic acid (manufactured by Tokyo Chemical Industry Co., Ltd.)

ωIPA: 14-메틸펜타데칸산[Aldrich사제]ωIPA: 14-methylpentadecanoic acid (manufactured by Aldrich)

ωISA: 16-메틸헵타데칸산[Aldrich사제]ωISA: 16-methylheptadecanoic acid (manufactured by Aldrich)

AllBr: 알릴브로마이드[칸토화학(주)제]AllBr: Allyl bromide (manufactured by Kanto Chemical Co., Ltd.)

CHMA: 3-시클로헥세닐메탄올[Aldrich사제]CHMA: 3-cyclohexenylmethanol (manufactured by Aldrich)

ECH: 에피클로로하이드린[도쿄화성공업(주)제]ECH: Epichlorohydrin (manufactured by Tokyo Chemical Industry Co., Ltd.)

EGMAE: 에틸렌글리콜모노알릴에테르[도쿄화성공업(주)제]EGMAE: Ethylene glycol monoallyl ether (manufactured by Tokyo Chemical Industry Co., Ltd.)

OEO: 7-옥텐-1-올[(주)쿠라레제, 순도 95%]OEO: 7-octen-1-ol [Curare Co., Ltd., purity 95%]

PEO: 4-펜텐-1-올[도쿄화성공업(주)제]PEO: 4-penten-1-ol [manufactured by Tokyo Chemical Industry Co., Ltd.]

DMAP: 4-디메틸아미노피리딘[와코순약공업(주)제]DMAP: 4-dimethylaminopyridine (manufactured by Wako Pure Chemical Industries, Ltd.)

EDC: 1-에틸-3-(3-(디메틸아미노)프로필)카르보디이미드염산염[도쿄화성공업(주)제]EDC: 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride (manufactured by Tokyo Chemical Industry Co., Ltd.)

TMAC: 염화테트라메틸암모늄[도쿄화성공업(주)제]TMAC: Tetramethylammonium chloride (manufactured by Tokyo Chemical Industry Co., Ltd.)

mCPBA: m-클로로과안식향산[와코순약공업(주)제, 순도 70%]mCPBA: m-chloroperbenzoic acid [manufactured by Wako Pure Chemical Industries, Ltd., purity 70%]

BGE: 부틸글리시딜에테르[도쿄화성공업(주)제]BGE: Butyl glycidyl ether (manufactured by Tokyo Chemical Industry Co., Ltd.)

EHGE: 2-에틸헥실=글리시딜=에테르[도쿄화성공업(주)제]EHGE: 2-ethylhexyl=glycidyl=ether (manufactured by Tokyo Chemical Industry Co., Ltd.)

SGEs: 스테아르산글리시딜[도쿄화성공업(주)제]SGEs: Glycidyl stearate (manufactured by Tokyo Chemical Industry Co., Ltd.)

BPA: 비스페놀A형 에폭시 수지[미쯔비시화학(주)제 jER(등록상표) 828]BPA: Bisphenol A type epoxy resin [jER (registered trademark) 828 manufactured by Mitsubishi Chemical Corporation]

CEL: 3,4-에폭시시클로헥산카르본산(3,4-에폭시시클로헥실)메틸[(주)다이셀제 셀록사이드2021P]CEL: 3,4-epoxycyclohexanecarboxylic acid (3,4-epoxycyclohexyl)methyl [Celoxide 2021P manufactured by Daicel Co., Ltd.]

TEPIC: 트리글리시딜이소시아누레이트[닛산화학공업(주)제 TEPIC(등록상표) -L]TEPIC: Triglycidyl isocyanurate [TEPIC (registered trademark) -L, manufactured by Nissan Chemical Industries, Ltd.]

DOX: 비스((3-에틸-3-옥세타닐)메틸)에테르[토아합성(주)제 아론옥세탄(등록상표) OXT-221]DOX: Bis((3-ethyl-3-oxetanyl)methyl)ether [Aronoxetane (registered trademark) OXT-221 manufactured by Toa Synthetics Co., Ltd.]

MH700: 4-메틸헥사하이드로무수프탈산/헥사하이드로무수프탈산 혼합물(몰비70:30)[신일본이화(주)제 리카시드(등록상표) MH-700]MH700: 4-methylhexahydrophthalic anhydride/hexahydrophthalic anhydride mixture (molar ratio 70:30) [Ricaced (registered trademark) MH-700 manufactured by Nippon Ewha Co., Ltd.]

PX4ET: 테트라부틸포스포늄O,O-디에틸포스포로디티오에이트[일본화학공업(주)제 히시콜린(등록상표) PX-4ET]PX4ET: Tetrabutylphosphonium O,O-diethylphosphorodithioate [Hycicoline (registered trademark) PX-4ET manufactured by Nippon Chemical Industry Co., Ltd.]

C101A: 디페닐(4-(페닐티오)페닐)설포늄헥사플루오로안티모네이트(V)/50질량% 프로필렌카보네이트용액[산아프로(주)제 CPI(등록상표) -101A]C101A: Diphenyl (4-(phenylthio)phenyl)sulfonium hexafluoroantimonate (V)/50% by mass propylene carbonate solution [CPI (registered trademark) -101A manufactured by San Apro Co., Ltd.]

SI100: 벤질(4-하이드록시페닐)(메틸)설포늄헥사플루오로안티모네이트(V)[산신화학공업(주)제 선에이드 SI-100]SI100: Benzyl (4-hydroxyphenyl) (methyl) sulfonium hexafluoroantimonate (V) [Sun Aid SI-100 manufactured by Sanshin Chemical Industry Co., Ltd.]

2EHA: 2-에틸헥산산[쥰세이화학(주)제]2EHA: 2-ethylhexanoic acid (Junsei Chemical Co., Ltd.)

NMP: N-메틸-2-피롤리돈NMP: N-methyl-2-pyrrolidone

THF: 테트라하이드로푸란THF: tetrahydrofuran

[실시예 1] 2-헥실데칸산글리시딜(IPGEs)의 제조[Example 1] Preparation of 2-hexyldecanoate glycidyl (IPGEs)

반응플라스크에, IPA 30.0g(117mmol), AllBr 17.0g(141mmol), 탄산칼륨 19.4g(140mmol) 및 NMP 300g을 투입하였다. 이것을 70℃에서 1시간 교반하였다. 반응액을 여과하고, 불용물을 제거하였다. 이 여액에 톨루엔 260g을 첨가하고, 물 300g으로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 2-헥실데칸산알릴(IPAEs) 33.6g을 무색투명액체로서 얻었다.Into the reaction flask, 30.0 g (117 mmol) of IPA, 17.0 g (141 mmol) of AllBr, 19.4 g (140 mmol) of potassium carbonate, and 300 g of NMP were added. This was stirred at 70°C for 1 hour. The reaction solution was filtered and insoluble matter was removed. 260 g of toluene was added to this filtrate, washed with 300 g of water, and the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 33.6 g of allyl 2-hexyldecanoate (IPAEs) as a colorless transparent liquid.

1H NMR(300MHz,CDCl3):δ=5.96~5.86(m,1H),5.34~5.20(m,2H),4.59~4.57(m,2H),2.32(m,1H),1.56~1.26(m,24H),0.88(t,J=7.2Hz,6H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=5.96~5.86(m,1H),5.34~5.20(m,2H),4.59~4.57(m,2H),2.32(m,1H),1.56~1.26( m,24H),0.88(t,J=7.2Hz,6H)(ppm)

GC-MS(CI):m/z=297(M+1)GC-MS(CI): m/z=297(M+1)

반응플라스크에, 상기 IPAEs 33.2g(112mmol) 및 클로로포름 740g을 투입하였다. 이 용액에, mCPBA 55.2g(정미(正味) 224mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 4일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 300mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 목적물인 2-헥실데칸산글리시딜(IPGEs) 30.7g을 무색투명액체로서 얻었다. 얻어진 IPGEs의, 점도는 11mPa·s(25℃), JIS K7236:2009에 준하여 측정한 에폭시당량은 315였다.Into the reaction flask, 33.2 g (112 mmol) of the IPAEs and 740 g of chloroform were added. To this solution, 55.2 g (224 mmol of pure rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 4 days. To this reaction solution, 300 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 30.7 g of the target product, glycidyl 2-hexyldecanoate (IPGEs), as a colorless and transparent liquid. The viscosity of the obtained IPGEs was 11 mPa·s (25°C), and the epoxy equivalent weight measured according to JIS K7236:2009 was 315.

1H NMR(300MHz,CDCl3):δ=4.43~4.38(m,1H),3.96~3.90(m,1H),3.21~3.18(m,1H),2.85~2.82(m,1H),2.65~2.63(m,1H),2.41~2.35(m,1H),1.60~0.85(m,30H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=4.43~4.38(m,1H),3.96~3.90(m,1H),3.21~3.18(m,1H),2.85~2.82(m,1H),2.65~ 2.63(m,1H),2.41~2.35(m,1H),1.60~0.85(m,30H)(ppm)

GC-MS(CI):m/z=313(M+1)GC-MS(CI): m/z=313(M+1)

[실시예 2] 2-옥틸데칸산글리시딜(ISTGEs)의 제조[Example 2] Preparation of 2-octyldecanoate glycidyl (ISTGEs)

반응플라스크에, ISAT 30.0g(105mmol), AllBr 15.2g(126mmol), 탄산칼륨 17.4g(126mmol) 및 NMP 300g을 투입하였다. 이것을 70℃에서 3시간 교반하였다. 반응액을 여과하고, 불용물을 제거하였다. 이 여액에 톨루엔 260g을 첨가하고, 물 300g으로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 2-옥틸데칸산알릴(ISTAEs) 33.3g을 무색투명액체로서 얻었다.Into the reaction flask, 30.0 g (105 mmol) of ISAT, 15.2 g (126 mmol) of AllBr, 17.4 g (126 mmol) of potassium carbonate, and 300 g of NMP were added. This was stirred at 70°C for 3 hours. The reaction solution was filtered and insoluble matter was removed. 260 g of toluene was added to this filtrate, washed with 300 g of water, and the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 33.3 g of allyl 2-octyldecanoate (ISTAEs) as a colorless transparent liquid.

1H NMR(300MHz,CDCl3):δ=5.97~5.86(m,1H),5.35~5.21(m,2H),4.60~4.57(m,2H),2.35(m,1H),1.57~1.25(m,28H),0.88(t,J=6.9Hz,6H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=5.97~5.86(m,1H),5.35~5.21(m,2H),4.60~4.57(m,2H),2.35(m,1H),1.57~1.25( m,28H),0.88(t,J=6.9Hz,6H)(ppm)

GC-MS(CI):m/z=325(M+1)GC-MS(CI): m/z=325(M+1)

반응플라스크에, 상기 ISTAEs 32.9g(101mmol) 및 클로로포름 740g을 투입하였다. 이 용액에, mCPBA 62.4g(정미 253mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 4일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 300mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 목적물인 2-옥틸데칸산글리시딜(ISTGEs) 30.0g을 무색투명액체로서 얻었다. 얻어진 ISTGEs의, 점도는 14mPa·s(25℃), 에폭시당량은 341이었다.Into the reaction flask, 32.9 g (101 mmol) of the ISTAEs and 740 g of chloroform were added. To this solution, 62.4 g (253 mmol of net rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 4 days. To this reaction solution, 300 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 30.0 g of the target product, glycidyl 2-octyldecanoate (ISTGEs), as a colorless and transparent liquid. The obtained ISTGEs had a viscosity of 14 mPa·s (25°C) and an epoxy equivalent weight of 341.

1H NMR(300MHz,CDCl3):δ=4.43~4.38(m,1H),3.96~3.90(m,1H),3.20(m,1H),2.85~2.82(m,1H),2.65~2.63(m,1H),2.38(m,1H),1.57~0.85(m,34H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=4.43~4.38(m,1H),3.96~3.90(m,1H),3.20(m,1H),2.85~2.82(m,1H),2.65~2.63( m,1H),2.38(m,1H),1.57~0.85(m,34H)(ppm)

GC-MS(CI):m/z=341(M+1)GC-MS(CI): m/z=341(M+1)

[실시예 3] 8-메틸-2-(4-메틸헥실)데칸산글리시딜(ISNGEs)의 제조[Example 3] Preparation of 8-methyl-2-(4-methylhexyl)glycidyl decanoate (ISNGEs)

반응플라스크에, ISAN 30.0g(105mmol), AllBr 15.2g(126mmol), 탄산칼륨 17.4g(126mmol) 및 NMP 300g을 투입하였다. 이것을 70℃에서 3.5시간 교반하였다. 반응액을 여과하고, 불용물을 제거하였다. 이 여액에 톨루엔 260g을 첨가하고, 물 300g으로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 8-메틸-2-(4-메틸헥실)데칸산알릴(ISNAEs) 33.9g을 무색투명액체로서 얻었다.Into the reaction flask, 30.0 g (105 mmol) of ISAN, 15.2 g (126 mmol) of AllBr, 17.4 g (126 mmol) of potassium carbonate, and 300 g of NMP were added. This was stirred at 70°C for 3.5 hours. The reaction solution was filtered and insoluble matter was removed. 260 g of toluene was added to this filtrate, washed with 300 g of water, and the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 33.9 g of 8-methyl-2-(4-methylhexyl) allyl decanoate (ISNAEs) as a colorless transparent liquid. .

1H NMR(300MHz,CDCl3):δ=5.99~5.86(m,1H),5.35~5.21(m,2H),4.58(d,J=2.7Hz,2H),2.36(m,1H),1.58~0.71(m,34H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=5.99~5.86(m,1H),5.35~5.21(m,2H),4.58(d,J=2.7Hz,2H),2.36(m,1H),1.58 ~0.71(m,34H)(ppm)

GC-MS(CI):m/z=325(M+1)GC-MS(CI): m/z=325(M+1)

반응플라스크에, 상기 ISNAEs 33.4g(103mmol) 및 클로로포름 740g을 투입하였다. 이 용액에, mCPBA 48.3g(정미 253mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 5일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 300mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 목적물인 8-메틸-2-(4-메틸헥실)데칸산글리시딜(ISNGEs) 28.4g을 무색투명액체로서 얻었다. 얻어진 ISNGEs의, 점도는 18mPa·s(25℃), 에폭시당량은 340이었다.Into the reaction flask, 33.4 g (103 mmol) of the ISNAEs and 740 g of chloroform were added. To this solution, 48.3 g (253 mmol of net rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 5 days. To this reaction solution, 300 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 28.4 g of the target product, glycidyl 8-methyl-2-(4-methylhexyl)decanoate (ISNGEs), as colorless. Obtained as a transparent liquid. The obtained ISNGEs had a viscosity of 18 mPa·s (25°C) and an epoxy equivalent weight of 340.

1H NMR(300MHz,CDCl3):δ=4.41(m,1H),3.96~3.89(m,1H),3.22~3.18(m,1H),2.85~2.83(m,1H),2.66~2.64(m,1H),2.54~2.33(m,1H),1.60~0.72(m,34H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=4.41(m,1H),3.96~3.89(m,1H),3.22~3.18(m,1H),2.85~2.83(m,1H),2.66~2.64( m,1H),2.54~2.33(m,1H),1.60~0.72(m,34H)(ppm)

GC-MS(CI):m/z=341(M+1)GC-MS(CI): m/z=341(M+1)

[실시예 4] 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산글리시딜(ISGEs)의 제조[Example 4] Preparation of 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanate glycidyl (ISGEs)

반응플라스크에, ISA 28.4g(100mmol), ECH 62.5g(676mmol) 및 TMAC 0.3g(2.7mmol)을 투입하였다. 이것을 100℃에서 2시간 교반한 후, 실온(대략 23℃)까지 냉각하였다. 여기에, 48질량% 수산화나트륨수용액 25.0g(mmol)을 첨가하고, 실온(대략 23℃)에서 24시간 교반하였다. 이 반응액에, 10질량% 인산이수소나트륨수용액 20mL를 첨가하여 수산화나트륨을 중화하였다. 이 유기층을, 물로 세정한 후, ECH를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=90:10(체적비))로 정제함으로써, 목적물인 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산글리시딜(ISGEs) 30.0g을 무색투명액체로서 얻었다. 얻어진 ISGEs의, 점도는 41mPa·s(25℃), 에폭시당량은 334였다.Into the reaction flask, 28.4 g (100 mmol) of ISA, 62.5 g (676 mmol) of ECH, and 0.3 g (2.7 mmol) of TMAC were added. This was stirred at 100°C for 2 hours and then cooled to room temperature (approximately 23°C). Here, 25.0 g (mmol) of a 48 mass% aqueous sodium hydroxide solution was added, and the mixture was stirred at room temperature (approximately 23°C) for 24 hours. To this reaction solution, 20 mL of a 10% by mass aqueous solution of sodium dihydrogen phosphate was added to neutralize the sodium hydroxide. This organic layer was washed with water, and then ECH was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 90:10 (volume ratio)) to obtain the target product, 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid. 30.0 g of glycidyl (ISGEs) was obtained as a colorless and transparent liquid. The obtained ISGEs had a viscosity of 41 mPa·s (25°C) and an epoxy equivalent weight of 334.

1H NMR(300MHz,CDCl3):δ=4.45~4.34(m,1H),4.39~3.94(m,1H),3.20(m,1H),2.86~2.83(m,1H),2.66~2.65(m,1H),2.19(m,1H),1.75~0.88(m,34H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=4.45~4.34(m,1H),4.39~3.94(m,1H),3.20(m,1H),2.86~2.83(m,1H),2.66~2.65( m,1H),2.19(m,1H),1.75~0.88(m,34H)(ppm)

GC-MS(CI):m/z=341(M+1)GC-MS(CI): m/z=341(M+1)

[실시예 5] 5,9-디메틸-2-(1,5-디메틸헥실)데칸산글리시딜(IAGEs)의 제조[Example 5] Preparation of 5,9-dimethyl-2-(1,5-dimethylhexyl)glycidyl decanoate (IAGEs)

반응플라스크에, IAA 30.0g(96mmol), AllBr 13.9g(115mmol), 탄산칼륨 21.0g(152mmol) 및 NMP 300g을 투입하였다. 이것을 70℃에서 1시간 교반하였다. 반응액을 여과하고, 불용물을 제거하였다. 이 여액에 톨루엔 260g을 첨가하고, 물 300g으로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 5,9-디메틸-2-(1,5-디메틸헥실)데칸산알릴(IAAEs) 33.0g을 무색투명액체로서 얻었다.Into the reaction flask, 30.0 g (96 mmol) of IAA, 13.9 g (115 mmol) of AllBr, 21.0 g (152 mmol) of potassium carbonate, and 300 g of NMP were added. This was stirred at 70°C for 1 hour. The reaction solution was filtered and insoluble matter was removed. 260 g of toluene was added to this filtrate, washed with 300 g of water, and the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 33.0 g of 5,9-dimethyl-2-(1,5-dimethylhexyl) allyl decanoate (IAAEs) as colorless. Obtained as a transparent liquid.

1H NMR(300MHz,CDCl3):δ=5.97~5.86(m,1H),5.35~5.21(m,2H),4.58(m,2H),2.36(m,1H),1.56~0.73(m,38H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=5.97~5.86(m,1H),5.35~5.21(m,2H),4.58(m,2H),2.36(m,1H),1.56~0.73(m, 38H)(ppm)

GC-MS(CI):m/z=353(M+1)GC-MS(CI): m/z=353(M+1)

반응플라스크에, 상기 IAAEs 32.6g(93mmol) 및 클로로포름 740g을 투입하였다. 이 용액에, mCPBA 52.4g(정미 213mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 6일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 300mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 목적물인 5,9-디메틸-2-(1,5-디메틸헥실)데칸산글리시딜(IAGEs) 28.4g을 무색투명액체로서 얻었다. 얻어진 IAGEs의, 점도는 32mPa·s(25℃), 에폭시당량은 371이었다.Into the reaction flask, 32.6 g (93 mmol) of the IAAEs and 740 g of chloroform were added. To this solution, 52.4 g (213 mmol of net rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 6 days. To this reaction solution, 300 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain the target product, glycidyl decanoate (IAGEs), 5,9-dimethyl-2-(1,5-dimethylhexyl). 28.4 g was obtained as a colorless transparent liquid. The obtained IAGEs had a viscosity of 32 mPa·s (25°C) and an epoxy equivalent weight of 371.

1H NMR(300MHz,CDCl3):δ=4.40(m,1H),3.95(m,1H),3.19(m,1H),2.85~2.82(m,1H),2.64(m,1H),2.35(m,1H),0.87~0.75(m,38H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=4.40(m,1H),3.95(m,1H),3.19(m,1H),2.85~2.82(m,1H),2.64(m,1H),2.35 (m,1H),0.87~0.75(m,38H)(ppm)

GC-MS(CI):m/z=369(M+1)GC-MS(CI): m/z=369(M+1)

[실시예 6] 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산4,5-에폭시펜틸(ISEPEs)의 제조[Example 6] Preparation of 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid 4,5-epoxypentyl (ISEPEs)

반응플라스크에, ISA 30.0g(105mmol), PEO 10.0g(116mmol) 및 디클로로메탄 800g을 투입하였다. 이 용액에, DMAP 15.4g(126mmol) 및 EDC 24.2g(126mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 3일간 교반하였다. 이 반응액을, 1N 염산 및 5질량% 식염수로 세정한 후, 용매를 유거함으로써, 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산5-펜테닐(ISPEs)의 조물을 얻었다.Into the reaction flask, 30.0 g (105 mmol) of ISA, 10.0 g (116 mmol) of PEO, and 800 g of dichloromethane were added. To this solution, 15.4 g (126 mmol) of DMAP and 24.2 g (126 mmol) of EDC were added while stirring, and stirred at room temperature (approximately 23°C) for 3 days. This reaction solution was washed with 1N hydrochloric acid and 5% by mass saline solution, and then the solvent was distilled off to obtain 5-pentenyl 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid. (ISPEs) were obtained.

얻어진 조물을, 클로로포름 440g에 용해시켰다. 이 용액에, mCPBA 12.7g(정미 52mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 5일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 300mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(용매그래디언트, 헥산:아세트산에틸=99:1 내지 95:5(체적비))로 정제함으로써, 목적물인 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산4,5-에폭시펜틸(ISEPEs) 13.1g을 무색투명액체로서 얻었다. 얻어진 ISEPEs의, 점도는 44mPa·s(25℃), 에폭시당량은 366이었다.The obtained crude product was dissolved in 440 g of chloroform. To this solution, 12.7 g (52 mmol of net rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 5 days. To this reaction solution, 300 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (solvent gradient, hexane:ethyl acetate = 99:1 to 95:5 (volume ratio)) to obtain the target product, 2-(4,4-dimethylpentan-2-yl)-5, 13.1 g of 4,5-epoxypentyl 7,7-trimethyloctanoic acid (ISEPEs) was obtained as a colorless and transparent liquid. The obtained ISEPEs had a viscosity of 44 mPa·s (25°C) and an epoxy equivalent weight of 366.

1H NMR(300MHz,CDCl3):δ=4.11(t,J=6.3Hz,2H),2.95(m,1H),2.76~2.79(m,1H),2.48~2.50(m,1H),2.13(m,1H),1.84~0.88(m,38H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=4.11(t,J=6.3Hz,2H),2.95(m,1H),2.76~2.79(m,1H),2.48~2.50(m,1H),2.13 (m,1H),1.84~0.88(m,38H)(ppm)

GC-MS(CI):m/z=369(M+1)GC-MS(CI): m/z=369(M+1)

[실시예 7] 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산7,8-에폭시옥틸(ISEOEs)의 제조[Example 7] Preparation of 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid 7,8-epoxyoctyl (ISEOEs)

반응플라스크에, ISA 30.0g(105mmol), OEO 15.7g(정미 116mmol) 및 디클로로메탄 800g을 투입하였다. 이 용액에, DMAP 15.4g(126mmol) 및 EDC 24.2g(126mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 4일간 교반하였다. 이 반응액을, 1N 염산 및 5질량% 식염수로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산7-옥테닐(ISOEs) 33.8g을 무색투명액체로서 얻었다.Into the reaction flask, 30.0 g (105 mmol) of ISA, 15.7 g (116 mmol of polished rice) of OEO, and 800 g of dichloromethane were added. To this solution, 15.4 g (126 mmol) of DMAP and 24.2 g (126 mmol) of EDC were added while stirring, and stirred at room temperature (approximately 23°C) for 4 days. This reaction liquid was washed with 1N hydrochloric acid and 5% by mass saline solution, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid 7-. 33.8 g of octenyl (ISOEs) was obtained as a colorless transparent liquid.

1H NMR(300MHz,CDCl3):δ=5.87~5.73(m,1H),5.02~4.92(m,2H),4.09~4.03(m,2H),2.11~0.82(m,45H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=5.87~5.73(m,1H),5.02~4.92(m,2H),4.09~4.03(m,2H),2.11~0.82(m,45H)(ppm)

GC-MS(CI):m/z=395(M+1)GC-MS(CI): m/z=395(M+1)

반응플라스크에, 상기 ISOEs 33.3g(84mmol) 및 클로로포름 740g을 투입하였다. 이 용액에, mCPBA 27.1g(정미 110mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 2일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 300mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(용매그래디언트, 헥산:아세트산에틸=99:1 내지 95:5(체적비))로 정제함으로써, 목적물인 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산7,8-에폭시옥틸(ISEOEs) 20.8g을 무색투명액체로서 얻었다. 얻어진 ISEOEs의, 점도는 51mPa·s(25℃), 에폭시당량은 408이었다.Into the reaction flask, 33.3 g (84 mmol) of the ISOEs and 740 g of chloroform were added. To this solution, 27.1 g (110 mmol of polished rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 2 days. To this reaction solution, 300 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (solvent gradient, hexane:ethyl acetate = 99:1 to 95:5 (volume ratio)) to obtain the target product, 2-(4,4-dimethylpentan-2-yl)-5, 20.8 g of 7,8-epoxyoctyl 7,7-trimethyloctanoic acid (ISEOEs) was obtained as a colorless and transparent liquid. The obtained ISEOEs had a viscosity of 51 mPa·s (25°C) and an epoxy equivalent weight of 408.

1H NMR(300MHz,CDCl3):δ=4.07~4.03(m,2H),2.90(m,1H),2.76~2.73(m,1H),2.47~2.45(m,1H),2.11(m,1H),1.63~0.88(m,44H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=4.07~4.03(m,2H),2.90(m,1H),2.76~2.73(m,1H),2.47~2.45(m,1H),2.11(m, 1H),1.63~0.88(m,44H)(ppm)

GC-MS(CI):m/z=411(M+1)GC-MS(CI): m/z=411(M+1)

[실시예 8] 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산2-글리시딜옥시에틸(ISGEEs)의 제조[Example 8] Preparation of 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid 2-glycidyloxyethyl (ISGEEs)

반응플라스크에, ISA 30.0g(105mmol), EGMAE 11.9g(117mmol) 및 디클로로메탄 400g을 투입하였다. 이 용액에, DMAP 15.5g(127mmol) 및 EDC 24.3g(127mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 4일간 교반하였다. 이 반응액을, 1N 염산 및 5질량% 식염수로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(용매그래디언트, 헥산:아세트산에틸=99:1 내지 95:5(체적비))로 정제함으로써, 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산2-알릴옥시에틸(ISAEEs) 19.1g을 무색투명액체로서 얻었다.Into the reaction flask, 30.0 g (105 mmol) of ISA, 11.9 g (117 mmol) of EGMAE, and 400 g of dichloromethane were added. To this solution, 15.5 g (127 mmol) of DMAP and 24.3 g (127 mmol) of EDC were added while stirring, and stirred at room temperature (approximately 23°C) for 4 days. This reaction liquid was washed with 1N hydrochloric acid and 5% by mass saline solution, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (solvent gradient, hexane:ethyl acetate = 99:1 to 95:5 (volume ratio)) to obtain 2-(4,4-dimethylpentan-2-yl)-5,7, 19.1 g of 2-allyloxyethyl 7-trimethyloctanoic acid (ISAEEs) was obtained as a colorless and transparent liquid.

1H NMR(300MHz,CDCl3):δ=5.94~5.87(m,1H),5.31~5.12(m,2H),4.31~4.17(m,2H),4.03(m,2H),3.65~3.63(m,2H),2.21~2.16(m,1H),1.85~0.83(m,34H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=5.94~5.87(m,1H),5.31~5.12(m,2H),4.31~4.17(m,2H),4.03(m,2H),3.65~3.63( m,2H),2.21~2.16(m,1H),1.85~0.83(m,34H)(ppm)

GC-MS(CI):m/z=369(M+1)GC-MS(CI): m/z=369(M+1)

반응플라스크에, 상기 ISAEEs 19.0g(52mmol) 및 클로로포름 440g을 투입하였다. 이 용액에, mCPBA 15.6g(정미 63mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 5일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 200mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=90:10(체적비))로 정제함으로써, 목적물인 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산2-글리시딜옥시에틸(ISGEEs) 16.9g을 무색투명액체로서 얻었다. 얻어진 ISGEEs의, 점도는 47mPa·s(25℃), 에폭시당량은 382였다.Into the reaction flask, 19.0 g (52 mmol) of the ISAEEs and 440 g of chloroform were added. To this solution, 15.6 g (63 mmol of net rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 5 days. To this reaction solution, 200 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 90:10 (volume ratio)) to obtain the target product, 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid. 16.9 g of 2-glycidyloxyethyl (ISGEEs) was obtained as a colorless and transparent liquid. The obtained ISGEEs had a viscosity of 47 mPa·s (25°C) and an epoxy equivalent weight of 382.

1H NMR(300MHz,CDCl3):δ=4.24(m,2H),3.81~3.71(m,3H),3.47~3.41(m,1H),3.14(m,1H),2.79(m,1H),2.62(m,1H),2.17(m,1H),1.86~0.89(m,34H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=4.24(m,2H),3.81~3.71(m,3H),3.47~3.41(m,1H),3.14(m,1H),2.79(m,1H) ,2.62(m,1H),2.17(m,1H),1.86~0.89(m,34H)(ppm)

GC-MS(CI):m/z=385(M+1)GC-MS(CI): m/z=385(M+1)

[합성예 1] 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산3,4-에폭시시클로헥실메틸(ISECHEs)의 제조[Synthesis Example 1] Preparation of 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid 3,4-epoxycyclohexylmethyl (ISECHEs)

반응플라스크에, ISA 30.0g(105mmol), CHMA 13.0g(116mmol) 및 디클로로메탄 800g을 투입하였다. 이 용액에, DMAP 15.4g(126mmol) 및 EDC 24.2g(126mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 2일간 교반하였다. 이 반응액을, 1N 염산 및 5질량% 식염수로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=90:10(체적비))로 정제함으로써, 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산3-시클로헥세닐메틸(ISCHEs) 30.0g을 무색투명액체로서 얻었다.Into the reaction flask, 30.0 g (105 mmol) of ISA, 13.0 g (116 mmol) of CHMA, and 800 g of dichloromethane were added. To this solution, 15.4 g (126 mmol) of DMAP and 24.2 g (126 mmol) of EDC were added while stirring, and stirred at room temperature (approximately 23°C) for 2 days. This reaction liquid was washed with 1N hydrochloric acid and 5% by mass saline solution, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 90:10 (volume ratio)) to obtain 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid 3-. 30.0 g of cyclohexenylmethyl (ISCHEs) was obtained as a colorless transparent liquid.

1H NMR(300MHz,CDCl3):δ=5.67(m,2H),4.01~3.97(m,2H),2.15~0.88(m,42H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=5.67(m,2H),4.01~3.97(m,2H),2.15~0.88(m,42H)(ppm)

GC-MS(CI):m/z=379(M+1)GC-MS(CI): m/z=379(M+1)

반응플라스크에, 상기 ISCHEs 29.5g(78mmol) 및 클로로포름 740g을 투입하였다. 이 용액에, mCPBA 23.1g(정미 94mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 17시간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 300mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 목적물인 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥탄산3,4-에폭시시클로헥실메틸(ISECHEs) 28.4g을 무색투명액체로서 얻었다. 얻어진 ISECHEs의, 점도는 92mPa·s(25℃), 에폭시당량은 413이었다.Into the reaction flask, 29.5 g (78 mmol) of the ISCHEs and 740 g of chloroform were added. To this solution, 23.1 g (94 mmol net weight) of mCPBA was added while stirring, and stirred at room temperature (approximately 23°C) for 17 hours. To this reaction solution, 300 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain the target product, 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctanoic acid. 28.4 g of 3,4-epoxycyclohexylmethyl (ISECHEs) was obtained as a colorless and transparent liquid. The obtained ISECHEs had a viscosity of 92 mPa·s (25°C) and an epoxy equivalent weight of 413.

1H NMR(300MHz,CDCl3):δ=3.87~3.83(m,2H),3.17~3.14(m,2H),2.20~0.88(m,42H)(ppm) 1 H NMR (300MHz, CDCl 3 ): δ=3.87~3.83(m,2H),3.17~3.14(m,2H),2.20~0.88(m,42H)(ppm)

GC-MS(CI):m/z=395(M+1)GC-MS(CI): m/z=395(M+1)

[합성예 2] 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥틸=글리시딜=에테르(ISGE)의 제조[Synthesis Example 2] Preparation of 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctyl=glycidyl=ether (ISGE)

반응플라스크에, ISOL 30.0g(111mmol), AllBr 24.2g(200mmol), 수소화나트륨 11.3g(471mmol) 및 THF 270g을 투입하였다. 이것을 70℃에서 29시간 교반하였다. 이 반응액을 물 600g으로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥틸=알릴=에테르(ISAE)33.4g을 무색투명액체로서 얻었다.Into the reaction flask, 30.0 g (111 mmol) of ISOL, 24.2 g (200 mmol) of AllBr, 11.3 g (471 mmol) of sodium hydride, and 270 g of THF were added. This was stirred at 70°C for 29 hours. This reaction liquid was washed with 600 g of water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctyl=allyl= 33.4 g of ether (ISAE) was obtained as a colorless and transparent liquid.

1H NMR(400MHz,CDCl3):δ=5.97~5.87(m,1H),5.30~5.24(m,1H),5.18~5.14(m,1H),3.96~3.37(m,1H),3.37~3.22(m,2H),1.82~1.71(m,1H),1.56~0.83(m,36H)(ppm) 1 H NMR (400MHz, CDCl 3 ): δ=5.97~5.87(m,1H),5.30~5.24(m,1H),5.18~5.14(m,1H),3.96~3.37(m,1H),3.37~ 3.22(m,2H),1.82~1.71(m,1H),1.56~0.83(m,36H)(ppm)

GC-MS(CI):m/z=311(M+1)GC-MS(CI): m/z=311(M+1)

반응플라스크에, 상기 ISAE 33.1g(107mmol) 및 클로로포름 440g을 투입하였다. 이 용액에, mCPBA 52.5g(정미 213mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 3일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 300mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=90:10(체적비))로 정제함으로써, 목적물인 2-(4,4-디메틸펜탄-2-일)-5,7,7-트리메틸옥틸=글리시딜=에테르(ISGE) 30.5g을 무색투명액체로서 얻었다. 얻어진 ISGEEs의, 점도는 18mPa·s(25℃), 에폭시당량은 366이었다.Into the reaction flask, 33.1 g (107 mmol) of the ISAE and 440 g of chloroform were added. To this solution, 52.5 g (213 mmol of net rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 3 days. To this reaction solution, 300 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 90:10 (volume ratio)) to obtain the target product, 2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctyl= 30.5 g of glycidyl=ether (ISGE) was obtained as a colorless and transparent liquid. The obtained ISGEEs had a viscosity of 18 mPa·s (25°C) and an epoxy equivalent weight of 366.

1H NMR(400MHz,CDCl3):δ=3.67~3.64(m,1H),3.41~3.23(m,3H),3.13(m,1H),2.80~2.77(m,1H),2.61~2.59(m,1H),1.80~0.82(m,35H)(ppm) 1 H NMR (400MHz, CDCl 3 ): δ=3.67~3.64(m,1H),3.41~3.23(m,3H),3.13(m,1H),2.80~2.77(m,1H),2.61~2.59( m,1H),1.80~0.82(m,35H)(ppm)

GC-MS(CI):m/z=327(M+1)GC-MS(CI): m/z=327(M+1)

[합성예 3] 팔미트산글리시딜(PGEs)의 제조[Synthesis Example 3] Preparation of glycidyl palmitate (PGEs)

반응플라스크에, PA 30.0g(96mmol), AllBr 17.0g(141mmol), 탄산칼륨 19.3g(140mmol) 및 NMP 300g을 투입하였다. 이것을 70℃에서 1시간 교반하였다. 반응액을 여과하고, 불용물을 제거하였다. 이 여액에 톨루엔 260g을 첨가하고, 물 300g으로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=90:10(체적비))로 정제함으로써, 팔미트산알릴(PAEs) 34.4g을 백색고체로서 얻었다.Into the reaction flask, 30.0 g (96 mmol) of PA, 17.0 g (141 mmol) of AllBr, 19.3 g (140 mmol) of potassium carbonate, and 300 g of NMP were added. This was stirred at 70°C for 1 hour. The reaction solution was filtered and insoluble matter was removed. 260 g of toluene was added to this filtrate, and after washing with 300 g of water, the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 90:10 (volume ratio)) to obtain 34.4 g of allyl palmitate (PAEs) as a white solid.

1H NMR(400MHz,CDCl3):δ=5.96~5.89(m,1H),5.34~5.22(m,2H),4.59~4.57(m,2H),2.33(t,J=7.6Hz,2H),1.65~1.61(m,2H),1.32~1.25(m,24H),0.88(t,J=6.8Hz,3H)(ppm) 1 H NMR (400MHz, CDCl 3 ): δ=5.96~5.89(m,1H),5.34~5.22(m,2H),4.59~4.57(m,2H),2.33(t,J=7.6Hz,2H) ,1.65~1.61(m,2H),1.32~1.25(m,24H),0.88(t,J=6.8Hz,3H)(ppm)

GC-MS(CI):m/z=297(M+1)GC-MS(CI): m/z=297(M+1)

반응플라스크에, 상기 PAEs 34.1g(115mmol) 및 클로로포름 440g을 투입하였다. 이 용액에, mCPBA 56.6g(정미 230mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 4일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 300mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=90:10(체적비))로 정제함으로써, 목적물인 팔미트산글리시딜(PGEs) 29.8g을 백색고체로서 얻었다. 얻어진 PGEs의, 융점은 47℃, 에폭시당량은 309이었다.Into the reaction flask, 34.1 g (115 mmol) of the PAEs and 440 g of chloroform were added. To this solution, 56.6 g (230 mmol of net rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 4 days. To this reaction solution, 300 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 90:10 (volume ratio)) to obtain 29.8 g of the target product, glycidyl palmitate (PGEs), as a white solid. The obtained PGEs had a melting point of 47°C and an epoxy equivalent weight of 309.

1H NMR(400MHz,CDCl3):δ=4.44~4.40(m,1H),3.94~3.89(m,1H),3.23~3.19(m,1H),2.86~2.84(m,1H),2.66~2.64(m,1H),2.35(t,J=7.6Hz,2H),1.66~1.62(m,2H),1.33~1.25(m,24H),0.90~0.86(m,3H)(ppm) 1 H NMR (400MHz, CDCl 3 ): δ=4.44~4.40(m,1H),3.94~3.89(m,1H),3.23~3.19(m,1H),2.86~2.84(m,1H),2.66~ 2.64(m,1H),2.35(t,J=7.6Hz,2H),1.66~1.62(m,2H),1.33~1.25(m,24H),0.90~0.86(m,3H)(ppm)

GC-MS(CI):m/z=313(M+1)GC-MS(CI): m/z=313(M+1)

[합성예 4] 14-메틸펜타데칸산글리시딜(ωIPGEs)의 제조[Synthesis Example 4] Preparation of 14-methylpentadecanoic acid glycidyl (ωIPGEs)

반응플라스크에, ωIPA 295mg(1.2mmol), AllBr 167mg(1.4mmol), 탄산칼륨 191mg(1.4mmol) 및 NMP 5g을 투입하였다. 이것을 70℃에서 4시간 교반하였다. 반응액을 여과하고, 불용물을 제거하였다. 이 여액에 톨루엔 26g을 첨가하고, 물 30g으로 세정한 후, 용매를 유거함으로써, 14-메틸펜타데칸산알릴(ωIPAEs)의 조물을 얻었다.Into the reaction flask, 295 mg (1.2 mmol) of ωIPA, 167 mg (1.4 mmol) of AllBr, 191 mg (1.4 mmol) of potassium carbonate, and 5 g of NMP were added. This was stirred at 70°C for 4 hours. The reaction solution was filtered and insoluble matter was removed. 26 g of toluene was added to this filtrate, washed with 30 g of water, and the solvent was distilled off to obtain a crude product of allyl 14-methylpentadecanoate (ωIPAEs).

얻어진 조물을, 클로로포름 7g에 용해시켰다. 이 용액에, mCPBA 536mg(정미 2.2mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 2일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 10mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 목적물인 14-메틸펜타데칸산글리시딜(ωIPGEs) 258mg을 백색고체로서 얻었다. 얻어진 ωIPGEs의, 융점은 39℃, 에폭시당량은 316이었다.The obtained crude product was dissolved in 7 g of chloroform. To this solution, 536 mg (2.2 mmol of net rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 2 days. To this reaction solution, 10 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 258 mg of the target product, glycidyl 14-methylpentadecanoate (ωIPGEs), as a white solid. The obtained ωIPGEs had a melting point of 39°C and an epoxy equivalent weight of 316.

1H NMR(400MHz,CDCl3):δ=4.44~4.40(m,1H),3.93~3.89(m,1H),3.23~3.19(m,1H),2.86~2.84(m,1H),2.66~2.64(m,1H),2.37~2.33(m,2H),1.65~1.14(m,23H),0.87~0.85(m,6H)(ppm) 1 H NMR (400MHz, CDCl 3 ): δ=4.44~4.40(m,1H),3.93~3.89(m,1H),3.23~3.19(m,1H),2.86~2.84(m,1H),2.66~ 2.64(m,1H),2.37~2.33(m,2H),1.65~1.14(m,23H),0.87~0.85(m,6H)(ppm)

GC-MS(CI):m/z=313(M+1)GC-MS(CI): m/z=313(M+1)

[합성예 5] 16-메틸헵타데칸산글리시딜(ωISGEs)의 제조[Synthesis Example 5] Preparation of 16-methylheptadecanoic acid glycidyl (ωISGEs)

반응플라스크에, ωISA 275mg(1.0mmol), AllBr 140mg(1.2mmol), 탄산칼륨 160mg(1.2mmol) 및 NMP 5g을 투입하였다. 이것을 70℃에서 2시간 교반하였다. 반응액을 여과하고, 불용물을 제거하였다. 이 여액에 톨루엔 26g을 첨가하고, 물 30g으로 세정한 후, 용매를 유거함으로써, 14-메틸펜타데칸산알릴(ωISAEs)의 조물을 얻었다.Into the reaction flask, 275 mg (1.0 mmol) of ωISA, 140 mg (1.2 mmol) of AllBr, 160 mg (1.2 mmol) of potassium carbonate, and 5 g of NMP were added. This was stirred at 70°C for 2 hours. The reaction solution was filtered and insoluble matter was removed. 26 g of toluene was added to this filtrate, washed with 30 g of water, and the solvent was distilled off to obtain a crude product of 14-methylpentadecanoate allyl (ωISAEs).

얻어진 조물을, 클로로포름 7g에 용해시켰다. 이 용액에, mCPBA 861mg(정미 3.5mmol)을 교반하면서 첨가하고, 실온(대략 23℃)에서 2일간 교반하였다. 이 반응액에, 10질량% 티오황산나트륨수용액 10mL를 첨가하여 mCPBA를 분해하였다. 이 유기층을, 5질량% 중조수용액 및 물로 세정한 후, 용매를 유거하였다. 얻어진 잔사를, 실리카겔크로마토그래피(헥산:아세트산에틸=95:5(체적비))로 정제함으로써, 목적물인 16-메틸헵타데칸산글리시딜(ωISGEs) 235mg을 백색고체로서 얻었다. 얻어진 ωISGEs의, 융점은 47℃, 에폭시당량은 334였다.The obtained crude product was dissolved in 7 g of chloroform. To this solution, 861 mg (3.5 mmol of pure rice) was added while stirring, and stirred at room temperature (approximately 23°C) for 2 days. To this reaction solution, 10 mL of 10 mass% sodium thiosulfate aqueous solution was added to decompose mCPBA. This organic layer was washed with a 5% by mass aqueous sodium bicarbonate solution and water, and then the solvent was distilled off. The obtained residue was purified by silica gel chromatography (hexane:ethyl acetate = 95:5 (volume ratio)) to obtain 235 mg of the target product, glycidyl 16-methylheptadecanoate (ωISGEs), as a white solid. The melting point of the obtained ωISGEs was 47°C and the epoxy equivalent weight was 334.

1H NMR(400MHz,CDCl3):δ=4.44~4.40(m,1H),3.94~3.89(m,1H),3.22~3.20(m,1H),2.86~2.84(m,1H),2.66~2.64(m,1H),2.37~2.33(m,2H),1.65~1.14(m,27H),0.87~0.85(m,6H)(ppm) 1 H NMR (400MHz, CDCl 3 ): δ=4.44~4.40(m,1H),3.94~3.89(m,1H),3.22~3.20(m,1H),2.86~2.84(m,1H),2.66~ 2.64(m,1H),2.37~2.33(m,2H),1.65~1.14(m,27H),0.87~0.85(m,6H)(ppm)

GC-MS(CI):m/z=341(M+1)GC-MS(CI): m/z=341(M+1)

[실시예 9, 비교예 1] 비스A형 에폭시 수지와의 상용성 및 휘발성[Example 9, Comparative Example 1] Compatibility and volatility with Bis-A type epoxy resin

표 1에 기재된 각 에폭시 화합물(반응성 희석제)에 대하여, 비스페놀A형 에폭시 수지인 BPA와의 상용성(相溶性)을 평가하였다.For each epoxy compound (reactive diluent) listed in Table 1, compatibility with BPA, a bisphenol A type epoxy resin, was evaluated.

각 에폭시 화합물을, 그 농도가 10질량%가 되도록 BPA와 혼합하고, 에폭시 수지 조성물을 조제하였다. 이것을 실온(대략 23℃)에서 5분간 교반한 후, 육안으로 혼합상태를 확인하고, 이하의 기준에 따라서 평가하였다. 또한, 상용한 것에 대해서는, 이 조성물의 25℃에 있어서의 점도를 측정하였다. 결과를 표 1에 함께 나타낸다.Each epoxy compound was mixed with BPA so that the concentration was 10% by mass, and an epoxy resin composition was prepared. After stirring this for 5 minutes at room temperature (approximately 23°C), the mixing state was visually confirmed and evaluated according to the following standards. Additionally, for commercially available products, the viscosity of this composition at 25°C was measured. The results are shown together in Table 1.

나아가, 휘발성의 평가로서, 각 에폭시 화합물의 5% 중량감소온도(Td5%)를 표 1에 함께 나타낸다.Furthermore, as an evaluation of volatility, the 5% weight loss temperature (Td 5% ) of each epoxy compound is shown in Table 1.

[상용성 평가기준][Commercial evaluation criteria]

A: 균일하게 상용하여 투명A: Transparent by uniformly mixing

B: 약간 백탁되어 있음B: Slightly cloudy

C: 불용물이 있고 고액이 분리되어 있음C: Insoluble matter is present and solid and liquid are separated.

[표 1][Table 1]

Figure 112018040298624-pct00010
Figure 112018040298624-pct00010

표 1에 나타낸 바와 같이, 본 발명에 이용하는 에폭시 화합물(반응성 희석제)은, 범용의 에폭시 수지인 BPA에 대하여 상용하였다. 또한, BPA가 약 12,000mPa·s의 점도를 갖는 것에 반해, BPA에 에폭시 화합물을 10질량%가 되도록 혼합한 본 발명의 수지 조성물은, 그 점도가 2,000~6,200mPa·s까지 저하되었다. 또한, 본 발명에 이용하는 에폭시 화합물은, 5% 중량감소온도가 매우 높고, 저휘발성인 것이 확인되었다.As shown in Table 1, the epoxy compound (reactive diluent) used in the present invention was compatible with BPA, a general-purpose epoxy resin. In addition, while BPA has a viscosity of about 12,000 mPa·s, the resin composition of the present invention, in which BPA is mixed with an epoxy compound at 10% by mass, has a viscosity lowered to 2,000 to 6,200 mPa·s. Additionally, it was confirmed that the epoxy compound used in the present invention has a very high 5% weight loss temperature and low volatility.

한편, -CR1R2R3기의 탄소원자수가 동일 정도여도, R1 및 R2가 각각 탄소원자수 2 이상의 알킬기는 아닌 에폭시 화합물은, BPA에 대하여 상용되지 않았다. 또한, R1 및 R2가 각각 탄소원자수 2 이상인 알킬기여도, -CR1R2R3기의 탄소원자수가 7인 에폭시 화합물은, 5% 중량감소온도가 매우 낮고 휘발성이 높았다.On the other hand, even if the number of carbon atoms of the -CR 1 R 2 R 3 group is the same, epoxy compounds in which R 1 and R 2 are not each alkyl groups with 2 or more carbon atoms are not compatible with BPA. In addition, the epoxy compound in which R 1 and R 2 each have an alkyl contribution of 2 or more carbon atoms and the -CR 1 R 2 R 3 group has 7 carbon atoms had a very low 5% weight loss temperature and high volatility.

이상으로부터, 본 발명에 이용하는 에폭시 화합물이 우수한 반응성 희석제로서 사용할 수 있는 것이 시사되었다.From the above, it was suggested that the epoxy compound used in the present invention can be used as an excellent reactive diluent.

[실시예 10~17, 비교예 2~4] 경화물의 제작[Examples 10 to 17, Comparative Examples 2 to 4] Production of cured product

표 2에 기재된 에폭시 수지 조성물 100질량부에, 경화제로서 MH700을 에폭시 화합물의 에폭시기와 등몰량, 및 경화촉진제로서 PX4ET 1질량부를 첨가하였다. 이 혼합물을, 감압하, 실온(대략 23℃)에서 30분간 교반함으로써 탈포하고, 경화성 조성물 1 내지 11을 조제하였다.To 100 parts by mass of the epoxy resin composition shown in Table 2, MH700 as a curing agent was added in an equimolar amount to the epoxy group of the epoxy compound, and 1 part by mass of PX4ET as a curing accelerator was added. This mixture was degassed by stirring at room temperature (approximately 23°C) for 30 minutes under reduced pressure to prepare curable compositions 1 to 11.

각 조성물을, 두께 3mm의 U자형(コ 字型)의 실리콘고무제 스페이서와 함께, 미리 옵툴(등록상표) DSX[다이킨공업(주)제]로 이형처리한 유리기판 2매로 끼워넣었다. 이것을, 100℃의 오븐에서 2시간 가열(예비경화)하고, 그 후 150℃까지 승온하여 5시간 가열(본 경화)하였다. 서랭한 후, 유리기판을 제거하여, 두께 3mm의 각 경화물을 얻었다.Each composition was sandwiched between two glass substrates previously subjected to release treatment with Optool (registered trademark) DSX (manufactured by Daikin Kogyo Co., Ltd.) along with a U-shaped silicone rubber spacer with a thickness of 3 mm. This was heated in an oven at 100°C for 2 hours (pre-curing), and then the temperature was raised to 150°C and heated for 5 hours (main curing). After slow cooling, the glass substrate was removed to obtain each cured product with a thickness of 3 mm.

얻어진 경화물에 대하여, 흡수율, 비유전율 및 유리전이점(Tg)을 평가하였다. 한편, 각 물성값은 이하의 순서로 측정하였다. 결과를 표 2에 함께 나타낸다.The obtained cured product was evaluated for water absorption, relative dielectric constant, and glass transition point (Tg). Meanwhile, each physical property value was measured in the following order. The results are shown together in Table 2.

[흡수율][Absorption rate]

JIS K-6911:2006에 준하여 측정하였다. 구체적으로는, 우선, 전처리로서, 오일배스에서 50℃로 유지한 유리용기 중에서 시험편을 24시간 건조하였다. 이 시험편을 데시케이터내에서 20℃까지 냉각하고, 그 질량(W1[g])을 잰다. 이어서, 이 시험편을 비등한 증류수 중에 100시간 침지하고 나서 취출하고, 20℃의 유수 중에서 30분간 냉각하여 수분을 닦아낸 후, 즉시 흡수후의 질량(W2[g])을 쟀다. 이들 값으로부터, 이하의 식에 의해 흡수율을 산출하였다.Measurement was made according to JIS K-6911:2006. Specifically, first, as a pretreatment, the test piece was dried in a glass container maintained at 50°C in an oil bath for 24 hours. This test piece is cooled to 20°C in a desiccator, and its mass (W 1 [g]) is measured. Next, this test piece was immersed in boiled distilled water for 100 hours, then taken out, cooled in running water at 20°C for 30 minutes, the moisture was wiped off, and the mass after absorption (W 2 [g]) was immediately measured. From these values, the water absorption rate was calculated using the following equation.

흡수율[%]=(W2-W1)÷W1×100Absorption rate [%]=(W 2 -W 1 )÷W 1 ×100

[비유전율][relative permittivity]

홀더의 전극간에 끼워넣은 시험편에, 1V, 1MHz의 전압을 인가했을 때의 정전용량Cp을 측정하고, 동일조건으로 측정한 공기의 정전용량C0으로 나누어, 비유전율εr을 산출하였다. 또한, 반응성 희석제를 첨가하지 않은 조성물로부터 얻어진 경화물의 비유전율εr0에 대한 저감율을, 이하의 식에 의해 산출하였다.The capacitance Cp when a voltage of 1 V, 1 MHz was applied to the test piece sandwiched between the electrodes of the holder was measured, and divided by the capacitance C 0 of air measured under the same conditions to calculate the relative dielectric constant ε r . In addition, the reduction rate with respect to the relative dielectric constant ε r0 of the cured product obtained from the composition to which no reactive diluent was added was calculated using the following equation.

저감율[%]=(εr0r)÷εr0×100Reduction rate [%]=(ε r0r )÷ε r0 ×100

[유리전이점][Glass transition point]

시험편의 TMA를 측정하고, 얻어진 TMA곡선의 전후의 곡선에 접선을 긋고, 이 접선의 교점으로부터 Tg를 구했다.The TMA of the test piece was measured, a tangent line was drawn on the curve before and after the obtained TMA curve, and Tg was determined from the intersection of the tangent lines.

[표 2][Table 2]

Figure 112018040298624-pct00011
Figure 112018040298624-pct00011

표 2에 나타낸 바와 같이, 본 발명의 에폭시 수지 조성물(실시예 10~17)은, 반응성 희석제를 포함하지 않는 경우(비교예 4)에 비해, 대폭 비유전율이 저감된 것이 확인되었다. 한편, 종래 공지의 반응성 희석제를 포함하는 에폭시 수지 조성물은, 비유전율의 저감율이 낮았다(비교예 2, 3).As shown in Table 2, it was confirmed that the relative dielectric constant of the epoxy resin composition of the present invention (Examples 10 to 17) was significantly reduced compared to the case where the reactive diluent was not contained (Comparative Example 4). On the other hand, the epoxy resin composition containing a conventionally known reactive diluent had a low reduction rate in relative dielectric constant (Comparative Examples 2 and 3).

[실시예 18~21, 비교예 5] 경화물의 제작[Examples 18-21, Comparative Example 5] Production of cured product

표 3에 기재된 에폭시 수지 조성물 100질량부에, 경화제로서 MH700을 에폭시 화합물의 에폭시기와 등몰량을 첨가하였다. 이 혼합물을, 90℃에서 30분간 교반하여 혼합한 후, 실온(대략 23℃)까지 냉각하였다. 여기에 경화촉진제로서 PX4ET 1질량부를 첨가하였다. 이 혼합물을, 실온(대략 23℃)에서 5분간 교반함으로써 탈포하고, 경화성 조성물 12 내지 16을 조제하였다.To 100 parts by mass of the epoxy resin composition shown in Table 3, MH700 was added as a curing agent in an equimolar amount to the epoxy group of the epoxy compound. This mixture was mixed by stirring at 90°C for 30 minutes and then cooled to room temperature (approximately 23°C). 1 part by mass of PX4ET was added here as a curing accelerator. This mixture was degassed by stirring at room temperature (approximately 23°C) for 5 minutes to prepare curable compositions 12 to 16.

얻어진 각 조성물을 사용한 것 이외는 실시예 10과 동일한 방법으로, 두께 3mm의 경화물을 제작하고, 평가하였다. 결과를 표 3에 함께 나타낸다.A cured product with a thickness of 3 mm was produced and evaluated in the same manner as in Example 10, except that each of the obtained compositions was used. The results are shown together in Table 3.

[표 3][Table 3]

Figure 112018040298624-pct00012
Figure 112018040298624-pct00012

표 3에 나타낸 바와 같이, 본 발명의 에폭시 수지 조성물(실시예 18~21)은, 반응성 희석제를 포함하지 않는 경우(비교예 5)에 비해, 대폭 비유전율 및 흡수율이 저감된 것이 확인되었다.As shown in Table 3, it was confirmed that the relative dielectric constant and water absorption were significantly reduced in the epoxy resin composition of the present invention (Examples 18 to 21) compared to the case that did not contain a reactive diluent (Comparative Example 5).

[실시예 22, 23, 비교예 6~8] 열양이온경화물의 제작[Examples 22, 23, Comparative Examples 6 to 8] Production of thermal cation cured product

표 4에 기재된 에폭시 수지 조성물 100질량부에, 열산발생제로서 미리 탄산프로필렌 1질량부에 용해시킨 SI100 1질량부를 첨가하였다. 이 혼합물을, 교반탈포(2,000rpm, 4분간, 다시 1,000rpm, 4분간)하고, 경화성 조성물 17 내지 21을 조제하였다.To 100 parts by mass of the epoxy resin composition shown in Table 4, 1 part by mass of SI100 previously dissolved in 1 part by mass of propylene carbonate as a thermal acid generator was added. This mixture was stirred and degassed (2,000 rpm for 4 minutes, then again at 1,000 rpm for 4 minutes) to prepare curable compositions 17 to 21.

각 조성물을, 두께 200μm의 실리콘고무제 스페이서와 함께, 미리 옵툴(등록상표) DSX[다이킨공업(주)제]로 이형처리한 유리기판 2매로 끼워넣었다. 이것을, 100℃의 핫플레이트에서 1시간 가열(예비경화)하고, 그 후 150℃까지 승온하여 1시간 가열(본 경화)하였다. 서랭한 후, 유리기판을 제거하여, 두께 200μm의 각 경화물을 얻었다.Each composition was sandwiched between two glass substrates previously subjected to release treatment with Optool (registered trademark) DSX (manufactured by Daikin Kogyo Co., Ltd.) along with a 200-μm-thick silicone rubber spacer. This was heated on a hot plate at 100°C for 1 hour (pre-curing), and then the temperature was raised to 150°C and heated for 1 hour (main curing). After slow cooling, the glass substrate was removed to obtain each cured product with a thickness of 200 μm.

얻어진 경화물에 대하여, 실시예 10과 동일한 방법으로 비유전율을 평가하였다. 결과를 표 4에 함께 나타낸다.The relative dielectric constant of the obtained cured product was evaluated in the same manner as in Example 10. The results are shown together in Table 4.

[표 4][Table 4]

Figure 112018040298624-pct00013
Figure 112018040298624-pct00013

표 4에 나타낸 바와 같이, 본 발명의 에폭시 수지 조성물(실시예 22, 23)은, 반응성 희석제를 포함하지 않는 경우(비교예 8)에 비해, 대폭 비유전율이 저감되는 것이 확인되었다. 한편, 종래 공지의 반응성 희석제를 포함하는 에폭시 수지 조성물은, 비유전율의 저감율이 낮았다(비교예 6, 7).As shown in Table 4, it was confirmed that the relative dielectric constant of the epoxy resin composition of the present invention (Examples 22 and 23) was significantly reduced compared to the case where the reactive diluent was not contained (Comparative Example 8). On the other hand, the epoxy resin composition containing a conventionally known reactive diluent had a low reduction rate in relative dielectric constant (Comparative Examples 6 and 7).

[실시예 24, 25, 비교예 9~11] 광양이온 경화물의 제작[Examples 24, 25, Comparative Examples 9 to 11] Production of photocationic cured product

표 5에 기재된 에폭시 수지 조성물 100질량부에, 광산발생제로서 C101A 1질량부(유효성분환산)를 첨가하였다. 이 혼합물을, 교반탈포(2,000rpm, 4분간, 다시 1,000rpm, 4분간)하고, 경화성 조성물 22 내지 26을 조제하였다.To 100 parts by mass of the epoxy resin composition shown in Table 5, 1 part by mass of C101A (effective ingredient conversion) was added as a photoacid generator. This mixture was stirred and degassed (2,000 rpm for 4 minutes, then 1,000 rpm for 4 minutes) to prepare curable compositions 22 to 26.

각 조성물을, 두께 200μm의 실리콘고무제 스페이서와 함께, 미리 옵툴(등록상표) DSX[다이킨공업(주)제]로 이형처리한 석영유리기판 2매로 끼워넣었다. 이 끼워넣은 조성물을, 공기분위기하, 조도 20mW/cm2(파장 365nm)로 150초간 UV노광하고, 다시 100℃의 핫플레이트에서 1시간 가열(포스트큐어)하였다. 서랭한 후, 석영유리기판을 제거하여, 두께 200μm의 각 경화물을 얻었다.Each composition was sandwiched between two quartz glass substrates previously subjected to release treatment with Optool (registered trademark) DSX (manufactured by Daikin Kogyo Co., Ltd.) along with a 200-μm-thick silicone rubber spacer. This embedded composition was exposed to UV light for 150 seconds at an illuminance of 20 mW/cm 2 (wavelength 365 nm) in an air atmosphere, and then heated on a hot plate at 100°C for 1 hour (post-cure). After slow cooling, the quartz glass substrate was removed to obtain each cured product with a thickness of 200 μm.

얻어진 경화물에 대하여, 실시예 10과 동일한 방법으로 비유전율을 평가하였다. 결과를 표 5에 함께 나타낸다.The relative dielectric constant of the obtained cured product was evaluated in the same manner as in Example 10. The results are shown together in Table 5.

[표 5][Table 5]

Figure 112018040298624-pct00014
Figure 112018040298624-pct00014

표 5에 나타낸 바와 같이, 본 발명의 에폭시 수지 조성물(실시예 24, 25)은, 반응성 희석제를 포함하지 않는 경우(비교예 11)에 비해, 대폭 비유전율이 저감되는 것이 확인되었다. 한편, 종래 공지의 반응성 희석제를 포함하는 에폭시 수지 조성물은, 비유전율의 저감율이 낮았다(비교예 9, 10).As shown in Table 5, it was confirmed that the relative dielectric constant of the epoxy resin composition of the present invention (Examples 24 and 25) was significantly reduced compared to the case where the reactive diluent was not contained (Comparative Example 11). On the other hand, the epoxy resin composition containing a conventionally known reactive diluent had a low reduction rate in relative dielectric constant (Comparative Examples 9 and 10).

[참고예 1~3] 반응성 평가[Reference Examples 1 to 3] Reactivity evaluation

ISGEs, ISECHEs 및 ISGE에 대하여, 표 6에 기재한 양의 2EHA 및 자일렌을 혼합하고, 140℃에서 8시간 교반하였다. 각 반응혼합물의 에폭시기의 전화율을 GC에 의해 측정하였다. 결과를 표 6에 나타낸다.For ISGEs, ISECHEs and ISGE, the amounts of 2EHA and xylene shown in Table 6 were mixed and stirred at 140°C for 8 hours. The conversion rate of the epoxy group in each reaction mixture was measured by GC. The results are shown in Table 6.

[표 6][Table 6]

Figure 112018040298624-pct00015
Figure 112018040298624-pct00015

표 6에 나타낸 바와 같이, 에폭시부위로는, 3,4-에폭시시클로헥실기(상기 식[3]으로 표시되는 기를 포함하는 경우)보다 에폭시에틸기(상기 식[2]로 표시되는 기를 포함하는 경우)가 보다 반응성이 높고(참고예 1, 2), 또한 상기 식[1]의 X로는, 에테르결합보다 에스테르결합이 반응성이 높은(참고예 1, 3) 것이 확인되었다.As shown in Table 6, the epoxy moiety is an epoxyethyl group (when it contains a group represented by the above formula [2]) rather than a 3,4-epoxycyclohexyl group (when it contains a group shown by the above formula [3]). ) is more reactive (Reference Examples 1 and 2), and it was confirmed that, as for

Claims (18)

식[1]로 표시되는 적어도 1종의 에폭시 화합물, 및 분자내에 적어도 2개의 에폭시기를 갖는 에폭시 수지를 포함하는 에폭시 수지 조성물.

(식 중, R1은 3,5,5-트리메틸헥실기를 나타내고, R2는 4,4-디메틸펜탄-2-일기를 나타내고, R3은 수소원자를 나타내고, X는, *-C(=O)O-를 나타내고(여기서 *는 -CR1R2R3기에 결합하는 단을 나타낸다.), L은 메틸렌기를 나타내고, E는 식[2]로 표시되는 기를 나타낸다.)

(식 중, R4 내지 R6은 수소원자를 나타낸다.)
An epoxy resin composition comprising at least one epoxy compound represented by formula [1] and an epoxy resin having at least two epoxy groups in the molecule.

(Wherein, R 1 represents a 3,5,5-trimethylhexyl group, R 2 represents a 4,4-dimethylpentan-2-yl group, R 3 represents a hydrogen atom, and =O)O- (where * represents a stage bonded to the -CR 1 R 2 R 3 group), L represents a methylene group, and E represents a group represented by formula [2].)

(In the formula, R 4 to R 6 represent a hydrogen atom.)
삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete (a)제1항에 기재된 에폭시 수지 조성물, 및 (b)경화제를 포함하는, 경화성 조성물.A curable composition comprising (a) the epoxy resin composition according to claim 1, and (b) a curing agent. 제8항에 있어서,
상기 (b)경화제가, 산무수물, 아민, 페놀 수지, 폴리아미드 수지, 이미다졸류, 및 폴리메르캅탄으로 이루어진 군으로부터 선택되는 적어도 1종인, 경화성 조성물.
According to clause 8,
A curable composition wherein the curing agent (b) is at least one selected from the group consisting of acid anhydrides, amines, phenol resins, polyamide resins, imidazoles, and polymercaptans.
제8항 또는 제9항에 있어서,
상기 (a)에폭시 수지 조성물의 에폭시기 1당량에 대하여, 0.5~1.5당량의 상기 (b)경화제를 포함하는, 경화성 조성물.
According to clause 8 or 9,
A curable composition comprising 0.5 to 1.5 equivalents of the curing agent (b) based on 1 equivalent of the epoxy group of the (a) epoxy resin composition.
(a)제1항에 기재된 에폭시 수지 조성물, 및 (c1)산발생제 및/또는 (c2)염기발생제로 이루어진 (c)경화촉매를 포함하는, 경화성 조성물.A curable composition comprising (a) the epoxy resin composition according to claim 1, and (c) a curing catalyst consisting of (c1) an acid generator and/or (c2) a base generator. 제11항에 있어서,
상기 (c)경화촉매가 (c1)산발생제인, 경화성 조성물.
According to clause 11,
A curable composition wherein the curing catalyst (c) is an acid generator (c1).
제12항에 있어서,
상기 (c1)산발생제가, 광산발생제, 및 열산발생제로 이루어진 군으로부터 선택되는 적어도 1종인, 경화성 조성물.
According to clause 12,
A curable composition wherein the (c1) acid generator is at least one selected from the group consisting of photoacid generators and thermal acid generators.
제13항에 있어서,
상기 (c1)산발생제가 오늄염인, 경화성 조성물.
According to clause 13,
A curable composition wherein the (c1) acid generator is an onium salt.
제14항에 있어서,
상기 (c1)산발생제가, 설포늄염, 또는 요오드늄염인, 경화성 조성물.
According to clause 14,
A curable composition wherein the (c1) acid generator is a sulfonium salt or an iodonium salt.
제12항 내지 제15항 중 어느 한 항에 있어서,
상기 (a)에폭시 수지 조성물 100질량부에 대하여, 상기 (c1)산발생제 0.1~20질량부를 포함하는, 경화성 조성물.
According to any one of claims 12 to 15,
A curable composition comprising 0.1 to 20 parts by mass of the acid generator (c1) based on 100 parts by mass of the epoxy resin composition (a).
식[1]로 표시되는 적어도 1종의 에폭시 화합물을 에폭시 수지 조성물에 있어서의 반응성 희석제로서 사용하는 방법.
Figure 112023102373870-pct00018

(식 중, R1은 3,5,5-트리메틸헥실기를 나타내고, R2는 4,4-디메틸펜탄-2-일기를 나타내고, R3은 수소원자를 나타내고, X는, *-C(=O)O-를 나타내고(여기서 *는 -CR1R2R3기에 결합하는 단을 나타낸다.), L은 메틸렌기를 나타내고, E는 식[2]로 표시되는 기를 나타낸다.)

(식 중, R4 내지 R6은 수소원자를 나타낸다.)
A method of using at least one type of epoxy compound represented by formula [1] as a reactive diluent in an epoxy resin composition.
Figure 112023102373870-pct00018

(Wherein, R 1 represents a 3,5,5-trimethylhexyl group, R 2 represents a 4,4-dimethylpentan-2-yl group, R 3 represents a hydrogen atom, and =O)O- (where * represents a stage bonded to the -CR 1 R 2 R 3 group), L represents a methylene group, and E represents a group represented by formula [2].)

(In the formula, R 4 to R 6 represent a hydrogen atom.)
식[1a]로 표시되는 에폭시 화합물.
Figure 112023102373870-pct00020

(식 중, R1은 3,5,5-트리메틸헥실기를 나타내고, R2는 4,4-디메틸펜탄-2-일기를 나타내고, R3은 수소원자를 나타내고, R4 내지 R6은 수소원자를 나타내고, L은 메틸렌기를 나타낸다.)
Epoxy compound represented by formula [1a].
Figure 112023102373870-pct00020

(Wherein, R 1 represents a 3,5,5-trimethylhexyl group, R 2 represents a 4,4-dimethylpentan-2-yl group, R 3 represents a hydrogen atom, and R 4 to R 6 represent hydrogen represents an atom, and L represents a methylene group.)
KR1020187011472A 2015-11-05 2016-10-17 Epoxy-based reactive diluent and epoxy resin composition containing the same KR102629442B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015217866 2015-11-05
JPJP-P-2015-217866 2015-11-05
PCT/JP2016/080701 WO2017077846A1 (en) 2015-11-05 2016-10-17 Epoxy-based reactive diluent and epoxy resin composition including same

Publications (2)

Publication Number Publication Date
KR20180080200A KR20180080200A (en) 2018-07-11
KR102629442B1 true KR102629442B1 (en) 2024-01-25

Family

ID=58662525

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187011472A KR102629442B1 (en) 2015-11-05 2016-10-17 Epoxy-based reactive diluent and epoxy resin composition containing the same

Country Status (5)

Country Link
JP (1) JP6823294B2 (en)
KR (1) KR102629442B1 (en)
CN (1) CN108350252B (en)
TW (1) TWI722027B (en)
WO (1) WO2017077846A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190140474A (en) * 2017-05-09 2019-12-19 닛산 가가쿠 가부시키가이샤 Method of producing epoxy compound
TWI647265B (en) * 2018-02-05 2019-01-11 Taiwan Union Technology Corporation Resin composition, and prepreg, metal foil laminate, and printed circuit board prepared using the same
KR102253501B1 (en) * 2018-09-28 2021-05-18 주식회사 엘지화학 Encapsulating composition
JP7241389B2 (en) * 2019-02-21 2023-03-17 ナミックス株式会社 Liquid epoxy resin composition and cured product obtained by curing it
JP7421297B2 (en) * 2019-09-26 2024-01-24 積水化学工業株式会社 Photocurable resin composition for electronic devices
KR102110817B1 (en) * 2020-02-12 2020-05-13 주식회사다원시스템 Water tank with excellent corrosion and thermal resistance
JPWO2021261071A1 (en) * 2020-06-22 2021-12-30
CN117355557A (en) * 2021-05-24 2024-01-05 东丽精细化工株式会社 Polymer composition, epoxy resin composition, curing agent for epoxy resin, and quick-setting adhesive

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002526484A (en) 1998-09-23 2002-08-20 レゾリューション・リサーチ・ネーデルランド・ベー・ウィ Process for producing glycidyl ester of branched carboxylic acid
JP2006193745A (en) 2005-01-14 2006-07-27 Xerox Corp Radiation curing ink containing curative gelling additive
JP2006232888A (en) 2005-02-22 2006-09-07 Konica Minolta Medical & Graphic Inc Active radiation-curing composition, active radiation-curing ink, image-forming method using the same and inkjet recording apparatus
WO2012128325A1 (en) * 2011-03-23 2012-09-27 日産化学工業株式会社 Polyfunctional epoxy compound
JP2014047144A (en) * 2012-08-30 2014-03-17 Daicel Corp Alicyclic epoxy compound and method for producing the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6026087B2 (en) * 1978-06-15 1985-06-21 カネボウ株式会社 cosmetics
JPS603392B2 (en) * 1980-02-01 1985-01-28 花王株式会社 Manufacturing method of glycidyl ether
JP2744280B2 (en) * 1989-03-15 1998-04-28 株式会社クラレ Nitrogen-containing hydroxy ethers and cerebral function improving agents containing the same as active ingredients
JPH03169873A (en) * 1989-11-28 1991-07-23 Idemitsu Petrochem Co Ltd Production of aliphatic tertiary carboxylic acid glycidyl ester
JPH04314797A (en) * 1991-04-12 1992-11-05 Nippon Oil & Fats Co Ltd Ester composition
JP2002293755A (en) 2001-03-30 2002-10-09 Yokkaichi Chem Co Ltd METHOD FOR PRODUCING beta-ALKYLHALOHYDRIN ETHER
CN102408396B (en) * 2010-09-26 2014-09-10 西南化工研究设计院 Method for preparing versatate glycidyl
JP5469194B2 (en) 2011-05-02 2014-04-09 日東電工株式会社 Adhesive, adhesive layer, and adhesive sheet

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002526484A (en) 1998-09-23 2002-08-20 レゾリューション・リサーチ・ネーデルランド・ベー・ウィ Process for producing glycidyl ester of branched carboxylic acid
JP2006193745A (en) 2005-01-14 2006-07-27 Xerox Corp Radiation curing ink containing curative gelling additive
JP2006232888A (en) 2005-02-22 2006-09-07 Konica Minolta Medical & Graphic Inc Active radiation-curing composition, active radiation-curing ink, image-forming method using the same and inkjet recording apparatus
WO2012128325A1 (en) * 2011-03-23 2012-09-27 日産化学工業株式会社 Polyfunctional epoxy compound
JP2014047144A (en) * 2012-08-30 2014-03-17 Daicel Corp Alicyclic epoxy compound and method for producing the same

Also Published As

Publication number Publication date
CN108350252B (en) 2021-04-09
WO2017077846A1 (en) 2017-05-11
JPWO2017077846A1 (en) 2018-08-23
KR20180080200A (en) 2018-07-11
CN108350252A (en) 2018-07-31
TW201731830A (en) 2017-09-16
TWI722027B (en) 2021-03-21
JP6823294B2 (en) 2021-02-03

Similar Documents

Publication Publication Date Title
KR102629442B1 (en) Epoxy-based reactive diluent and epoxy resin composition containing the same
KR102629458B1 (en) Multifunctional epoxy compound and curable composition containing the same
JP6949821B2 (en) Curable composition and cured product obtained by curing the curable composition
JP6931199B2 (en) Epoxy resin composition containing a long chain alkylene group
KR101926076B1 (en) Polyfunctional epoxy compound
KR20120127459A (en) Long-chain alkylene-containing curable epoxy resin composition
JP6893921B2 (en) Epoxy compounds, curable compositions containing them, and cured products obtained by curing curable compositions.
KR101886060B1 (en) Polyfunctional epoxy compound
CN109843965B (en) Epoxy resin composition for forming printed wiring board
JP6954898B2 (en) Epoxy compounds, curable compositions containing them, and cured products obtained by curing curable compositions.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant